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Abstract 
The purpose of this study was to prepare concentrated and stable gold colloids for the 
enhancement of the signal response of the SPR technique for detecting small 
molecules such as progesterone. The gold colloids developed in this study were 
prepared by hydrazine hydrate, sodium borohydride, and tri-potassium citrate 
reduction routes. The study revealed that the sodium borohydride reduced gold 
colloids were extremely stable and it was able to be utilised in the progesterone 
immunoassay developed previously by Mitchell et al. The experiment was carried out 
on BIAcore 3000 using two different sensor surfaces (CM5 and SAM). The results 
showed that the enhancement species prepared from the borohydride-reduced gold 
colloids were able to improve the SPR signal response by 13 times higher than SPR 
signal produced without the enhancement species on the CM5 surface. The signal 
enhancement on the SAM surface using the same enhancement species was even 
greater at 29 times higher. The sensitivity of the assay was, however, unable to be 
determined due to time constraint. The limit of detection (LOD) of the progesterone 
assay using the CM5 chip was estimated to be ca. 5-20 pg/mL. Whilst for the SAM 
chip, the LOD of the progesterone assay was estimated to be ca. 5-20 fg/mL. Further 
work is required to confirm these estimated LOD values. 
 ii 
Acknowledgements 
This study have not been possible without the continued guidance and support of my 
supervisors Dr. Michael Mucalo (University of Waikato) and Dr. Yinqiu Wu 
(HortResearch, Ruakura). I am also very grateful for the advice and recommendations 
given by Jing Yuan (HortResearch, Ruakura) during the course of this project. 
 
I would also like to show my appreciation to the people at University of Waikato who 
assisted me during this study and supported me until the end of the project. 
 
Prof. Brian Nicholson for the encouragement given during the first year of this study. 
Wendy Jackson, Pat Gread, Jannine Rhodes, Annie Barker, and Amu Upreti for 
their assistance with various laboratory related issues during the two years. 
 
The continued support of my family and friends has been unprecedented during the 
study. 
 
Last but not least, the financial assistance from HortResearch at Ruakura, Hamilton 
was greatly appreciated. 
 
 
 iii
Table of Contents 
Abstract ......................................................................................................................i 
Acknowledgements................................................................................................... ii 
Table of Contents ..................................................................................................... iii 
List of Figures..........................................................................................................vii 
List of Tables ...........................................................................................................xv 
List of Terms and Abbreviations............................................................................xviii 
1. Introduction........................................................................................................1 
1.1 Definitions of Colloids, Sols, & Nanoparticles ........................................1 
1.2 Preparation of Colloidal Dispersions .......................................................2 
1.3 Important Properties of Colloids .............................................................4 
1.3.1 Brownian motion.........................................................................4 
1.3.2 Electrophoresis and electro-osmosis ............................................4 
1.3.3 Scattering of light ........................................................................5 
1.4 Colloidal Stability ...................................................................................7 
1.4.1 Electrical double layer .................................................................7 
1.4.2 Inter-particle attractive forces ......................................................9 
1.4.3 Inter-particle repulsive forces ....................................................11 
1.4.4 DLVO theory for explaining the interactions between colloidal 
particles ..................................................................................................12 
1.4.5 Aggregation of colloidal particles ..............................................14 
1.5 Application of Colloids .........................................................................15 
1.6 Gold Colloids........................................................................................16 
1.6.1 Introduction...............................................................................16 
 iv 
1.6.2 Some properties and applications of colloidal gold ....................17 
1.6.3 The use of gold colloids in biomolecular interaction analysis 
systems ..................................................................................................19 
1.7 Aim of the study ...................................................................................21 
2. Theory of Instrumental Techniques...................................................................23 
2.1 UV-Vis..................................................................................................23 
2.2 TEM .....................................................................................................25 
2.3 Zetasizer ...............................................................................................28 
2.3.1 Introduction...............................................................................28 
2.3.2 How size is measured on Zetasizer instrument...........................29 
2.3.3 Making a measurement..............................................................32 
2.4 BIAcore ................................................................................................34 
2.4.1 Introduction...............................................................................34 
2.4.2 Microfluidic Flow-cell system...................................................36 
2.4.3 Surface plasmon resonance (SPR) .............................................37 
2.4.4 Immobilisation of macromolecules............................................41 
2.4.5 Applications ..............................................................................42 
3. Preparation & Characterisation of Gold Nanoparticles......................................45 
3.1 Introduction ..........................................................................................45 
3.2 Materials...............................................................................................46 
3.3 Gold Nanoparticle Preparation ..............................................................47 
3.3.1 Gold colloids prepared by hydrazine reduction ..........................48 
3.3.2 Gold colloids prepared by sodium borohydride reduction ..........49 
3.3.3 Gold colloids prepared by tri-potassium citrate reduction ..........50 
3.4 Observations, characterisation, and general discussion on gold colloids 
prepared for this study ......................................................................................53 
 v 
3.4.1 Observations .............................................................................53 
3.4.2 pH measurement........................................................................55 
3.4.3 Characterisation of gold colloids by UV-Vis spectrophotometry 57 
3.4.4 Particle size measurements of gold colloids using TEM.............67 
3.4.5 Zetasizer size determination ......................................................73 
4. BIAcore Sensitivity Enhancement Using the Gold Colloids Generated from this 
Study........................................................................................................................86 
4.1 Introduction ..........................................................................................86 
4.2 Preparation of Buffer Solutions Used for Sensor Chip Preparation ........88 
4.2.1 Preparation of pH 4.0, 0.01 mol/L sodium acetate immobilisation 
buffer ..................................................................................................88 
4.2.2 Preparation of the pH 2.0, 0.01mol/L glycine regeneration buffer ..
 ..................................................................................................89 
4.3 Sensor Chip Preparation........................................................................89 
4.3.1 Preparation of the CM5 sensor chip ...........................................89 
4.3.2 Preparation of the Self-assembled Monolayer (SAM) sensor chip..
 ..................................................................................................94 
4.4 Progesterone-antibody analysis using BIAcore SPR technology............98 
4.4.1 Introduction...............................................................................98 
4.4.2 Preparation of Materials for Progesterone-antibody analysis....101 
4.4.3 Signal Enhancement Study Using SAb (IgG) and SAb-Au 
Conjugates..............................................................................................105 
4.5 Signal Enhancement Results & Discussions ........................................115 
4.5.1 Non-specific binding study......................................................115 
4.5.2 Enhancement effect of particle size & SAb-Au........................118 
4.5.3 Binding curves of the first CM5 sensor chip used ....................120 
 vi 
4.5.4 Binding curves of a newly prepared CM5 sensor chip .............127 
4.5.5 Binding curves for the SAM sensor chip..................................130 
4.6 Progesterone – mAb Competition Assay .............................................134 
4.6.1 Introduction.............................................................................134 
4.6.2 Sample preparation for progesterone-mAb competition assay..138 
4.6.3 Development of the progesterone-mAb competition assay using 
CM5 sensor chip.....................................................................................139 
4.6.4 Development of progesterone-mAb competition assay using SAM 
sensor chip..............................................................................................141 
4.7 Results & Discussion - Competition Assay..........................................142 
4.7.1 Competition assay using the CM5 sensor chip .........................142 
4.7.2 Competition assay using the SAM sensor chip.........................144 
5. Conclusions....................................................................................................147 
5.1 Recommendations for further study ....................................................150 
6. References......................................................................................................151 
Appendix A............................................................................................................156 
 vii 
List of Figures 
Figure 1.2-1 a plot of the nuclei concentration versus the extent of reaction 4
...........................................................................................................3 
Figure 1.4-2 DLVO theory describing the total potential energy of 
inter-particle interaction versus inter-particle distances. VT is the total 
potential energy of interaction between two approaching particles; VR 
is the potential energy of the repulsive force; VA is the potential energy 
of the attractive force; and VS is the potential energy arises from 
solvent layer adjacent to the particle surfaces 4. .................................13 
Figure 2.1-1 Optical diagram of Cary 100 UV-Visible spectrometer 58 ......23 
Figure 2.2-1 drawing which shows the different parts of the TEM column 32.
.........................................................................................................26 
Figure 2.2-2 TEM specimen rod. The sample (deposited on the copper grid) 
is inserted at the place on the rod indicated by the arrow and the 
sample grid is held in place by a spring clip 32. ..................................27 
Figure 2.3-1 Optical diagram of Zetasizer 3000HS 38 ................................29 
Figure 2.4-1 A BIAcore instrument ...........................................................35 
Figure 2.4-2 Formation of microfluidic flow-cells on the surface of a sensor 
chip (www.biacore.com) ...................................................................36 
Figure 2.4-3 The four flow-cells can be used independently (left) or in 
series (right) (www.biacore.com) ......................................................37 
Figure 2.4-4 Illustration of the modified sensor surface.............................38 
Figure 2.4-5 A diagram which shows how the instrument detects the change 
in SPR angle and produces a response signal 39 .................................39 
 viii
Figure 2.4-6 Illustration of the characteristic response signal of different 
types of interaction 39 ........................................................................40 
Figure 2.4-7 Sensorgram of a system involving a weak binding interaction, 
which does not require regeneration ..................................................41 
Figure 3.4-1 UV-Visible spectrum of 0.00072 mol/L KAuBr4 solution......58 
Figure 3.4-2 UV-Visible spectra of the three hydrazine hydrate reduced gold 
colloids .............................................................................................60 
Figure 3.4-3 UV-Visible spectra of the three sodium borohydride reduced 
gold colloids with 0.00144 mol/L KAuBr4 solution ...........................61 
Figure 3.4-4 UV-Visible spectra of 0.036 and 0.072 mol/L sodium 
borohydride reduced gold colloids with 0.00721 mol/L KAuBr4 
solution .............................................................................................63 
Figure 3.4-5 UV-Visible spectra of 0.007, 0.014, 0.029 mol/L tri-potassium 
citrate reduced gold colloids..............................................................65 
Figure 3.4-6 UV-Visible spectra of AG protected and unprotected gold 
colloids .............................................................................................66 
Figure 3.4-7 A Venturi used to transfer the gold colloids onto the TEM grids
.........................................................................................................68 
Figure 3.4-8 TEM images of AG-protected hydrazine-reduced gold colloids 
(using 0.00144 mol/L KAuBr4 solution and 0.007 mol/L hydrazine 
hydrate). Left image is a low magnification image showing 
aggregation of the gold particles. Right image is a high magnification 
image showing more clearly the morphology of the aggregated colloid 
particles ............................................................................................69 
Figure 3.4-9 The TEM image of AG-protected sodium borohydride reduced 
gold colloids (using 0.00721 mol/L KAuBr4 solution and 0.036 mol/L 
 ix
sodium borohydride) is shown on the left. The bar-graph on the right is 
the size distribution plot obtained from the TEM image ....................70 
Figure 3.4-10 The TEM image on the left is a AG-protected sodium 
borohydride reduced gold colloids (using 0.00721 mol/L KAuBr4 
solution and 0.072 mol/L sodium borohydride). The size distribution is 
shown in the graph on the right. ........................................................71 
Figure 3.4-11 TEM image of unprotected citrate reduced gold colloids 
prepared from 0.00144 mol/L KAuBr4 solution and 0.007 mol/L 
tri-potassium citrate. Flocculation clearly occurs between the colloidal 
particles. The size distribution of the sample is shown in the bar-graph 
on the right........................................................................................71 
Figure 3.4-12 TEM image (left) and size distribution (right) of 
arabinogalactan protected gold colloids (prepared from 0.00144 mol/L 
KAuBr4 solution, 0.007 mol/L tri-potassium citrate, and 5 g/L 
arabinogalactan). ...............................................................................72 
Figure 3.4-13 TEM image (left) and size distribution (right) of unprotected 
gold colloids prepared from 0.00144 mol/L KAuBr4 solution and 0.014 
mol/L tri-potassium citrate. With increased concentration of citrate 
used, , aggregation and particle coalescence were observed in this 
TEM image. In contrast, the TEM image of gold colloids generated 
from a lower concentration (0.007 mol/L) of citrate, featured the 
colloidal particles that had merely flocculated. ..................................72 
Figure 3.4-14 TEM image (left) and size distribution (right) of 
arabinogalactan protected gold colloids (prepared from 0.00144 mol/L 
KAuBr4 solution, 0.014 mol/L tri-potassium citrate, and 5 g/L 
arabinogalactan). The size distribution shows there were more 
 x 
larger-sized particles in this sample than the arabinogalactan protected 
gold colloids prepared using 0.007 mol/L citrate. ..............................73 
Figure 3.4-24 Correlation plot of particle sizes measured by TEM and 
Zetasizer ...........................................................................................85 
Figure 4.1-1 SPR Sensorgram illustrating how the analyte response is 
enhanced by accumulation of mass at the chip interface. 1) the binding 
of the ligand (monoclonal antibody) which gives rise to the “ligand 
response”. 2) the signal enhancement step which involves the binding 
between the enhancement species with the ligand. The accumulation of 
mass on the surface of the sensor chip gives rise to a much higher 
signal response. This is the “enhanced response”. 3) the regeneration 
step washes away the analyte and the enhancement species. The 
response is reduced back to the baseline so that the sensor surface is 
fully regenerated and ready for the next analysis. ..............................87 
Figure 4.3-1 Dextran layer on the gold sensor surface ...............................90 
Figure 4.3-2 Schematic diagram illustrating surface immobilisation with 
P4-PEG-OVA. 1. the carboxyl groups of the dextran layer is activated 
with EDC/NHS mixture; 2. a P-4-OVA conjugate was immobilised on 
one of the activated site on the dextran layer; 3. Deactivation of free 
activated carboxyl sites on the dextran layer. .....................................92 
Figure 4.3-3 Sensorgram of P4-PEG-OVA immobilisation on the CM5 chip. 
1) Surface activation with EDC/NHS. 2) 500 mg/mL P4-PEG-OVA 
immobilisation. 3) Surface deactivation with EAH. 4) four surface 
washes with pH 2.0, 0.01 mol/L glycine. The large increase in 
responses observed for 1) and 3) were caused by solvent effect (change 
in refractive index due to solvent) rather than binding on the sensor 
 xi
surface. A) Response (ca. 1050 RU) due to surface activation. B) 
Response (ca. 9200 RU) cuased by P4-PEG-OVA binding after the 
unbound P4-PEG-OVA was washed away. ........................................93 
Figure 4.3-4 Sensorgram showing the binding of 100 mg/mL mAb on the 
immobilised progesterone (CM5 chip) surface. The surface was 
regenerated with Regen Buffer 1. The spikes shown in the sensorgram 
were due to the solvent effect (change in refractive index due to Reg 
Buffer 1) rather than to any actual binding. .......................................94 
Figure 4.3-5 Sensorgram of the P4-PEG-OVA immobilisation on the SAM 
chip. 1) Surface activation with EDC/NHS. 2) 500 mg/mL 
P4-PEG-OVA immobilisation. 3) Surface deactivation with EAH. 4) 
three surface washes with pH 2.0, 0.01 mol/L glycine. The large 
increase in responses observed for 1) and 3) were caused by solvent 
effects (change in refractive index due to solvent) rather than binding 
on sensor surface...............................................................................96 
Figure 4.3-6 ensorgram showing the binding of 100 mg/mL mAb on the 
immobilised progesterone (SAM chip) surface. The surface was 
regenerated with Regen Buffer 1. The spikes shown in the sensorgram 
were due to solvent effects (change in refractive index due to Regen 
Buffer 1) rather than being caused by binding. ..................................97 
Figure 4.4-1 Sensorgram showing SAb-Au conjugate enhancement of the 
mAb response signal. 1) The mAb binding response (A). 2) SAb-Au 
conjugate binding on top of the surface-bound mAb inducing a higher 
response (B). 3) & 4) Regeneration of the sensor surface...................99 
Figure 4.4-2 Four key steps required for the development of the 
progesterone immunoassay .............................................................107 
 xii 
Figure 4.5-1 Sensorgrams of the non-specific binding study of SAb (IgG). 
The sensorgram shown in black was SAb (IgG) without the (0.3 mol/L 
NaCl + 1 mL/100 mL PEG + HBS) dilution buffer. The non-specific 
binding was ca.870 RU. SAb (IgG) with added dilution buffer (shown 
in red) showed significantly lower level (ca. 7 RU) of non-specific 
binding on the progesterone surface (CM5 chip). ............................116 
Figure 4.5-2 Response signals of SAb-Au conjugate (100 mg/mL) with 
different concentration of Au colloids (130806-1) at 5 mg/mL mAb 
concentration (each data point was averaged from the measurement of 
three replicates)...............................................................................121 
Figure 4.5-3 Response signals of SAb-Au conjugate (17.5 mg/mL) with 
different concentrations of Au colloids (130806-2) at 5 mg/mL mAb 
concentration (each data point was averaged from three replicate of 
measurements) ................................................................................121 
Figure 4.5-4 Binding curve of SAb-Au conjugate using borohydride 
reduced Au colloids (smaller particle size, ca. 10 nm). Signal responses 
were given rise by SAb-Au conjugate at different concentrations of 
SAb (IgG) at 5 mg/mL mAb. (each data point was averaged from three 
replicates of measurement)..............................................................122 
Figure 4.5-5 Binding curve of SAb-Au conjugate using borohydride 
reduced Au colloids (larger particle size, ca. 16 nm). Signal responses 
are due to the SAb-Au conjugate at different concentrations of SAb 
(IgG) at 5 mg/mL mAb (each data point was averaged from three 
replicates of measurement)..............................................................123 
Figure 4.5-6 Sensorgrams of signal enhancement using 100 mg/mL SAb-Au 
conjugate with 15 and 25 mg/mL mAb ............................................124 
 xiii
Figure 4.5-7 mAb binding curve with (red) and without (black) SAb-Au 
enhancement (small colloids). The non-specific binding response of 
the SAb-Au conjugate has been subtracted from the plot. ................125 
Figure 4.5-8 mAb binding curve with (red) and without (black) SAb-Au 
enhancement (larger colloids). The non-specific binding response of 
the SAb-Au conjugate was subtracted off from the plot. ..................126 
Figure 4.5-9 True SAb-Au enhancement at “High” and “Low” points.....129 
Figure 4.5-10 mAb binding curve with 200 mg/mL SAb-Au conjugate 
enhancement (with 1:1 diluted gold colloids) on the new CM5 surface
.......................................................................................................130 
Figure 4.5-11 SAb-Au binding curve (at 2.5 mg/mL mAb concentration) 
using the SAM surface ....................................................................131 
Figure 4.5-12 Sensorgram showing 100 mg/mL SAb-Au conjugate 
enhancement of response from 2.5 mg/mL mAb. The red dotted line 
indicates the residue response (ca. 60 RU) after 2 regenerations of the 
progesterone surface on the SAM chip. It was suspected that SAb-Au 
conjugates were irreversibly deposited on the sensor surface. ..........132 
Figure 4.5-13 mAb binding curve with (red) and without (black) 100 mg/mL 
SAb-Au enhancement using the SAM chip .....................................133 
Figure 4.6-1 Schematic diagram showing the principle behind the 
progesterone-mAb competition assay. 1) The progesterone sample is 
firstly mixed with a known excess concentration of mAb. 2) Since the 
mAb is in excess, after it has been mixed with the progesterone a small 
amount of free (not bound with progesterone) mAb is still present in 
the sample. 3) The sample is flowed over the sensor surface with 
immobilised progesterone. Free mAb will bind to the immobilised 
 xiv 
progesterone while progesterone-mAb complexes are flowed pass 
without interacting with the surface. 4) SAb-Au conjugates are then 
flowed pass over the surface-bound mAb for signal enhancement. ..134 
Figure 4.6-2 Assay Standard Curve Using 10nm-Streptavidin / Biotinylated 
Antibody Pre-Incubation (43.75 mg/mL final mAb concentration) 
studied by Mitchell et al. The signal responses decreased as the 
concentration of mAb decreased or the concentration of progesterone 
in the sample increased. ..................................................................137 
 Figure 4.7-1 Progesterone-mAb competition assay binding curve using 
CM5 surface ...................................................................................143 
 Figure 4.7-2 Progesterone-mAb competition assay binding curve using 
SAM surface ...................................................................................145 
 xv 
List of Tables 
Table 2.1-1 Colour absorbed by a sample in relation to sample colour 
observed............................................................................................25 
Table 2.3-1 Four parameters given by the Zetasizer to indicate the quality of 
the particle size result 37 ....................................................................33 
Table 2.3-2 Some of the common failing criteria when measuring the 
particle size using the Zetasizer 37 .....................................................34 
Table 2.4-1 Some of the drug targets and binding partners that were being 
studied by using BIAcore 47 ..............................................................43 
Table 3.3-1 Summary of the gold colloids prepared...................................52 
Table 3.4-1 pH measurements of the gold colloids prepared......................56 
Table 3.4-2 Comparison of the observed colour of colloidal gold prepared 
using hydrazine reduction with the UV-Vis plasmon resonance peaks 
of the same samples ..........................................................................60 
Table 3.4-3 Comparison of the observed colour of colloidal gold prepared 
using borohydride reduction with the UV-Vis plasmon resonance peaks 
of the same samples ..........................................................................62 
Table 3.4-4 Comparison of the observed colour of colloidal gold prepared 
using higher concentrations of KAuBr4 solution and borohydride with 
the UV-Vis plasmon resonance peaks observed for the same samples 63 
Table 3.4-5 Comparison of the observed colour of colloidal gold prepared 
using citrate reduction with the UV-Vis plasmon resonance peaks of 
the same samples ..............................................................................65 
Table 3.4-6 Comparison of the observed colour of protected and 
 xvi 
unprotected colloidal gold prepared using citrate reduction with the 
observed UV-Vis plasmon resonance peaks of the same samples .......66 
Table 3.4-7 A350 values of the gold colloids prepared in this study as an 
indirect indicator of relative concentrations of the gold colloids 
between preparations.........................................................................67 
Table 3.4-8 Some instrumental settings used in the Malvern Zetasizer 
3000HS.............................................................................................73 
Table 3.4-9 Intensity based measurements of 130806-2.............................77 
Table 3.4-10 Volume based measurements of 130806-2 ............................77 
Table 3.4-11 Number based measurements of 130806-2............................77 
Table 3.4-12 Intensity based measurements of 070806-1...........................78 
Table 3.4-13 Volume based measurements of 070806-1 ............................78 
Table 3.4-14 Number based measurements of 070806-1............................78 
Table 3.4-15 Intensity based measurements of 070806-2...........................79 
Table 3.4-16 Volume based measurements of 070806-2 ............................79 
Table 3.4-17 Number based measurements of 070806-2............................79 
Table 3.4-18 Intensity based me0asurements of 160806-1A......................81 
Table 3.4-19 Volume based measurements of 160806-1A..........................81 
Table 3.4-20 Number based measurements of 160806-1A.........................81 
Table 3.4-21 Intensity based measurements of 160806-1B ........................82 
Table 3.4-22 Volume based measurements of 160806-1B..........................82 
Table 3.4-23 Number based measurements of 160806-1B.........................82 
Table 3.4-24 Intensity based measurements of 160806-2A........................83 
Table 3.4-25 Volume based measurements of 160806-2A..........................83 
Table 3.4-26 Number based measurements of 160806-2A.........................83 
Table 3.4-27 Intensity based measurements of 160806-2B ........................84 
 xvii 
Table 3.4-28 Volume based measurements of 160806-2B..........................84 
Table 3.4-29 Number based measurements of 160806-2B.........................84 
Table 4.5-1 Non-specific bindings of the enhancement species on CM5 
sensor chip (average responses from measurement of three replicates 
of each sample) ...............................................................................117 
Table 4.5-2 Non-specific binding of SAb-Au conjugates on SAM surface 
(average responses from measurement of three replicates of each 
sample) ...........................................................................................118 
Table 4.5-3 Comparison of response signals of SAb (IgG), SAb-Au 
conjugate, and particle effect on CM5 surface (average responses from 
measurement of three replicates of each sample) .............................119 
Table 4.5-4 Non-specific and signal enhancement of SAb-Au conjugate on 
new CM5 surface ............................................................................128 
Table A-1 Gold colloids prepared from various concentrations of KAuBr4, 
AG, and sodium borohydride...........................................................156 
Table A-2 Gold colloids prepared from various concentrations of KAuBr4, 
AG, and hydrazine hydrate ..............................................................157 
 xviii 
List of Terms and Abbreviations 
c.c.c. critical coagulation concentration 
TEM transmission electron microscope 
Ppb parts per billion 
SERS surface enhanced Raman scattering 
SPR surface plasmon resonance 
SAM self-assembled monolayer 
ELISA enzyme-linked immunosorbent assay 
kDa kilo Dalton 
mAb monoclonal antibody 
SAb (IgG) secondary antibody (immunoglobulin) 
SAb-Au 
secondary antibody (immunoglobulin)-gold colloids 
conjugate 
pg picogram (1x10-12 gram) 
fg femtogram (1x10-15 gram) 
PCS photon correlation spectroscopy 
DLS dynamic light scattering 
QELS quasi-elastic light scattering 
Zave mean particle size measured using the Zetasizer 
GE General Electric 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HBS-EP (HBS) HEPES buffered silane with EDTA and P-20 surfactant 
LC liquid chromatography 
IFC integrated micro-fluidic cartridge 
EDTA ethylenediaminetetraacetic acid 
RU response unit 
EDC N-ethyl-N-(3-dimethylaminopropyl)-carbodiimide 
NHS N-hydroxysuccinimide 
EAH ethanolamine hydrochloride 
ADME absorption, distribution, metabolism, and excretion 
AG arabinogalactan 
LMCT ligand to metal charge transfer 
A350 absorbance at wavelength of 350 nm 
kCps kilo counts per second 
LOD limit of detection 
 xix 
OVA ovalbumin 
PEG polyethylene glycol 
P4-PEG-OVA progesterone-polyethylene glycol-ovalbumin conjugate 
Reg regeneration 
DMF N, N-dimethylformamide 
UF ultra-fine 
  
  
  
  
  
  
 1 
1. Introduction 
1.1 Definitions of Colloids, Sols, & Nanoparticles 
Colloids and sols are terms that define particles falling within a size range of 1 nm to 
1μm 1. Nanoparticles are meant to refer to particles in the nanometre size range. 
Although the three terms are used interchangeably in many scientific studies of this 
area, the terms do have strict definitions. Colloids are submicroscopic particles that 
are uniformly dispersed in a dispersion medium. The dispersed particles take the form 
of a liquid, gas or solid. Dispersions of liquids in another liquid are called an 
“emulsions” while dispersions of gases in liquid are called, “foams”. For the case of 
dispersions of solid in liquids, if the solid is polymeric in nature, the dispersion is 
termed a “latex”. However, if the solid is non-polymeric such as metal, the dispersion 
is usually referred to as a “sol” 2. As a further distinction, sols can be differentiated 
according to the dispersion medium. If the dispersion medium is aqueous, the term 
“hydrosols” is used; whereas dispersions in organic liquids are referred to as 
“organosols” 2. With the recent advances in nanotechnology, “nanoparticle” is 
becoming the more popular term that describes particles of nanometre dimensions. 
 
Fogs, smokes, milk, paints, mud, jellies, and ruby stained glass are just some simple 
colloidal systems that are encountered in everyday life. Many biological structures are 
also colloidal in nature. For example, blood is a dispersion of corpuscles in serum, 
and bone is fundamentally a solid state dispersion of hydroxyapatite in collagen3. 
 2 
1.2 Preparation of Colloidal Dispersions 
The preparation of colloidal dispersions is divided into two categories namely 
dispersion and condensation 4, of which the latter is for more fine (with smaller 
particle size) material and more of significance in this study. In the dispersion method, 
a sample of bulk material is broken down to colloidal dimensions by a mechanical 
process. The most direct method is by grinding in a colloid mill. This device involves 
forcing coarse suspension of particles through a narrow gap between two rapidly 
rotating surfaces. Particles are torn apart by the shearing process, and the colloidal 
dispersion is formed, provided that the dispersion medium keeps small particles from 
aggregating (see Section 1.4.5 in Chapter 1). Ultrasonication is a method that uses 
high frequency sound waves to produce emulsions from a mixture solution with two 
phases 4. Condensation methods involve reprecipitation, condensation from vapour, or 
chemical reaction. An example of reprecipitation method is the formation of zinc 
oxide colloids. This can be prepared by dissolving zinc (II) salt in an aqueous solution. 
The resulting solution is then added to a solution of urea to form solid zinc complex, 
which is decomposed to zinc oxide upon heating to > 300°C 5. The formation of fog 
or mist from supersaturated vapour exemplifies the second category of condensation 
methods described above. 
 
When using chemical methods of synthesis, colloidal particles are formed by 
“growing” nuclei until a particle in the typical colloid size range is reached. 
Nucleation or formation of dispersed species with a size in an intermediate range of 1 
to 10 nm occurs initially before these species come together to form colloidal particles. 
This process can be illustrated by Figure 1.2-1, which is a plot of the concentration of 
the dispersed species (nuclei concentration) versus the extent of reaction. The model 
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explains that in order for nucleation of the nuclei to occur, the concentration of these 
dissolved species must firstly be above the saturation concentration of the system, that 
is the system must be supersaturated with the dispersed species. Only at a certain 
value of the supersaturation concentration, will nucleation occur. Once nuclei are 
formed, subsequent depositions of the newly formed nuclei will occur on the already 
formed nuclei. By controlling the temperature and concentration during the reaction, 
the growth-rate of dispersed nuclei can be varied. As a result, colloidal particles with 
different sizes can be produced. Preparation of monodisperse colloids have become 
quite important, as these systems allow a more precise study and understanding of the 
properties that colloids possess. To prepare monodisperse colloids, it is necessary for 
large amount of nuclei to be formed in a short period of time at the beginning of the 
chemical reaction. The nuclei formed will grow rapidly at first and this causes the 
concentration of the dispersed species to drop below the nucleation concentration. As 
a result, no new nuclei are formed and simultaneous growth of existing nuclei thus 
takes place. 
 
 
Figure 1.2-1 a plot of the nuclei concentration versus the extent of reaction 4 
 
Chemical methods include oxidation or reduction of anions or cations. Various 
oxidation or reducing agents can be used in the preparation. For instance, sulphur 
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colloids can be prepared by oxidising hydrogen sulphide or thiosulphate 4. Silver 
colloids may be conventionally prepared by reducing silver nitrate with reducing 
agents like tri-sodium citrate, sodium borohydride, or carbon monoxide. Reduction of 
metal salts using UV or gamma irradiation has also been reported 6, 7. Hydrolysis of 
metal salts is another important technique for preparing highly monodisperse sols of 
the transition metal oxides and hydroxides 8, 9. 
 
1.3 Important Properties of Colloids 
1.3.1 Brownian motion 
Particles in colloidal suspension exhibit rapid and erratic motion called, “Brownian 
motion”. This phenomenon was first observed in 1827 by Robert Brown who carried 
out microscope examination of pollen particles floating on top of pond water at the 
time. An explanation was provided based on the kinetic-molecular theory of matter, 
which postulated that the erratic motion observed was caused by the fluctuating forces 
that surrounding molecules of the dispersion medium were applying to the particle 
surface through random bombardment. Under such circumstances, a net force with 
varying magnitude and direction will be exerted on a particle at any given moment 
from the surrounding molecules, leading to a random motion of the particle. 
 
1.3.2 Electrophoresis and electro-osmosis 
Electrically charged particles tend to move under the influence of an electric field. 
The motion of a charged particle relative to the surrounding liquid is termed, 
“electrophoresis”. A similar phenomenon can occur for the oppositely charged 
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solution ions or counter-ions surrounding a charged particle (see Section 1.4.1). The 
movement of the counter-ions relative to the charged particle is called, 
“electro-osmosis”. This phenomenon occurs when the solid is in the form of a 
capillary or a porous plug which is filled with the liquid. When an electric field is 
applied to the charged wall of the capillary the solution can be moved in response to 
the field 10. 
 
1.3.3 Scattering of light 
The optical properties of a colloidal suspension were first observed by Faraday in his 
work on gold colloids in the 19th century. Further study by Tyndall led to the 
discovery of the Tyndall effect, which describes the scattering of light by 
submicroscopic particles when a light beam is passed through a colloidal system. In 
the study, Tyndall suggested that the intensity of the scattered light is proportional to 
the volume of the colloidal particles 11. 
 
The basic theory underlying the interactions between light and matter is based on 
Rayleigh’s theory on light scattering by particles with dimensions that are much 
smaller than the wavelength of light. When a small particle is subjected to an electric 
field from light the whole particle is subjected to the same field, and a dipole moment 
is induced. As the light passes over the particle, the electric field and the induced 
dipole fluctuate in magnitude. The oscillating dipole is induced from the movement of 
electrons in the particle. The electron movement constitutes in effect an oscillating 
current which produces its own electromagnetic field and radiates light of the same 
frequency as the incident light 3. The theory also suggested that since the particles are 
much smaller than the wavelength of the passing light, every part of each particle 
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should experience the same magnitude of electromagnetic radiation as the light passes 
over the particle. Hence, light that are scattered at different angles by the same 
particle should have equal intensity. 
 
Rayleigh’s theory, however, only applies to spherical particles with small particle size. 
The particle size limit is determined by the size parameter, a. Rayleigh’s theory only 
applies to particles with a << 1 11. a is described by the equation, a = 2pa/l, where a 
is the radius of the particle and l is the wavelength of the incident light. 
 
The Rayleigh-Debye-Gans theory and Mie theory were later developed and overcame 
the limitations faced by Rayleigh’s theory. Debye and Gans put forward ideas based 
on Rayleigh’s theory that when light interacts with a larger particle all parts of the 
particle are not subjected to the same electric field. Therefore, the intensity of the 
scattered light varies at different scattering angles. As a result, the theory becomes 
very complex as particles become much larger. Mie Theory takes into account the 
absorption of light from a large particle and also illustrated that the intensity of 
scattered light is angle-dependent. 
 
All of the above mentioned light scattering theories are limited to dilute dispersions of 
particles. In more concentrated colloidal dispersions light scattered by the colloidal 
particles can be further scattered by other particles within the dispersion before 
leaving the dispersed system (i.e. there is multiple scattering). This becomes a 
problem when carrying out size measurements using light scattering techniques such 
as dynamic light scattering as the intensity of the scattered light becomes independent 
of the particle size (see Section 2.2.2 in Chapter 2). 
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1.4 Colloidal Stability 
1.4.1 Electrical double layer 
Colloidally suspended particles possess negative or positive charges at their surfaces.  
In accordance with Coulomb’s law on electrostatic theory, like-charges repel while 
opposites attract. Hence, for a negatively charged electrolyte an excess of positively 
charged ions will surround a given negatively charged ion and vice versa. This model; 
for describing the distribution of charged ions in solution is called the ionic 
atmosphere model 3. For colloidal systems, the ionic atmosphere around a charged 
colloidal particle is an important factor in determining the stability of the dispersion. 
 
For a charged particle, the charge separation between the surface of the particle and 
the bulk electrolyte is called the electrical double layer. The concept of this electrical 
double layer was first introduced by Helmholtz who suggested that the double layer 
consists of two fixed layers of opposite charge like a parallel plate capacitor. The 
model was then improved independently by Gouy and Chapman to compensate for 
the thermal diffusion gradients, which can disrupt the fixed ionic layer proposed in 
Helmholtz’s theory. The Gouy-Chapman’s diffusion model also suggested the 
potential at the surface decreases exponentially with distance due to the diffuse layer 
of counter-ions from the solution 10, in contrast to the linear decrease in potential 
through a Helmholtz double layer. 
 
The Gouy-Chapman-Stern theory is based on both Helmholtz theory and 
Gouy-Chapman theory 3. This theory basically served as a compromise of the two 
models so that both the charge ordering (predicted by Helmholtz) plus random 
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ordering effect of ions (predicted by Guoy-Chapman) around a charged particle or 
interface could be accounted for. Hence it proposed that an electrical double layer 
consisted of an inner layer or the Stern layer which contains a monolayer of ions that 
are tightly bound to the charged particle/interface (Helmholtz theory) with an outer 
more loosely bound layer (the “diffuse layer”) consisting of randomly ordered ions 
(Gouy-Chapman theory). In this compromise model, the potential varied linearly with 
distance through the Helmholtz layer and then exponentially with distance through the 
diffuse layer of the model. 
 
Within the diffused layer there is a theoretical boundary within which the ions and the 
particle centre act as one entity. When the particle moves the associated ions move 
with it. Any ion beyond this boundary does not move with the particle. This boundary 
is called the slipping plane or shear plane (see Figure 1.4-1). The potential at this 
plane is termed the zeta potential 10. The stability of a colloidal dispersion can be 
determined from the magnitude of the zeta potential. Colloidal dispersions with zeta 
potential of greater than ±30 eV are considered to be stable against aggregation. 
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1.4.2 Inter-particle attractive forces 
The origin of attraction between colloidal particles does not lie in strong 
intermolecular interaction, but in the weak interactions known as van der Waals forces 
1. This weak interaction may be created from three possible sources: Keesom 
interactions, Debye interactions, and London (dispersion) interactions. 
 
Keesom interactions describe the attraction between two permanent dipole centres. 
Debye interactions involve permanent dipole and induced dipole attraction. The 
London interactions, which arise between two temporary dipoles, is the most 
important of the three because the interaction is long-range and much stronger than 
the Keesom and Debye contributions in most colloidal dispersions 1. In general, a 
temporary dipole is induced by the movement of electron cloud around a nucleus. As 
two nuclei come in contact with each other the temporary dipoles become aligned and 
Net negative 
particle 
Shear plane 
Particle surface 
Diffused layer 
Stern layer 
Figure 1.4-1 The double layer region surrounding a negatively charged particle 
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interaction occurs. 
 
Other forces of attraction may include hydrophobic forces and polymeric bridging 
forces 11. Hydrophobic interactions may occur naturally or be induced by the adsorbed 
hydrophobic species on the particle surface. If one considers hydrophobic particles in 
a polar solvent, contact between the particle surface and polar solvent molecule is 
avoided. Therefore these particle surfaces have a preference to associate with each 
other to minimise the surface-solvent interaction. An example of this is the 
aggregation of coal or graphite, which possesses natural hydrophobicity, in polar 
solvents. Adsorption of hydrophobic surfactants on particle surfaces may also induce 
hydrophobicity on particles in polar solvents. 
 
Polymers adsorbed on the surface of a particle may also induce repulsion (see Section 
1.4.3) as well as attraction. The nature of the interaction depends on the interactions 
between the adsorbed polymers and the dispersion medium. If the adsorbed polymers 
are compatible with the solvent molecules, the suspension will remain stable. On the 
other hand, if the polymers are not compatible with the dispersion medium, the 
thickness of the adsorbed layer of polymer will decrease and there will be a tendency 
for the adsorbed polymers on a particle to interpenetrate into an adsorbed layer of 
polymers on another particle 11. Hence, aggregation may occur depending on the 
density of the adsorbed polymers on the surfaces (see Section 1.4.4). 
 
Polymers can be attached to two or more particles if polymers have several active 
sites and providing the particles are not fully covered by the polymers. If particles are 
fully covered with polymers, bridging between particles can happen only when a 
portion of the adsorbed polymer becomes detached, and provides sites for adsorption 
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on other particles or bonding with other polymers. 
 
1.4.3 Inter-particle repulsive forces 
The two major repulsive forces between colloidal particles are the electrostatic 
repulsion induced by the electrical double layer model and steric repulsion induced by 
adsorbed polymers on interacting particle surfaces. 
 
As mentioned in Section 1.4.1, a charged colloidal particle and a portion of the ionic 
atmosphere around it act as a single entity. When a charged colloidal particle moves 
its associated counter-ions move with it. These counter-ions act as a protecting shield, 
which prevents the charged colloidal particles from interacting with each other by the 
van der Waals force (see Section 1.4.2). The thickness of the electrical double layer, 
which depends on the ionic strength of the dispersion, can affect the magnitude of the 
electrostatic repulsion. As ionic strength in the dispersion is increased through 
addition of a salt, the thickness of the electrical double layer decreases 2. Hence the 
strength of the electrostatic repulsion can be overpowered by the van der Waals force 
and aggregation may occur. 
 
Adsorption of polymers on particle surfaces can also induce repulsive forces between 
interacting particles. Following on from Section 1.4.2, polymers adsorbed on any 
given colloidal particle can interpenetrate into the molecular domain of another 
adsorbed polymer on another colloidal particle upon collision. However, this process 
has two consequences. Firstly, the local density of polymers increases, which causes 
the dispersion medium to diffuse into the region between the surfaces, which acts to 
reduce the polymer concentration so pushing the two surfaces apart (osmotic effect). 
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Secondly, since the polymers are tangled together, the number of configurations that 
these polymers can adopt decreases. This means a reduction in the entropy of the 
system has occurred and an increase in the free energy of the system 3. This is 
unfavourable thermodynamically so favouring the separation of the two particles 
(entropic effect). These mechanisms serve to explain how certain polymers when 
added to colloidal dispersions can impart greater colloidal stability on a system. 
Polymers or other molecules fulfilling such a role in a colloidal system are called 
“protecting agents” and the colloids that are stabilised by them are termed “protected 
colloids”.  
 
1.4.4 DLVO theory for explaining the interactions between 
colloidal particles 
In the 1940s, Derjaguin and Landau, and independently by Verwey and Overbeek 
developed this theory that describes the interaction between colloidal particles. It 
states that the stability of a colloidal system is determined by the total potential energy 
between the van der Waals force and the electrical double-layer repulsive force. 
However, further study has found that not all colloidal systems can be explained in 
terms of the DLVO theory 4. The steric repulsive force was found to be the missing 
factor in the total potential energy. The revised theory is illustrated in Figure 1.4-2. 
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Figure 1.4-2 DLVO theory describing the total potential energy of inter-particle interaction versus 
inter-particle distances. VT is the total potential energy of interaction between two approaching 
particles; VR is the potential energy of the repulsive force; VA is the potential energy of the 
attractive force; and VS is the potential energy arises from solvent layer adjacent to the particle 
surfaces 4. 
 
The diagram shows the total potential energy as a function of inter-particle distances. 
The minimum that occurs at longer inter-particle distance is termed the secondary 
minimum. At this region, the van der Waals force is strong enough to induce loose 
aggregation (known as flocculation) which can usually be redispersed. With repulsive 
forces such as electrostatic and steric repulsions, the secondary minimum can be 
overcome. The primary maximum is shown by the increase in potential energy 
between two colloidal particles at close proximity. This energy barrier indicates the 
potential energy required to be overcome by the collision between two particles, in 
order for aggregation to occur. If the maximum is sufficiently large, it ensures that the 
rate of coagulation is slow so that the suspension has a long-term stability. If the 
Primary maximum 
Secondary minimum 
Primary minimum 
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energy barrier is absent, collision between two particles will rapidly bring the 
potential energy to the region on the graph where a large drop in potential energy is 
observed. This region is called the primary minimum, and at this area rapid 
coagulation between particles results. 
 
1.4.5 Aggregation of colloidal particles 
The term aggregation generally describes the process by which colloidal particles 
become irreversibly attached to one another through interaction. Coagulation and 
flocculation are two terms that clearly define the morphology of the aggregated 
particles. Coagulation is derived from the Latin verb “coagulare”, which means “to 
cause to curdle”. Flocculation, on the other hand, is derived from “floccus”, which 
means a flock of wool 2. These two terms are often used interchangeably. However, 
differentiation should be made between the two terms. 
 
Flocculation involves the loose aggregation of particles without the destruction of 
each particle’s individuality 3. In contrast, coagulation involves the process of particle 
growth upon aggregation. Flocculation can be induced when the total free energy of a 
system decreases (the DVLO theory) and a flocculated colloid can be redipersed via 
disruption of the flocs through some externally applied disintegration process such as 
ultrasonication. 
 
Coagulation of sols by addition of electrolytes was observed by Faraday in 1856. The 
independent studies of Schulze and Hardy led to the conclusion that flocculation was 
controlled mainly by the nature of the added counter-ions and under certain conditions 
the effectiveness of the counter-ion was strongly dependent on its valency. The 
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minimum concentration of electrolyte required to induce flocculation or coagulation is 
termed the critical coagulation concentration (c.c.c.). As the valency on the ion 
increases, the value of the c.c.c decreases which demonstrates the valence 
dependency. 
 
As mentioned in Section 1.4.4, the kinetics of coagulation depends on the magnitude 
of the energy barrier (primary maximum). In the absence of this barrier, coagulation 
occurs rapidly as a result of inter-particle collisions. 
 
1.5 Application of Colloids 
The properties of colloidal systems were observed and utilised by man since the 
earliest days of civilisation, even though the true nature of colloids had not been fully 
understood 3. Preparation of butter, cheese, yoghurt, and the making of bread, bricks 
and ink pigment are just some examples of simple colloidal systems applied in the 
early days of civilisation. With the modern advances made in colloid science, the 
chemical and physical properties of colloids are better understood and able to be 
manipulated. 
 
The technical applications of colloidal systems are becoming more sophisticated in 
various areas. In biological applications, biomolecules have been encapsulated in 
mesoporous silica nanoparticles for controlled release applications by destabilisation 
of aqueous silica precursors in the water droplets of a water-in-oil emulsion. 12. Metal 
colloids have also been used for virus capture 13, biomolecule labelling for TEM 
imagery, and also in developing ultra-sensitive immunoassays 14 (the subject of this 
thesis). 
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Nanocomposite coatings made from 3-glycidoxypropyltrimethoxysilane (GPTMS) 
and various metal oxide nanoparticles have unique properties such as absorbing 
harmful UV radiation. Since different metal nanoparticles may have different 
properties, resulting materials may serve in applications such as optical, protective, 
catalytic, guest-host, and multifunctional coatings 15. 
 
Metal nanoparticles (Pt, Au, or Cu) together with multi-walled and single-walled 
carbon nanotubes solubilised in Nafion have been used to form nanocomposites for 
electrochemical detection of trinitrotoluene (TNT) and several other nitroaromatics.  
Using these nanocomposites, adsorptive stripping voltammetry for TNT resulted in a 
detection limit of 1 ppb 16. 
 
1.6 Gold Colloids 
1.6.1 Introduction 
In mediaeval times, colloidal gold was once prepared by alchemists mainly in two 
forms, viz., “aureum potable” or drinkable gold (regarded as the Elixir of Life) and 
purple of Cassius, which was used to make ruby glass. In 1774, Macquer had 
speculated that these systems had gold present in a finely divided form. However, it 
was not until 1856 that Michael Faraday had confirmed Macquer’s speculation, and 
made the first comprehensive scientific study of gold colloids at that time. This study 
put forward ideas that can still be seen in modern theories concerning the factors 
responsible for the stability of colloidal dispersions. In a series of experiments with 
gold sols, Faraday demonstrated many important properties of colloidal dispersions: 
light scattering, sedimentation, coagulation by salts, and “protection” from 
 17
coagulating effects of salt which was bestowed by use of gelatine 3. 
 
A number of simple preparative methods of charge-stabilised gold colloids by 
reduction of gold salt were developed in the early twentieth century. The most popular 
method is the citrate reduction route, which leads to size-tuned and monodisperse 
gold colloids 17. More recently, protected metal colloids are being utilised in more and 
more scientific studies. Due to stability issue, the gold colloids prepared in this study 
by various (citrate, hydrazine, and borohydride) reduction routes were also protected 
by a purified oligosaccharide (protecting agent) called, “arabinogalactan” (see Section 
3.1 in Chapter 3). 
 
1.6.2 Some properties and applications of colloidal gold 
One of the characteristic features of gold colloids is the various colours that the 
colloidal dispersions may exhibit. The different colours of gold colloids arise from the 
interaction between visible light and the gold particles in the dispersion. Depending 
on the size of the gold colloidal particles, the colour of stable gold colloids can vary 
from brown (particle diameter < 5 nm) 18 through to red (15 nm – 90 nm), and blue 
(ca. > 100 nm) 19. Aggregated gold colloids, in contrast, are grey/black in colour. 
 
Gold colloids have most notably been used in the Raman-based spectroscopic 
technique of Surface Enhanced Raman Scattering (SERS). This effect arises through a 
surface plasmon resonance (SPR) phenomenon, which will be described in more 
detail in Section 2.1.2 in Chapter 2. Basically, this phenomenon arises when a band of 
electrons on the metal surface resonates with the incident monochromatic radiation 
(provided by a laser) creating an induced evanescent wave at the surface of the 
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particles. The enhancement of Raman scattering occurs when both the induced 
evanescent wave and the incident radiation interacts with the Raman active vibrations 
of molecules adsorbed at the gold colloid surface. The induced dipole moment in the 
molecule is then greatly increased, and the resulting Raman signal is enhanced by a 
significant degree over what is expected for its concentration in solution 20. This can 
be useful if wishing to acquire spectra of molecules which are present in solutions at 
low concentrations. 
 
The resistance of gold metal against oxidation and other forms of reaction is another 
characteristic and advantage that gold has over other SPR inducible metals such as 
silver, copper and aluminium 21. However, despite the well known lack of reactivity of 
metallic gold, immobilisations of thiol-molecules are readily performed, as sulfur has 
a good affinity for gold, as predicted from the hard-soft acid base theory. 22 23. 
Immobilisation can be achieved by immersing naked gold metal in a solution of 
thiol-containing molecules 24. The immobilising process is a widely utilised technique 
in self-assembled monolayer (SAM) science which is used when different reactive 
sites are grafted onto a gold surface. 
 
The utilisation of gold colloids in biological studies is rapidly increasing. One of the 
growing areas of interest is signal enhancement of biomolecular interaction analysis 
systems such as SPR based instruments, BIAcore (see Section 2.4 in Chapter 2). This 
will form the basis for the research reported in this thesis. 
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1.6.3 The use of gold colloids in biomolecular interaction 
analysis systems 
Protein-protein interactions are commonly analysed by using the Enzyme-Linked 
ImmunoSorbent Assay, or ELISA. Its high sensitivity in antigen/antibody 
concentration analysis is the reason for this technique being preferred over other 
techniques such as SPR based instruments.  
 
However, ELISA is a labour-intensive technique, which often requires from hours to 
days to obtain results from an analysis. One of the limitations of this technique is the 
non-specificity or cross reactivity that an ELISA assay can have with similar proteins. 
The sensitivity and specificity of ELISA may also vary between different laboratories. 
Thus, variations of analyses/results of the same specimen often occur when the 
specimen is analysed by different laboratories. 
 
In the past decade, intensive effort has been put into developing techniques that are 
able to overcome the limitations of ELISA, and at the same time achieve a 
comparable sensitivity of ELISA. SPR based instruments (or biosensors) have been 
widely studied using different antigen-antibody interactions 25 with a view to 
providing this practical alternative. Biosensors were found to have the potential to 
replace ELISA due to their rapid and on-line (real-time) analysis (ie sample analysis 
can be performed outside a laboratory). A drawback, however, is the comparatively 
low sensitivity (compared to ELISA) of these techniques which means that biosensors 
are not yet in a position to totally replace ELISA as the technique of choice for 
analysing protein-protein interactions. 
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Recent studies have applied enhancement species, such as metal colloids, to improve 
the electronic signals given by biosensors (see Chapter 2 for the theory of SPR based 
instrument and Chapter 4 on details of signal enhancement of the instrument). 
Significant improvements (signal enhancement of 25 times the original signal 
response) through mass increase using gold colloids have been reported by Lyon et al 
24, and this type of mass increase-based signal enhancement method is now being 
widely used in the SPR studies especially for small molecules (molecular weight of < 
2 kDa). 
 
The detection of small molecules, such as progesterone, using SPR technology is 
quite challenging, as small molecules by virtue of their small mass produce little 
change in refractive index on the surface of the sensor chip (See Section 2.4 in 
Chapter 2 for more details on the theory behind SPR technique). Previous studies by 
Karlsson et al have utilised SPR technology to detect small molecules such as biotin, 
theophylline, and peptide (< 1200 Da) with immobilised antibodies 26, 27. However, 
the information obtained from the studies was more qualitative than quantitative due 
to SPR’s low sensitivity towards analytes with small molecular weight. 
 
In the study by Mitchell et al, progesterone was the small molecule of interest because 
of its unprecedented importance in the New Zealand agricultural industry. 
Progesterone is a non-aromatic female sex steroid hormone that sustains and controls 
pregnancy of mammals. Progesterone plays a major role in the oestrous cycle at 
which pregnancy may occur with timed insemination. The detection of progesterone, 
therefore, is the key in determining the timing of artificial insemination of livestock. 
Undetected or falsely detected oestrous can cause significant losses of income for the 
dairy and meat industries due to unexploited potential of milk and calf production. 
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Reports suggested that a 100% detection rate without false oestrous alert may be 
impossible 28. However, with better developed sensors and techniques, significant 
improvement on oestrous detection can be achieved.  
 
Mitchell et al have developed a sensitive progesterone immunoassay by using an 
indirect measurement protocol for the progesterone concentration in a sample. This 
was achieved by using an SPR based BIAcore instrument (see Section 2.4 in Chapter 
2 for the underyling theory of this technique) to monitor the interactions between 
immobilised progesterone molecules and the anti-progesterone monoclonal antibody 
(mAb). The sensitivity of the BIAcore response was greatly improved by binding an 
enhancement species, viz., a secondary antibody immunoglobulin or SAb (IgG) 
conjugated to Au colloidal particles, or “SAb-Au” (see Chapter 4 for more details) on 
top of the mAb. The detection limit of progesterone using this “response-enhanced” 
assay was reported to be at 8.60 pg/mL compared to 3.56 ng/mL from a previous 
study (which did not use any enhancement species) by Gillis et al 29. The 
enhancement species developed by Mitchell et al, however, was not at its at its most 
optimised. There was still room for improvement in the response that could be 
achieved by this enhancement method. This goal provided the impetus for this thesis. 
 
1.7 Aim of the study 
The purpose of this study was thus to improve upon the sensitive BIAcore SPR-based 
progesterone immunoassay that was developed by Mitchell et al. Mitchell et al.’s 
progesterone immunoassay used an indirect measurement in order to determine the 
concentration of progesterone (this involved using immobilised progesterone on the 
sensor surface to detect monoclonal anti-progesterone antibodies (mAb) that are not 
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complexed with the free progesterone molecules in a sample). The BIAcore signal 
enhancement in this technique was achieved using secondary antibody (IgG) 
conjugate with gold colloid. The resultant large mass increase (on the sensor surface) 
that is created by the conjugation with gold colloids was found to induce a greater 
response through refractive index change at the interface of the sensor from the SPR 
instrument (see later for theory relating to this technique). This novel enhancement 
system, however, suffered a drawback. The citrate-generated gold colloids prepared 
by Mitchell et al were susceptible to aggregation when concentrations greater than 0.1 
g/L of gold salt were used. As a compromise to avoid the aggregation problems, 
diluted (ca. 0.1 g/L gold salt) gold colloids were used (to minimise or eliminate the 
aggregation of the colloids). As a result, the level of enhancement observed was not 
perceived to be at an optimum level (i.e. there was room for improvement in the 
enhancement). Moreover, the unstable nature of the citrate-reduced gold colloids 
meant preparation of fresh colloids was required frequently. Hence the “shelf-life” for 
any potential commercial application of this technology was severely limited. This 
was a potentially serious issue identified by Mitchell et al 30 in the work done. 
 
Two main objectives were set out for this project. The first objective was to identify a 
suitable gold colloid preparation which could be prepared with different particle sizes 
and at higher concentrations than those used in studies by Mitchell et al 30. The second 
objective was to use the stabilised gold colloids to prepare stable secondary antibody 
(IgG) – gold conjugates for BIAcore (SPR) signal enhancement. 
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2. Theory of Instrumental Techniques 
This chapter provides a brief theoretical background to the techniques used in this 
study. 
 
2.1 UV-Vis 
UV-Visible spectrophotometry is a common analytical technique that is widely used 
in many areas of science. It can be used for colorimetric analysis, concentration 
measurements as well as kinetic studies. 
 
The optical diagram of a standard dual beam UV-Vis spectrophotometer is shown in 
Figure 2.1-1. 
 
 
Figure 2.1-1 Optical diagram of Cary 100 UV-Visible spectrometer 58 
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UV-Vis spectrometry involves absorption of electromagnetic radiation in the 
ultraviolet and visible region (10-800 nm) which leads to transitions between 
electronic energy levels in molecules. The electronic transitions (change in energy of 
the molecule from ground state to higher energy levels) involved are dependent and 
characteristic of the molecules that are being analysed. 
 
The Beer-Lambert Law is the fundamental law underlying UV-Vis spectroscopy that 
relates the concentration of the sample with the absorbance of the sample. The 
Beer-Lambert equation is shown below. The law states that for monochromatic 
radiation, absorbance (A) is directly proportional to the pathlength (b) through the 
medium and concentration (c) of the absorbing species. 
 
A = ebc 
Where e = the molar absorptivity and has units of L cm-1 mol-1. 
 
Table 2.1-1 illustrates the relationship between absorbed colour (its wavelength) and 
the observed colour that is transmitted by the solution. The table is of interest in this 
study as gold colloids can vary in colour depending on their particle size which 
depends directly on their UV/Vis absorption behaviour (see Section 3.4.3 in Chapter 
3). 
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Table 2.1-1 Colour absorbed by a sample in relation to sample colour observed 
Colour Absorbed Colour Observed Absorbed Radiation (nm) 
Violet Yellow-green 400-435 
Blue Yellow 435-480 
Green-blue Orange 480-490 
Blue-green Red 490-500 
Green Purple 500-560 
Yellow-green Violet 560-580 
Yellow Blue 580-595 
Orange Green-blue 595-605 
Red Blue-green 605-750 
 
2.2 TEM 
Transmission electron microscopy (TEM) is a well-known imaging technique that is 
widely used in all branches of science but most notably in the Materials and 
Biological Sciences fields. 
 
A TEM operates similarly to light microscopy. However, instead of a light beam, it 
uses a beam of electrons. The resolution of a TEM microscope is described by Abbe’s 
equation, which was developed by Ernst Abbe in the 1870s. 
 
Resolution power (RP) = 0.61lN.A. 
 
Where l is the wavelength of the light source. N.A. is the numerical aperture of the 
lens, which defines the maximum cone of light that a lens can take up from a point on 
the specimen 31. The term N.A. can be expressed as nsina, where n is the refractive 
index of the medium (approximately 1 for the vacuum in TEM), and a is the angle 
within the lens in which the most divergent rays can pass and form an image 
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(approximately 0.3° for a TEM) 31. For an optical-light microscope, the resolution is 
limited by the wavelength of visible light, as the wavelength is restricted to 400-700 
nm. The wavelength of electrons, however, can be adjusted to a much lower 
wavelength depending on the voltage at which the electrons are generated. At 50 kV, 
the wavelength of the electron beam is 0.005 nm which according to Abbe’s equation 
can give a 100,000 fold increase in resolution. This is not realised in practice due to 
lens aberrations. The scale of improvement is in fact about 1000 times better which is 
enough for most purposes. 
 
The general configuration of a TEM microscope can be illustrated by Figure 2.2-1 
shown below. 
 
Figure 2.2-1 drawing which shows the different parts of the TEM column 32. 
 
A beam of electron is generated in the electron gun which is found at the top of the 
chamber. A tungsten filament is commonly used as the source of electrons though 
LaB6 filaments are also used and have a longer lifetime. Under the vacuum that exists 
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in the instrument, emitted electrons are accelerated by an electric field, instead of 
glass lenses that focus the light in a light microscope. Focus to a very thin beam of 
elecetrons can be achieved in TEM. The electron beam then travels through the 
sample, which is carefully deposited onto a collodion coated copper grid. The sample 
grid is inserted into the system using a specimen rod similar to the one shown in 
Figure 2.2-2. 
 
 
Figure 2.2-2 TEM specimen rod. The sample (deposited on the copper grid) is inserted at the place on 
the rod indicated by the arrow and the sample grid is held in place by a spring clip 32. 
 
As the beam strikes the specimen on the collodion coated grid, the electrons can 
exhibit three different interactions. Electrons may be absorbed into a thick portion of 
the specimen or by atoms with high atomic numbers. Absorption processes may cause 
a build-up of heat in the area and result in distortion or destruction of the sample. In 
TEM, absorption of electrons does not contribute significantly to image contrast. 
Another interaction involves the elastic scattering of electrons. This occurs when 
electrons from the beam interact with the nuclei in specimen atoms. The electrons 
undergo by virtue of the interaction a large deviation in their path without loss of 
 28
energy. Elastically scattered electrons contribute to both amplitude and diffraction 
contrast in a TEM image. The third interaction is inelastic scattering, which is 
produced when electrons from the beam interact with electrons in specimen atoms. 
This interaction is particularly important for imaging samples of low atomic number. 
Inelastically scattered electrons contribute to chromatic aberration and phase contrast 
31. The image formation is based on the amount of electrons that are being scattered 
which is essentially dependent on the thickness or density of the sample. The image 
can be captured with a digital camera which is fitted into most conventional 
instruments and studied (e.g. for particle size measurements) using image processing 
software. 
 
2.3 Zetasizer 
2.3.1 Introduction 
Colloids prepared need to be characterised in terms of their particles size distributions 
and their zeta potential. Traditionally colloidal systems have had their particle size 
distributions measured by TEM where the colloidal particles are removed from 
solution by evaporation onto a collodion coated copper grid 32, 33, 34. Images from the 
TEM are then analysed using pixel measurements available on an image processing 
program. Thus TEM is an ex situ method for measuring particle size. Where in situ 
particle size measurements are needed, a light scattering photon correlation 
spectroscopy (PCS)-based technique must be used. The Zetasizer is an instrument 
which incorporates a PCS technique (see later) to measure the size and zeta-potential 
of colloidal particles. 
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The electronic setup of a typical Zetasizer 3000HS by Malven is illustrated in Figure 
2.3-1. 
 
 
Figure 2.3-1 Optical diagram of Zetasizer 3000HS 38 
 
With conventional dynamic light scattering (DLS) instrument such as Zetasizer 
3000HS, the particle size is an important factor in determining the maximum 
concentration at which the sample can be measured. Each sample has its own optimal 
measuring condition. If the concentration is too low or the particle size is too small, 
the amount of light scattered is not sufficient to make a measurement. If the sample is 
too concentrated, multiple scattering can occur. This involves scattered light 
interacting with other particles before reaching the detector. Consequently, the 
apparent measured particle size is reduced 35. 
 
2.3.2 How size is measured on Zetasizer instrument 
Dynamic light scattering (DLS), also known as quasi-elastic light scattering (QELS) 
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or photon correlation spectroscopy (PCS) is a technique that can quickly determine 
the particle size with minimal sample preparation. 
 
When the laser light from the Zetasizer hits small particles the light scatters in all 
directions with equal intensity (Rayleigh scattering). With large particles, the intensity 
is angle dependent (Mie scattering). In both cases, a time-dependent fluctuation in the 
scattering intensity is observed. These fluctuations are due to the Brownian motion 
that the colloidal particles are undergoing in the dispersion medium. The scattered 
light by a particle can either form constructive or destructive interference with light 
scattered by the neighbouring particles within the illuminated zone. These 
interferences give rise to the intensity fluctuation at the detector plane. The moving 
speckle pattern can be detected by a photon correlator, which works by counting the 
number of speckles/photons in a different time span rather than measuring the 
intensities of the scattered light 36. A correlator has over a hundred channels to carry 
out the measurement, and each channel measures the fluctuation at a particular time 
span or time delay. With a short time delay, τ, the particles have not moved a great 
distance between the initial measurement at time (t) and the measurement at time (t + 
τ). Hence, the correlation between them is high. However, with larger values of τ, the 
particles have moved some way from their initial positions due to Brownian motion, 
and the measurement made at time (t + τ) is therefore much less correlated to the 
initial measurement. An autocorrelation function can be derived from the number of 
photons counted at each time delay. As time delay increases, the autocorrelation 
function decreases exponentially. 
 
Now, with large particles, the Brownian motion is relatively slow compared to small 
particles which move more quickly. Therefore, the autocorrelation function of large 
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particles decays at a slower rate. This rate of decay is essentially related to the 
translational diffusion coefficient (D) of the colloidal particle. This can then be related 
mathematically to a hydrodynamic radius using the well known Stokes-Einstein 
equation. 
 
R
kTD
ph6
=  
 
Where D is the diffusion coefficient; R is the hydrodynamic radius; k is Boltzmann’s 
constant; T is the temperature in Kelvin, and h is the viscosity of the suspension. 
 
Particle size distributions are obtained by numerically processing the autocorrelation 
function with algorithms based on assumed distributions. A monodisperse sample 
would give rise to a single exponential decay, and the distribution calculation can be 
easily performed. For polydisperse samples, a series of exponential decays are 
involved and several complex algorithms have to be applied for calculating the 
distribution. In the Malven Zetasizer, there are five modes of analysis to choose from, 
namely Monomodal, Multimodal, Contin, Non-negatively Constrained Least Squares 
(NNLS), and Auto. 
 
For Malvern Zetasizer, the conversion of scattered light intensity to particle size is 
based on Rayleigh’s theory, which implies that the light scattering intensity, I, is 
dependent on the radius of the colloidal particle, R, to the sixth power (ie. I a R6). 
This relationship is critical to the PCS technique as it essentially means that the 
scattering intensity of larger particles (large R value) will dominate over the scattering 
intensity of smaller particles. Hence, if two particle size distributions on either sides 
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of the size scale are present in a colloidal sample, the size distribution at a lower size 
range may be overlooked as the scattered light produced by larger particles is much 
intense than the scattered light produced by smaller particles. More importantly if 
aggregated or large macroparticles of dust are present these will also contribute to the 
signal and may distort the particle size result. Therefore, when interpreting the 
Zetasizer size results it is important to look at all four mean particle size values, 
namely intensity based mean particle size, volume based mean particle size, number 
based mean particle size, and Z-average (Zave) value (see Section 3.4.5 in Chapter 3 
for more details on the four particle size measurements and the relative accuracy of 
each). 
 
2.3.3 Making a measurement 
Sample preparation for zetasizer measuremens is minimal before analysis as colloids 
can be sampled directly as received in most case. Sample concentration, however, is 
an important issue for size measurement. In order to satisfy Rayleigh and Mie theory, 
dilution of colloidal dispersion is required for particle size analysis to avoid multiple 
light-scattering by particles. Dilution of sample for size measurement should be done 
with the dispersion medium in which the colloidal particles are suspended in 37. 
Particle count-rate which is measurable on the instrument using a screen counter in 
the software is a good indication for the scale of dilution required before analysis. 
Count-rate of around 100 to 250 KCps (thousand counts per second) are considered 
ideal for size measurements. 
 
Cleanness of the sample cell is also crucial prior to analysis. Contaminants and air 
bubbles can skew the size measurements as mentioned earlier. Since materials such as 
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dusts particles are much larger than colloidal particles, the intensity of light scattered 
by them will dominate over the light scattered the sample. Even random 
measurements of passing dust paticles within the measurement zone of the sample  
can affect the results though there is a facility within the software which can reject 
any skewed results caused by random dust particle scattering in the sample during 
measurement. 
 
The Zetasizer size result has four major parameters for determining the quality of the 
results produced by the instrument. These four categories are listed and explained in 
Table 2.3-1. The particle size result is treated as a “fail” if any of the criteria shown in 
Table 2.3-2 are met. 
 
Table 2.3-1 Four parameters given by the Zetasizer to indicate the quality of the particle size result 37 
Polydispersity The width of the distribution 
Quality 
This is an indication of the success of the measurement. 
Only two values are displayed, pass or fail 
Merit % 
Signal to background ratio for the experiment. Sample 
dependent, may vary between 5% to 90% 
In range % 
Guide to the success of an experiment. Over 98% is 
excellent. Over 95% is good and can be used for a 
distribution analysis. Over 85%, is satisfactory, but the data 
are only good enough for a cumulants analysis and not a 
distribution analysis 
Fit 
Indication of the success of the measurement and analysis. 
Any value greater than 0.01 is a poor fit 
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Table 2.3-2 Some of the common failing criteria when measuring the particle size using the Zetasizer 37 
Parameter Fail criteria 
Count rate < 10Kcps, or > 500Kcps 
Merit <10%, > 99% 
Polydispersity > 0.7 
Fit Error > 0.005 
In Range < 80% 
 
2.4 BIAcore 
2.4.1 Introduction 
BIAcore is currently an emerging analytical technique that monitors the interactions 
between biomolecules in real-time. It is capable of performing quantitative analyses 
as well as carrying out kinetic studies. The name, BIA, is short for Biomolecular 
Interaction Analysis. The company that developed the series of BIAcore instruments 
is based in Uppsala, Sweden, and it is now part of GE Healthcare. 
 
BIAcore 3000 was the model used in this study (see later). The BIAcore consists of a 
running mobile phase, which is continuously pumping HEPES 
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) buffered Silane (HBS) running 
buffer through a microfluidic flow-cell (see later) and sensor chip compartment (see 
Figure 2.4-1). 
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Figure 2.4-1 A BIAcore instrument 
 
The preparation of the HBS-EP running buffer is made up of 0.01 mol/L HEPES [pH 
7.4], 0.15 mol/L sodium chloride, 0.003 mol/L EDTA, 0.005% v/v P-20 surfactant 
(Biacore AB, Uppsala, Sweden). The sensor chip, which can contain self-assembled 
monolayers of reactive sites, such as carboxyl, amino, epoxy, and biotinyl groups 38, 
acts like a column in an LC system; interactions between analytes and immobilised 
ligands occur on the surface of the sensor chip. Samples are fed into the microfluidic 
flow system by an auto sampler, which can take volumes of sample ranging from 5 mL 
up to 325 mL. The method of injection can be chosen from a list of options. 
“Quickinjection” is often used when conservation of sample is required. “Injection”, 
which requires slightly higher injection volume, is used for immobilisation of ligands. 
When target analytes are flowed over the sensor chip surface the interactions with the 
immobilised ligands are monitored using surface plasmon resonance (SPR) 
technology (see later for theory). The BIAcore instrument thus monitors the 
analyte-ligand interactions in real-time through changes in refractive index on the 
Sensor chip 
compartment 
Mobile phase 
and pump 
system 
Sample injection 
system 
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surface of the sensor chip. These changes in refractive index are induced by the 
accumulation of mass at the chip/solution interface which occurs due to the 
analyte-ligand interactions.  The refractive index changes wrought by the surface 
interactions are reported in graphs called, “sensorgrams”, which will be described in 
more detail later in this chapter. 
 
2.4.2 Microfluidic Flow-cell system 
The microfluidic flow-cell is an important component of the BIAcore system. It 
allows precise deliveries of analyte to the sensor chip surface. An integrated 
micro-fluidic cartridge (IFC) has four independent flow-cells in standard BIAcore 
3000. These four cells can be used to analyse interactions between different analytes 
and different binding partners in series, like a separating column. The cells can also be 
used independently or in combination, in which the latter method involves reference 
subtraction to eliminate non-specific binding or solvent effects and obtain 
sensorgrams that reflect true surface interactions. 
 
 
Figure 2.4-2 Formation of microfluidic flow-cells on the surface of a sensor chip (www.biacore.com) 
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Figure 2.4-3 The four flow-cells can be used independently (left) or in series (right) 
(www.biacore.com) 
 
2.4.3 Surface plasmon resonance (SPR) 
SPR is the underlying technique used in BIAcore instruments. SPR is an 
optical-electrical phenomenon induced by the interaction of light with a metal surface. 
In the case of a BIAcore, a thin gold film deposited on the sensor chip is involved 
with generating the SPR effect. The interaction involves an energy transfer from 
photons of light to clusters of free electrons on the gold surface at a specific resonance 
wavelength. This is a special phenomenon which is restricted to substrates like silver, 
gold, and copper and is responsible for such phenomena which underlie techniques 
like SERS (Surface Enhanced Raman Scattering). It is also responsible for the surface 
plamson resonance peaks that are detected in the UV-Visible spectra of gold, silver, 
and copper colloids and which give rise to the characteristic colours of these colloidal 
dispersions. 
 
The sensor chip of BIAcore is made up of a glass plate coated with a 50 nm thick film 
of gold (see Figure 2.4-4). On top of the gold film, a coupling layer may be grafted (or 
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which is available commercially with the layer already applied to the gold chip 
surface) that contains numerous active sites such as carboxyl or amine groups (the 
coupling layers used in this study will be discussed in Section 4.3 in Chapter 4). 
Ligand molecules can be immobilised at these active sites after surface activation (see 
later). 
 
 
Figure 2.4-4 Illustration of the modified sensor surface 
 
Each sensor chip is encased in a plastic cover for storage. In order for SPR to occur, a 
prism is mounted on the glass-side of the sensor chip, and the incident light is passed 
through this prism and on to the gold surface. The use of prism allows parts of the 
incident light to couple with the metal surface and other parts to be reflected off to the 
detector. As light travels from a medium with higher refractive index to a medium 
with lower refractive index above a certain angle, total internal reflection of light 
occurs. When a thin gold film is inserted in between the two media most wavelengths 
will be reflected off the metal surface. However, at a specific wavelength or the 
resonance wavelength which satisfies the resonance conditions, the light is almost 
completely absorbed by the gold surface (see Figure 2.4-5). This creates a drop in 
intensity of the reflected light, which can be identified by a spectrophotometer. The 
angle at which this sharp decrease in intensity of reflected light occurs is termed the 
Coupling layer 
Immobilised ligand 
Gold - film 
Glass chip 
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SPR angle. 
 
 
Figure 2.4-5 A diagram which shows how the instrument detects the change in SPR angle and produces 
a response signal 39  
 
Plasmons, a group of excited electrons which behave like a single electrical entity, are 
created when light is coupled to the metal surface, and this coupling is responsible for 
the drop in intensity of the reflected light. The plasmon, in turn, generates an 
evanescent electrical field which extends about 300 nanometres above and below the 
metal surface. Any change in chemical composition or refractive index at the metal 
surface results in a change in the wavelength at which the light resonates with the 
surface electrons. SPR is also able to monitor the accumulation of mass at the metal 
surface (see Section 4.1 in Chapter 4). This is essentially the principle behind signal 
enhancement of SPR technique. When the mass/refractive index on the metal surface 
changes a change in the SPR angle is observed. The detector is thus able monitor the 
movement of the SPR angle in real-time, and the data are presented in graphs called 
sensorgrams. 
 
A sensorgram (see Figure 2.4-6) is a simple graphical representation of the interaction 
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between the surface of the sensor chip and the analytes with respect to time. 
 
 
Figure 2.4-6 Illustration of the characteristic response signal of different types of interaction 39 
 
The response in response unit (RU) is on the y-axis of the sensorgram. It fluctuates 
according to changes in refractive index on the sensor chip surface. If interaction 
occurs between the analytes and the surface, the response would gradually increase 
over a period of time until no more analytes are flowed pass the surface. With strong 
analyte-surface interaction, the response would stay above the baseline, and 
regeneration buffer is required to remove the analyte from the surface, and bring the 
response back down to the baseline (see Figure 2.4-6). In the case of weak interaction, 
analytes would gradually dissociate from the surface with running buffer; therefore, 
surface regeneration is not required. The dissociation is illustrated by a gradual 
decrease of response to the baseline (see Figure 2.4-7). 
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Figure 2.4-7 Sensorgram of a system involving a weak binding interaction, which does not require 
regeneration 
 
2.4.4 Immobilisation of macromolecules 
Various types of macromolecules/ligands can be immobilised onto the sensor chip 
surface after it is activated with a mixture of 
N-ethyl-N-(3-dimethylaminopropyl)-carbodiimide (EDC) and N-hydroxysuccinimide 
(NHS). This process converts the carboxylic acid groups on the surface to active 
esters. Under the appropriate pH, macromolecules can then be immobilised on the 
surface by forming amide linkages with the amino groups of these molecules40. Other 
linkages such as biotinyl, carboxyl, and epoxy are also possible 38. 
 
The optimum pH for immobilisation should give the highest response when passing 
macromolecules over the surface. This can be determined by “pH scouting”, which 
involves a “trial and error” approach to monitor the responses of the inactivated 
sensor surface towards the molecule at different values of the pH. Once the 
Dissociation 
Association 
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macromolecules are immobilised on the surface, the un-reacted carboxylic acid 
groups are deactivated by reaction with ethanolamine to ensure minimal non-specific 
binding and no further immobilisation. 
 
After immobilisation, the surface is purged with weak HCl, NaOH, glycine, or 
organic solvent such as acetonitrile 41 to ensure any unbound macromolecules are 
removed from the sensor surface. Any unbound or weakly bound macromolecules in 
the system would give inconsistent responses from the instrument. The choice of 
regeneration buffer is very important, as it should wash away any weakly associated 
analytes on the surface without stripping off the immobilised macromolecules. 
 
2.4.5 Applications 
Since the introduction of BIAcore in 1990, the system has been widely used for 
thermodynamics, kinetics, affinity, and concentration analyse in various areas namely, 
protein interaction study in basic researches, drug discovery and development 42, 
herbicide detection 43, as well as quality control in industries such as the dairy 
industry 44. 
 
In drug discovery, preliminary steps such as target identification, screening and 
optimisation of lead candidates are very important. SPR based instruments provide the 
essential technology for rapid and informative study of the interactions between drug 
compound and drug target. BIAcore has been used in many studies involving drug 
screening. Some of them are listed in Table 2.4-1. 
 
In addition to these screening applications, absorption, distribution, metabolism, and 
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excretion (ADME) predictive assays have also been developed using BIAcore. One of 
these assays is based on interactions between small molecules and liposome surfaces 
for prediction of absorption properties 45. Another assay involves the determination of 
the complex affinity between drug and albumin interactions, which essentially 
provide information on drug compatibility and appropriate dosing levels 46. 
 
Table 2.4-1 Some of the drug targets and binding partners that were being studied by using BIAcore 47 
Drug Target Interaction Partner 
DNA Indolcarbazole analogues 
DNA R 132 compound 
DNA Furonapthalimides 
DNA Chromomycin, mithramycin, distamycin  
DNA Furmidine analogues 
Elastase, hyaluraonidase, and lysozyme Sulfated polysaccharides 
Estrogen receptor Agonists and antagonists 
HIV-1 protease Transition state analogue inhibitors 
Quadruplex DNA Ditercalinium 
Thrombin Thrombin inhibitors 
 
Concentration analysis of residue chemical, drugs, toxins, or nutrients in food industry 
is one of the most important applications of the SPR technology. The presence of 
herbicides or pesticides in vegetables, crops, and fruits as well as veterinary drugs in 
meats, milk, and fish are serious issues for farmers, food industry, and consumers. The 
appropriate level of nutrients that are being added to food products is also an interest 
for the industry and the consumers. Direct detection of bacterial species such as 
Salmonella using immobilised antibodies in BIAcore has been reported 48. A rapid 
sandwich immunoassay was also developed to determine the level of protein toxin, 
staphylococcal enterotoxin B in milk and meat 49. The development of inhibition 
assays based on competition between antibodies binding to immobilised antigens and 
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free antigens in the sample have also been widely reported 47; for example, 
measurement of progesterone in milk 29. Inhibition assays involving 
progesterone-antibody interactions are of relevance to this study. 
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3. Preparation & Characterisation of 
Gold Nanoparticles 
3.1 Introduction 
This chapter is devoted to research done on finding a suitable gold colloid preparation 
to be used as an enhancement species for the BIAcore SPR work. The preparation of 
gold (Au) colloids is well established in the chemical literature. There are various 
methods available for preparing colloidal gold. The preparations in this study 
involved the chemical reduction of Au (III) salts to Au metal. Three reducing agents 
were used in this study; hydrazine hydrate, sodium borohydride, and tri-potassium 
citrate. 
 
Au colloids, especially when concentrated, are generally unstable as these unprotected 
particles are susceptible to aggregation and sedimentation over time. Hence, the use of 
a protecting agent to induce steric stabilisation is crucial for keeping Au colloidal 
particles suspended in solution. Arabinogalactan (AG), a polysaccharide extracted 
from trees of genus Larix (known as “Western Larch”), has been demonstrated to be 
effective in maintaining colloidal particles in a stable suspension 50. AG consists of a 
backbone of D-galactopyranose residues with individual D-galactopyranose linked 
together by b-(1®3) configuration. The majority of these residues bear branches 
consisting of either one or two D-galactopyranosyl residues linked b-(1®6) 50. The 
study by Ponder et al. suggests that single AG molecules undergo transition to form 
trimers with spherical shape 51. 
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Arabinogalactan was the protecting agent of choice because it is highly soluble in 
water. Moreover, the viscosity of arabinogalactan solution does not increase 
dramatically when high concentrations of the polysaccharide are dissolved in water 52. 
 
In finding a recipe which produces stable colloidal Au suitable as an enhancement 
species in  BIAcore-based SPR measurements, various concentrations of Au salt, 
reducing agent, and arabinogalactan were employed. After each preparation, the Au 
colloids were subjected to a series of characterisation analyses including pH 
measurements, UV-Vis spectrophotometry, Zetasizer size analysis, and TEM size 
measurements. 
 
3.2 Materials 
The gold salt used in this study was potassium tetrabromoaurate (III) (KAuBr4) salt 
(assayed as 98% pure) provided by Monash University, Melbourne Australia. 
99-100% hydrazine hydrate (BDH Chemical Ltd, Poole England), 98% sodium 
borohydride powder (Aldrich, Milwaukee, WI, USA), and tri-potassium citrate (BDH, 
Poole, England) were the reducing agents used. The protecting agent, arabinogalactan 
(UF powder) was provided by Larex Inc. (now trading as Lonza Group Ltd. as of 
2006). 70% nitric acid (Ajax Finechem, Australia) and 36% hydrochloric acid (Ajax 
Finechem, Australia) were used for cleaning glassware. 
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3.3 Gold Nanoparticle Preparation 
In the previous study by J. Mitchell, citrate reduction of tetrachloroauric acid (HAuCl4) 
was the preferred method for the preparation of colloidal gold. The reason for this was 
because it was a preparation for which particle size of the resultant colloids was well 
controlled/predicted and it gave monodisperse colloids However, the citrate reduced 
colloids prepared in that study had short-term stability which necessitated the use of  
low concentrations of starting gold(III) salts (0.01 % w/v or 2.9 x 10-4 mol/L) salts 
when preparing the colloids. 
 
In this study, the use of the reducing agents stated above together with the 
arabinogalactan were tested as alternative synthetic methods for preparing colloidal 
gold with the aim of producing higher stability and more concentrated gold colloids 
that could be used in the BIACore measurements as enhancement species. 
 
Prior to each preparation, all glassware was cleaned with aqua regia, which was 
prepared by adding 75 mL of concentrated hydrochloric acid (HCl) to 25 mL of 
concentrated nitric acid (HNO3). After washing, the glassware was rinsed with 18 M
Ω Milli Q water. 
 
Numerous preparations which used varying starting concentrations of potassium 
tetrabromoaurate, KAuBr4, the reducing agents and the arabinogalactan were tested 
before identifying the optimum synthetic procedure that was then used consistently in 
this study (see Section 3.3.1 to 3.3.3). Table A-1 and A-2 in Appendix A contains all 
the gold colloid recipes tested in this study. The reactions used concentrations of 3 to 
50 g/L for arabinogalactan dissolved in 0.0014 to 0.007 mol/L of KAuBr4 solution. 
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The concentrations of hydrazine hydrate used ranged from 0.0002 to 0.002 mol/L, and 
sodium borohydride concentration used ranged from 0.008 to 0.08 mol/L. No 
extensive study was carried out with potassium citrate (i.e. at different concentrations) 
in this project, since this method of reduction is well established. All colloidal 
samples were prepared by adding 5 mL of reducing agent dropwise to an identical 
volume of KAuBr4 solution in a stirred beaker at room temperature. This led to the 
immediate formation of ruby red, purple or blue gold colloids. The gold colloids were 
then characterised by performing pH, UV-Vis and size analyses, and stored at room 
temperature away from sunlight at room temperature. Colloid samples were regarded 
as stable, if no visual evidence of sedimentation was detected two weeks after 
preparation. The following sections give details of the optimum gold colloid 
preparations decided upon after the development work described above. 
 
3.3.1 Gold colloids prepared by hydrazine reduction 
0.0014 mol/L of KAuBr4 solution was prepared in 18 MΩ deionised water. The 
KAuBr4 solution was normally prepared in batches of 20, 25, or 50 mL. 0.05 g of 
arabinogalactan was dissolved in each of three 5 mL aliquots of the 0.0014 mol/L 
KAuBr4 solution to obtain an initial AG concentration of 10 g/L. 8.7 mL, 17.5 mL, and 
35 mL of neat hydrazine hydrate were diluted with 18 MΩ deionised water to make 
25 mL of 0.007 mol/L, 0.014 mol/L, and 0.029 mol/L of hydrazine hydrate 
respectively. Each 5 mL aliquot of KAuBr4 with 10 g/L arabinogalactan was agitated 
with the magnetic stirrer on a medium speed setting. 5 mL of each concentration of 
hydrazine hydrate was then added drop-wise to the three respective 5 mL aliquots of 
KAuBr4 solutions with stirring. The orange colour of the KAuBr4 solution changed to 
ruby red or purple (depending on the concentration of the hydrazine hydrate added) 
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after the addition of the hydrazine hydrate solution. The stirring was continued for a 
further 30 seconds after the addition of hydrazine hydrate. The magnetic stirrers were 
removed from the samples, and each sample was stored in a closed vial at room 
temperature. 
 
3.3.2 Gold colloids prepared by sodium borohydride 
reduction 
0.0014 mol/L of KAuBr4 solution was used in the reactions involving sodium 
borohydride reduction of Au(III) to colloidal Au. 0.05 g of arabinogalactan was 
dissolved in each of three 5 mL aliquots of the KAuBr4 solution to produce 10 g/L 
arabinogalactan in KAuBr4 solution. 0.007 mol/L, 0.014 mol/L, and 0.029 mol/L 
sodium borohydride, NaBH4 samples, were prepared by dissolving 0.0066, 0.0137, 
and 0.0273 g of sodium borohydride respectively in three separate flasks containing 
25 mL of 18 MΩ deionised water. The three 5 mL aliquots of 0.0014 mol/L KAuBr4 
solution and the three different concentrations of sodium borohydride solutions were 
cooled to ~4 °C on ice. Stirring of the cooled KAuBr4 solutions was then commenced 
and to each solution, 5 mL of each concentration of sodium borohydride was then 
added drop-wise. The orange KAuBr4 solution turned to an orange/brown colour upon 
the addition of each concentration of sodium borohydride. The stirring continued for a 
further 30 seconds after the addition of sodium borohydride. The colloid samples 
were stored without further in a sealed vial at room temperature. 
 
The same procedure was carried out with a KAuBr4 solution at the higher 
concentration of 0.0072 mol/L, so that more concentrated colloids could be obtained. 
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The concentrations of sodium borohydride solution were also were also scaled up to 
0.036, 0.072, and 0.144 mol/L. The resulting colloidal samples were stored at room 
temperature. 
 
3.3.3 Gold colloids prepared by tri-potassium citrate 
reduction 
0.007 mol/L, 0.014 mol/L, and 0.029 mol/L tri-potassium citrate solutions were 
prepared in 18 MΩ deionised water. 5 mL of 0.04% w/v or 0.0014 mol/L KAuBr4 
solution was added to each of three 20 mL round bottom flasks. The KAuBr4 
solutions were then brought to the boil. Immediately after the boiling point was 
reached, 5 mL of each concentration of tri-potassium citrate was added drop-wise to 
the respective flasks. The orange KAuBr4 solution underwent a series of colour 
changes while the citrate solution was being added (see Section 3.4.1 for details on 
the colour changes). The final colour of the gold colloids was ruby red for the two 
samples with 0.007 and 0.014 mol/L of tri-potassium citrate. The colloids made from 
the 0.029 mol/L tri-potassium citrate turned purple. They were then gently boiled for 
10 minutes before being cooled to room temperature. These three samples of Au 
colloids were transferred into three separate capped sample vials and stored at room 
temperature. 
 
Two further samples of Au colloids were prepared again with 0.007 and 0.014 mol/L 
tri-potassium citrate by following the procedure described above. Each sample was 
subsequently divided into two parts and labelled “with arabinogalactan” and “without 
arabinogalactan”. 5 mL of each of these separate colloidal sample parts was added to 
 51
three separate sample vials into which. 0.025 g of arabinogalactan was dissolved and 
thoroughly mixed. These constituted the “with arabinogalactan” samples.  Any 
remaining colloids of each sample were transferred to three other sample vials. These 
constituted the “without arabinogalanctan” samples. All four vials were capped, and 
samples stored at room temperature until further analysis. 
 
All samples of gold colloids prepared from the three different routes of reduction are 
summarised in Table 3.3-1. The sample numbering protocol comprises the date of 
preparation (first 6 digits of the sample number) and the concentration of the reducing 
agent used (last digit, where 1 = least concentrated and 3 = most concentrated). In the 
case of citrate reduction, the letters A and B were also used to distinguish between 
samples with and without added arabinogalactan (A = without and B = with). 
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Table 3.3-1 Summary of the gold colloids prepared 
Reducing 
Agent 
Sample 
Concentration 
of KAuBr4 
(mol/L) 
Concentration of 
Reducing Agent 
(mol/L) 
Mole Ratio 
(KAuBr4 : Reducing 
Agent) 
010806-1 0.00144 0.007 1 : 5 
010806-2 0.00144 0.014 1 : 10 
Hydrazine 
Hydrate 
010806-3 0.00144 0.029 1 : 20 
040806-1 0.00144 0.007 1 : 5 
040806-2 0.00144 0.014 1 : 10 
040806-3 0.00144 0.029 1 : 20 
130806-1 0.00721 0.036 1 : 5 
130806-2 0.00721 0.072 1 : 10 
Sodium 
Borohydride 
130806-3 0.00721 0.144 1 : 20 
070806-1 0.00144 0.007 1 : 5 
070806-2 0.00144 0.014 1 : 10 
070806-3 0.00144 0.029 1 : 20 
160806-1A 0.00144 0.07 1 : 5 
160806-1B 0.00144 0.07 1 : 5 
160806-2A 0.00144 0.014 1 : 10 
Tri-potassium 
Citrate 
160806-2B 0.00144 0.014 1 : 10 
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3.4 Observations, characterisation, and general 
discussion on gold colloids prepared for this 
study 
3.4.1 Observations 
Gold colloids are intensely coloured. From the orange solution of KAuBr4, it can be 
converted into colloidal gold with colours ranging from brown, red, purple, blue, and 
yellow depending on the size of the colloidal particles. The colour transformation can 
be easily picked up by the naked eye, and this is a simple method for checking 
whether the reduction reaction of Au (III) ions to Au metal has taken place; though a 
more rigorous confirmation of reaction completion was achieved through the use of 
UV-Vis spectrophotometric measurements on the colloids (see later). 
 
Colloids prepared via citrate reduction underwent a series of colour transformation 
during the preparation. When the orange KAuBr4 solution started to boil the addition 
of a few drops of tri-potassium citrate caused the colour of the solution to fade to 
yellow. With addition of a little more citrate, the solution became clear. Before all of 
the 5 mL of tri-potassium citrate was added to the KAuBr4 solution, the colour of the 
solution changed to indigo before finally turning purple. This was the final colour of 
the colloids prepared with 0.029 mol/L tri-potassium citrate. This sample of gold 
colloids later aggregated, as it cooled to room temperature. In contrast, the two other 
samples prepared with lower concentrations (0.007 and 0.014 mol/L) of citrate 
underwent colour changes from purple to ruby red as a final colour, which suggested 
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that these two samples had smaller particle sizes and that aggregation had not 
occurred to any great extent during the preparation. 
 
Less variable colour change was observed in the preparation of the hydrazine and 
borohydride reduced gold colloids. In these preparations, the KAuBr4 solution turned 
ruby red with the first few drops of reducing agent added. The final colour was red for 
most of the samples after the reactions were completed. However, gold colloids 
prepared by reducing 0.0072 mol/L KAuBr4 solution with 0.144 mol/L sodium 
borohydride turned red with a tint of purple. As expected, the subtle purple colour was 
caused by some large particles in the sample of colloids, an observation that Faraday 
explained in his famous 1856 3 paper. 
 
For gold colloids prepared by reducing 0.0014 mol/L KAuBr4 solution with 0.007 
mol/L and 0.014 mol/L sodium borohydride, the colloid colours were brown/red. The 
brown colour might be an indication that very small colloidal particles were present in 
the dispersion 53. The colour of the colloids was suspiciously similar to the colour of 
the KAuBr4 solution; however, the UV-Vis spectra of these samples later confirmed 
that most, if not all, of the Au (III) were reduced to Au metal (see later). 
 
Colloidal samples prepared by hydrazine reduction were particularly unstable because 
they usually aggregated within two weeks of preparation. Indeed, colloids prepared 
from 0.0014 mol/L KAuBr4 solution with 0.029 mol/L hydrazine hydrate aggregated 
and dropped out of solution one day after the preparation while the other two colloidal 
samples prepared from 0.007 and 0.014 mol/L hydrazine hydrate had changed from 
red to purple within a week, with sedimentation occurring after one week. These 
observations indicated that larger particles sizes had been generated in these 
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preparations. 
 
Borohydride reduced gold colloids were in contrast very stable. No aggregation was 
observed in most samples after many weeks of storage at room temperature. One of 
the more concentrated gold colloids prepared from 0.0072 mol/L KAuBr4 solution 
and 0.144 mol/L sodium borohydride did, however, aggregate immediately after the 
preparation. 
 
Gold colloids prepared from 0.0014 mol/L KAuBr4 solution with 0.029 mol/L 
tri-potassium citrate was aggregated immediately after preparation. The 0.007 and 
0.014 mol/L tri-potassium citrate reduced gold colloids were unstable without 
arabinogalactan as the colour of the unprotected colloids changed from red to purple 
over the period of a day. After approximately one week, sedimentation occurred for 
these colloids. The samples with added arabinogalactan on the other hand were fully 
stable as the colour stayed red for more than a week, and no sedimentation was 
observed during that period of time. 
 
3.4.2 pH measurement 
The temperatures of the colloidal samples were measured using a mercury 
thermometer. The pH meter used was a WTW Microprocessor pH 539 pH meter with 
a Sensorex epoxy body combination pH electrode. It was calibrated with pH 7 and pH 
9.28 buffers. The pH 7 buffer was prepared by dissolving a pH 7 buffer tablet (BDH 
Laboratory Supplies, Poole, England) in 100 mL of 18 MΩ deionised water. The pH 
9.28 buffer was prepared by adding 1.905 g sodium borate (Aldrich, Milwaukee, WI, 
USA) to 100 mL of 18 MΩ deionised water. The pH measurements of the gold 
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colloids are shown in Table 3.4-1. The pH of 0.00144 mol/L KAuBr4 solution was 
3.60 at 19°C. 
 
Table 3.4-1 pH measurements of the gold colloids prepared 
Reducing 
Agent 
KAuBr4 
Concentration 
(mol/L) 
Added 
Arabinogalactan 
(Yes/No) 
Concentration 
(mol/L) 
pH 
Temperature 
(°C) 
0.00144 N 0.007 6.42 20 
0.00144 N 0.007 6.23 16 
0.00144 Y 0.007 6.59 16 
0.00144 N 0.014 6.87 16 
0.00144 Y 0.014 6.92 16 
0.00144 N 0.014 6.8 20 
Tri-potassium 
Citrate 
0.00144 N 0.029 6.58 20 
0.00144 Y 0.007 8.9 21 
0.00144 Y 0.014 9.64 21 
0.00144 Y 0.029 10.04 21 
0.00721 Y 0.036 9.22 18 
0.00721 Y 0.072 9.89 18 
Sodium 
Borohydride 
0.00721 Y 0.144 10.33 18 
0.00144 Y 0.007 4.07 19 
0.00144 Y 0.014 8.66 19 
Hydrazine 
Hydrate 
0.00144 Y 0.029 11.37 19 
 
The results showed that the pH of gold colloids prepared from hydrazine reduction 
was dependent on the concentration of hydrazine hydrate used. The colloids were 
alkaline if a large excess of hydrazine hydrate was used. The alkalinity was caused by 
hydrazine hydrate reacting with water, which in term produced hydroxyl ions 
(similarly to ammonia in water). This finding was confirmed by the preliminary 
samples of hydrazine reduced Au colloids (see Table A-1 in Appendix A), which had a 
large excess of hydrazine hydrate reducing agent added. The pH values of the 
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preliminary gold colloid samples prepared were consistently around pH 11-13. 
Sodium borohydride reduced gold colloids were also moderately alkaline. The 
measured pH values of the gold colloids were in the range 8.7 - 10.0 for the various 
concentrations of sodium borohydride reducing agent. The unprotected gold colloids 
prepared from the citrate reduction reaction were by contrast effectively pH neutral. 
The latter addition of arabinogalactan to these unprotected colloids had a negligible 
effect on the pH of the colloidal dispersions. 
 
3.4.3 Characterisation of gold colloids by UV-Vis 
spectrophotometry 
Samples for UV/Vis analysis were normally diluted before measurements with 
deionised water. The dilution consisted of adding 1 mL of colloidal dispersion or gold 
salt to 1 mL of deionised water. The Cary 100 model UV/Vis spectrophotometer from 
Varian was used in this study. It is a double beam, dual chopper, recording 
spectrophotometer controlled by a computer operating under Windows 2000, and 
running WinUV software. The instrument has a 0.28 M Czerny-Turner 
monochromator with a [1200 lines/mm] grating. The light sources are tungsten 
halogen for visible light and a deuterium arc for ultra-violet light. This creates a 
working wavelength ranging from 190 to 900 nm. It also has a working range up to 
3.5 absorbance units. Samples are analysed in quartz cuvette 1 cm pathlength cells. 
 
In this study, UV-Vis spectroscopy was used mainly for qualitative analysis. By 
comparing the spectrum of the gold salt with that of the gold colloids, albeit could be 
used to determine the stability of the colloidal dispersions and whether the reduction 
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of the starting Au (III) salt to gold metal was completed (see later). A comparative 
scale of the concentrations of colloidal gold in samples from preparation to 
preparation was also achieved by using UV-Vis spectroscopy. A relative density value 
can be calculated by multiplying the dilution factor by the measured absorbance of the 
diluted sample at an arbitrary wavelength. In this study the absorbance values were 
taken at 350 nm, a region free of any spectral interferences from other absorption 
maxima. 
 
The UV-Vis spectrum of 0.00072 mol/L KAuBr4 solution is shown in Figure 4.3-1. 
The spectrum features an intense band at ca. 249 nm and a band (containing a 
shoulder at longer wavelengths) at ca. 382 nm. The band at 249 and 382 nm are 
known to be caused by ligand to metal charge transfer (LMCT) electronic transitions 
between bromine ligands and the Au (III) ion 54. This charge transfer occurs when 
considerable electron density is transferred from the bromine ligand atoms to the Au 
(III) centre55. 
 
 
Figure 3.4-1 UV-Visible spectrum of 0.00072 mol/L KAuBr4 solution 
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Figure 3.4-2 to 3.4-6 are the UV-Vis spectra of gold colloids generated by hydrazine, 
borohydride, and citrate reduction. The absorbance spectrum of colloidal gold always 
feature a single peak at around 500-530 nm. This is known to be due to the localised 
plasmon resonance absorbance of the colloidal gold particles. Previous work has 
shown that the absorbance wavelength and the width of the plasmon resonance peak 
are dependent on the size and stability of the colloidal gold under study. Plasmon 
resonances observed at higher wavelengths in spectra of the colloids indicate that the 
colloidal particles in this dispersions are larger in size whilst smaller-sized colloidal 
particle dispersions generally give rise to plasmon resonance peak at shorter 
wavelengths 54. The breadth of the peak and appearance at longer wavelengths suggest 
large particles/aggregates are present in the system 53, 54. Broadening of the plasmon 
resonance peaks may also be caused by dampened plasmon resonance effects induced 
by small colloidal particles 51, however, if small colloidal particles are present, the 
wavelength at which these plasmon resonance peaks occur would be shorter compare 
to colloidal dispersions with large particles. 
 
Figure 3.4-2 shows the UV-Vis spectra of colloidal gold prepared by hydrazine 
reduction. The plasmon resonance peaks of the three colloidal samples generated by 
0.007, 0.014, and 0.029 mol/L hydrazine hydrate are listed in Table 3.4-2.  
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Figure 3.4-2 UV-Visible spectra of the three hydrazine hydrate reduced gold colloids 
 
Table 3.4-2 Comparison of the observed colour of colloidal gold prepared using hydrazine reduction 
with the UV-Vis plasmon resonance peaks of the same samples 
Sample 
Concentration 
of KAuBr4 
(mol/L) 
Concentration 
of Reducing 
Agent (mol/L) 
Peak (nm) 
Initial 
colour 
of the 
colloids 
010806-1 0.00144 0.007 515 Red 
010806-2 0.00144 0.014 513 Red 
010806-3 0.00144 0.029 510 Red 
 
The plasmon resonance peaks and the colours of the colloids suggested that 010806-1 
and 010806-2 were similar in size, and 010806-3 might be of smaller size (due to the 
shorted wavelength at which the plasmon resonance peak was observed for 010806-3) 
during the course of the analysis. The shape of the plasmon resonance peaks 
suggested that the colloidal dispersions were very stable. However, as mentioned 
earlier in Section 3.4.1 in Chapter 3, all three samples prepared by hydrazine 
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reduction had aggregated, and that 010806-3 was the least stable sample of the three 
gold colloids generated by hydrazine reduction. A discussion on this observation will 
be made later on in this chapter. 
 
Figure 3.4-3 shows the UV-Vis spectra of gold colloids prepared by using 0.007, 
0.014, and 0.029 mol/L sodium borohydride reducing agent. The plasmon resonance 
peaks of these colloidal samples are listed in Table 3.4-3. 
 
 
Figure 3.4-3 UV-Visible spectra of the three sodium borohydride reduced gold colloids with 0.00144 
mol/L KAuBr4 solution 
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Table 3.4-3 Comparison of the observed colour of colloidal gold prepared using borohydride reduction 
with the UV-Vis plasmon resonance peaks of the same samples 
Sample 
Concentration 
of KAuBr4 
(mol/L) 
Concentration 
of Reducing 
Agent (mol/L) 
Peak (nm) 
Initial 
colour 
of the 
colloids 
040806-1 0.00144 0.007 506 Red 
040806-2 0.00144 0.014 500 Red 
040806-3 0.00144 0.029 514 Red 
 
The plasmon resonance peaks indicated that the gold colloids prepared from sodium 
borohydride were overall smaller in size compared to the gold colloids prepared from 
the hydrazine reduction method. The breadth of the plasmon resonance peaks of gold 
colloids generated from borohydride reduction also indicated that the size of the 
borohydride reduced colloidal gold particles was very small. 
 
The sharper plasmon resonance peak of 040806-3 at 514 nm shown in Figure 3.4-3 
suggested that the colloidal particles in the dispersion were larger compared to the 
other two colloidal samples prepared from 0.007 and 0.014 mol/L sodium 
borohydride. This can be explained by the particle growth model mentioned in 
Section 1.2 in Chapter 1, which illustrated that larger colloidal particles are formed 
when the supersaturation concentration of the metal nuclei is reached rapidly during 
the synthesis reaction. This rapid rate of nuclei formation can be achieved by 
increasing the concentration of the metal salt or the reducing agent. 
 
As expected, when the concentration of KAuBr4 solution was increased from 0.00144 
mol/L to 0.00721 molL and the concentrations of sodium borohydride were changed 
from 0.007 and 0.014 mol/L to 0.036 and 0.072 respectively, colloidal dispersions 
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with larger particles were obtained. This was illustrated by Figure 3.4-4, which shows 
that the plasmon resonance peaks were shifted to a higher wavelength (see Table 3.4-4) 
and that the shape of the peaks was more distinctive compared to the peaks in Figure 
3.4-3. 
 
 
Figure 3.4-4 UV-Visible spectra of 0.036 and 0.072 mol/L sodium borohydride reduced gold colloids 
with 0.00721 mol/L KAuBr4 solution 
 
Table 3.4-4 Comparison of the observed colour of colloidal gold prepared using higher concentrations 
of KAuBr4 solution and borohydride with the UV-Vis plasmon resonance peaks observed for the same 
samples 
Sample 
Concentration 
of KAuBr4 
(mol/L) 
Concentration 
of Reducing 
Agent (mol/L) 
Peak (nm) 
Initial 
colour of 
the 
colloids 
130806-1 0.00721 0.036 519 Red 
130806-2 0.00721 0.072 528 Red/Purple 
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The plasmon resonance peaks of unprotected citrate reduced gold colloids are shown 
in Figure 3.4-5. The wavelength at which these peaks occur suggested that the gold 
colloids generated by citrate reduction had yielded colloidal particles that were 
significantly larger than the gold colloids prepared by borohydride reduction. By 
comparing the UV-Vis spectrum of gold colloids prepared by 0.029 mol/L hydrazine 
reduction (Figure 3.4-2) with the UV-Vis spectrum of 0.029 mol/L citrate reduced 
gold colloids (see Figure 3.4-5), it suggested that the rate of aggregation of hydrazine 
reduced gold colloids was hindered by the addition of arabinogalactan. Unprotected 
0.029 mol/L citrate reduced gold colloids showed sign of aggregation (broad peak at a 
longer wavelength shown in Table 3.4-5) in Figure 3.4-5. However, the UV-Vis 
spectrum of gold colloids reduced with 0.029 mol/L hydrazine did not show any 
spectroscopic signs of aggregation. 
 
Weak peaks at around 250 nm suggest that some unreduced AuBr4- ions were still 
present in the colloidal dispersions. 
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Figure 3.4-5 UV-Visible spectra of 0.007, 0.014, 0.029 mol/L tri-potassium citrate reduced gold 
colloids 
 
Table 3.4-5 Comparison of the observed colour of colloidal gold prepared using citrate reduction with 
the UV-Vis plasmon resonance peaks of the same samples 
Sample 
Concentration 
of KAuBr4 
(mol/L) 
Concentration 
of Reducing 
Agent (mol/L) 
Peak (nm) 
Initial 
colour 
of the 
colloids 
070806-1 0.00144 0.007 531 Red 
070806-2 0.00144 0.014 528 Red 
070806-3 0.00144 0.029 533 Purple 
 
The stability of unprotected versus arabinogalactan-protected citrate-reduced gold 
colloids is clearly illustrated in Figure 3.4-6. The unprotected colloidal samples gave 
rise to the two broad plasmon resonance peaks. The breadth of the peaks suggested 
that aggregation had occurred in the two colloidal samples (160806-1A and 
160806-2A) which did not have arabinogalactan added. In contrast, U.V./Vis spectra 
of the two arabinogalactan-protected colloids featured two relatively sharper peaks at 
0.029 mol/L 
citrate reduced 
Au colloids 
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ca. 530 nm (see Table 3.4-6). 
 
 
Figure 3.4-6 UV-Visible spectra of AG protected and unprotected gold colloids 
 
Table 3.4-6 Comparison of the observed colour of protected and unprotected colloidal gold prepared 
using citrate reduction with the observed UV-Vis plasmon resonance peaks of the same samples 
Sample 
Added 
Arabinogalactan 
Concentration 
of KAuBr4 
(mol/L) 
Concentration 
of Reducing 
Agent (mol/L) 
Peak (nm) 
Initial 
colour 
of the 
colloids 
160806-1A No 0.00144 0.07 532 Purple 
160806-1B Yes 0.00144 0.07 528 Red 
160806-2A No 0.00144 0.014 535 Purple 
160806-2B Yes 0.00144 0.014 529 Red 
 
The relative concentrations of the gold colloids prepared by hydrazine, borohydride, 
and citrate reduction reactions (as reflected by the magnitude of the A350 values) were 
obviously dependent on the concentration of the starting KAuBr4 solution used. This 
is clearly illustrated by Table 3.4-7, which shows the relative concentrations of gold 
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colloids prepared from 0.00144 mol/L KAuBr4 solution were all similar (similar A350 
values), and gold colloids prepared from 0.00721 mol/L had higher A350 values. 
 
Table 3.4-7 A350 values of the gold colloids prepared in this study as an indirect indicator of relative 
concentrations of the gold colloids between preparations 
Sample 
Concentration 
of KAuBr4 
(mol/L) 
Concentration 
of Reducing 
Agent (mol/L) 
A350 
010806-1 0.00144 0.007 1.81 
010806-2 0.00144 0.014 1.85 
010806-3 0.00144 0.029 1.89 
040806-1 0.00144 0.007 2.01 
040806-2 0.00144 0.014 2.11 
040806-3 0.00144 0.029 1.99 
070806-1 0.00144 0.007 1.69 
070806-2 0.00144 0.014 1.56 
070806-3 0.00144 0.029 1.07 
130806-1 0.00721 0.036 9.66 
130806-2 0.00721 0.072 8.61 
160806-1A 0.00144 0.07 1.15 
160806-1B 0.00144 0.07 1.16 
160806-2A 0.00144 0.014 1.1 
160806-2B 0.00144 0.014 1.12 
 
3.4.4 Particle size measurements of gold colloids using TEM 
Colloidal dispersions were deposited on TEM copper grids using a Venturi tube (see 
Figure 3.4-7). The deposition process involved connecting one end of the Venturi tube 
to a compressed nitrogen gas cylinder. The vertical tube of the apparatus was 
immersed in a colloidal sample. By turning on the nitrogen gas stream and blocking 
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(using a finger) the opening at the top of the Venturi tube, a vacuum was created at the 
inlet on the Venturi so allowing colloid solution to be sucked up and expelled as a fine 
mist from the outlet. By aiming this fine mist to an immobilised collodion coated 
copper grid (obtained from the Department of Biological Sciences, University of 
Auckland), colloid samples were able to uniformly sprayed onto the grid. The copper 
grid was dried and stored in a desiccator containing activated silica gel until required 
for analysis. 
 
 
Figure 3.4-7 A Venturi used to transfer the gold colloids onto the TEM grids 
 
The colloidal samples deposited on the copper grids were analysed by a Philips CM12 
TEM (at University of Auckland), which has an acceleration voltage range of 80-120 
kV so giving 50k to 750 k magnification. All TEM images were captured using a 
digital camera attached to the microscope. The digital images were analysed using 
Adobe Photoshop 7.0 which employed screen calipers, to measure the particle 
diameters in terms of the number of pixels. Over a hundred particle sizes were 
Connected to compressed 
nitrogen gas 
Tube that is immersed 
into the sample 
The opening 
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selected and measured from each digital image. These values were averaged on a 
Microsoft Excel worksheet and a mean particle size obtained. The size distributions 
were represented as bar-graphs of percentage of total population of colloidal particle 
versus the size range in nanometres. 
 
The TEM images of hydrazine reduced gold colloids are shown in Figure 3.4-8. The 
particle size distributions of hydrazine reduced gold colloids were not obtained due to 
coagulation of the colloidal samples. As shown in Figure 3.4-8, individual particles 
are impossible to be distinguished. The size results of the hydrazine reduced gold 
colloids obtained from the Zetasizer (see Figure 3.4-15) also suggested that large 
aggregates were present in the colloidal dispersions generated by hydrazine reduction. 
 
    
Figure 3.4-8 TEM images of AG-protected hydrazine-reduced gold colloids (using 0.00144 mol/L 
KAuBr4 solution and 0.007 mol/L hydrazine hydrate). Left image is a low magnification image 
showing aggregation of the gold particles. Right image is a high magnification image showing more 
clearly the morphology of the aggregated colloid particles 
 
Colloids from the sodium borohydride reduction were more stable to aggregation. The 
TEM images showed that the colloidal particles were finely dispersed with very few 
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aggregates as were apparent in the hydrazine reduced gold colloids. This means that 
the added 5 g/L arabinogalactan was more effective in preventing the gold colloidal 
particles from aggregating in borohydride-reduced gold colloid samples than 
hydrazine-reduced gold colloid samples. The main size-distribution of the gold 
colloids prepared from higher concentration (0.072 mol/L) of sodium borohydride 
was similar to the sample with lower concentration (0.036 mol/L) of sodium 
borohydride. However, the gold colloids prepared from 0.072 mol/L sodium 
borohydride had larger particles with diameter of 20-30 nm present in the colloidal 
dispersion. 
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Figure 3.4-9 The TEM image of AG-protected sodium borohydride reduced gold colloids (using 
0.00721 mol/L KAuBr4 solution and 0.036 mol/L sodium borohydride) is shown on the left. The 
bar-graph on the right is the size distribution plot obtained from the TEM image 
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Figure 3.4-10 The TEM image on the left is a AG-protected sodium borohydride reduced gold colloids 
(using 0.00721 mol/L KAuBr4 solution and 0.072 mol/L sodium borohydride). The size distribution is 
shown in the graph on the right. 
 
The effectiveness of arabinogalactan as a protecting agent against aggregation was 
clearly illustrated by the TEM images of protected and unprotected gold colloids 
prepared by citrate reduction. Flocculation was observed in images of the unprotected 
samples (see Figure 3.4-13 to Figure 3.4-16). Samples with added arabinogalactan 
were more dispersed. 
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Figure 3.4-11 TEM image of unprotected citrate reduced gold colloids prepared from 0.00144 mol/L 
KAuBr4 solution and 0.007 mol/L tri-potassium citrate. Flocculation clearly occurs between the 
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colloidal particles. The size distribution of the sample is shown in the bar-graph on the right. 
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Figure 3.4-12 TEM image (left) and size distribution (right) of arabinogalactan protected gold colloids 
(prepared from 0.00144 mol/L KAuBr4 solution, 0.007 mol/L tri-potassium citrate, and 5 g/L 
arabinogalactan). 
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Figure 3.4-13 TEM image (left) and size distribution (right) of unprotected gold colloids prepared from 
0.00144 mol/L KAuBr4 solution and 0.014 mol/L tri-potassium citrate. With increased concentration of 
citrate used, , aggregation and particle coalescence were observed in this TEM image. In contrast, the 
TEM image of gold colloids generated from a lower concentration (0.007 mol/L) of citrate, featured the 
colloidal particles that had merely flocculated. 
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Figure 3.4-14 TEM image (left) and size distribution (right) of arabinogalactan protected gold colloids 
(prepared from 0.00144 mol/L KAuBr4 solution, 0.014 mol/L tri-potassium citrate, and 5 g/L 
arabinogalactan). The size distribution shows there were more larger-sized particles in this sample than 
the arabinogalactan protected gold colloids prepared using 0.007 mol/L citrate. 
 
3.4.5 Zetasizer size determination 
The instrument used in this study was a Malven Zetasizer 3000HS, which has a 
Helium-Neon laser light source. Size measurements were carried out using standard 1 
cm plastic fluorescence cuvettes.  All measurement settings were set on default and 
are listed below in Table 3.4-8. 
 
Table 3.4-8 Some instrumental settings used in the Malvern Zetasizer 3000HS 
Mode of Analysis Auto 
Temperature of Sample 25°C 
Dectection Angle 90° 
Refractive Index of Dispersant 
(Relative to Air) 
1.33 
Wavelength of Laser 633 
Viscosity of Sample 0.89 
Attenuation Factor Auto 
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As mentioned in Section 2.3 in Chapter 2, Zetasizer has five modes of analysing the 
raw data. The Auto mode was recommended and used in this study as it uses the 
averaged calculation of the other four modes. 
 
Sample dilution was required before carrying out the size analysis. 1 mL of sample 
was diluted with 3 mL of 5 g/L arabinogalactan solution. All samples were measured 
at 25 °C. Each sample was measured in triplicate and each measurement was 
composed of ten sub-measurements. The duration of each measurement was set on 
Auto. Sizes were determined from a combination of scattering intensity generated by 
the colloidal particles, volume of the colloidal particles (calculated from the raw 
intensity measurement), and number (number of particles in the measured size) based 
mean values, where the latter two mean values are calculated (automatically by the 
instrument) from the intensity-based data. The Zave value is the mean hydrodynamic 
diameter of the colloidal particle that is calculated from the raw light scattering 
intensity data using the mononodal mode of data analysis. The Zave value is being 
included in the size result of each sample; however, it does not reflect the size 
distribution of a colloidal dispersion. There is always a finite particle size distribution 
in a colloidal dispersion, even with monodisperse colloids, in which the particle size 
distribution is merely narrower. In this study, the intensity, volume, number based 
mean values, and Zave value were used together to interpret the size and size 
distribution of each colloidal sample. The size results given by the Zetasizer are based 
on the assumption that all particles in the colloid sample are spherical. The drawback 
of this assumption is that large aggregates (especially flocs of loosely bound particles) 
may be treated as large individual particle by the Zetasizer, thus the size results may 
be overrated. 
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The Zetasizer size results were compared with the size distribution of each colloidal 
sample obtained from the TEM size analysis described in the previous chapter. The 
direct size measurements of colloidal particles using TEM provide an accurate 
comparison with the indirect colloidal size measurements (using PCS technique) 
using the Zetasizer. 
 
As shown in Figure 3.4-15, hydrazine reduced gold colloids had wide size 
distributions. Aggregation occurred for all hydrazine reduced samples even with 
added arabinogalactan. The sample with 0.029 mol/L of hydrazine hydrate was the 
most unstable, as sedimentation occurred immediately after preparation. All hydrazine 
reduced gold colloids were inappropriate for Zetasizer measurement due to the low 
stability (presence of aggregates) and high polydispersity of the dispersions. The 
result shown in Figure 3.4-15 represents the gold colloid sample generated using the 
lowest concentration (0.007mol/L) of hydrazine hydrate. The sample was analysed 
three times, and size distribution of each measurement was indicated by different 
colours. The result was, however, not reliable since the count-rate for the 
measurement was less than 30 kCps (as mentioned earlier in Section 2.3.3 in Chapter 
2, the best working count-rate should be at around 100-300 kCps) and the high 
polydispersity had prompted fail message in the size measurement reports (See 
Section 2.3.3 in Chapter 2 for details on the fail criteria of size measurement). Despite 
the failed result, the size distribution plots were still able to signal that large 
aggregates existed in the colloidal dispersion, which was supported by similar 
observations in the TEM images of the hydrazine reduced gold colloids shown in 
Section 3.4.4. 
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For certain concentrations of sodium borohydride and KAuBr4 solutions (such as 
samples 040806-1 to 040806-3 listed in Table 3.3-1), the particle size of 
borohydride-reduced gold colloids was often difficult to measure using the Zetasizer 
due to the low particle count-rate (see Section 2.3.3 in Chapter 2 for details on valid 
measurement). A drawback of borohydride reduction (in terms of particle size 
measurement by the Zetasizer) is that it produced colloids with small particle size 
(shown in the TEM images of borohydride-reduced gold colloids in Section 3.4.4). 
Hence, many samples could not be analysed by the Zetasizer due to the low intensity 
of scattered light induced by the small particles. 
 
The zetasizer size measurements of the resulting gold colloids prepared from 0.0072 
mol/L KAuBr4 solution and 0.072 mol/L sodium borohydride (sample 130806-2) are 
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Figure 3.4-15 Size distribution plots based on three intensity based measurements 
of gold colloids prepared from 0.00144 mol/L KAuBr4 solution and 0.007 mol/L 
hydrazine hydrate (Sample no. 010806-1).  
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shown in Tables 3.4-9 to 3.4-11. Figure 3.4-16 illustrates the size distributions of 
130806-2 Au colloids obtained from three repeated measurements. The figure shows 
that 130806-2 was reasonably monodisperse as the size distribution was narrow. This 
was also confirmed by the size distribution obtained from TEM shown in Figure 
3.4-9. 
 
Table 3.4-9 Intensity based measurements of 130806-2 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Green 1 27.1 100 
Blue 1 28.8 100 
Red 1 29.6 100 
Table 3.4-10 Volume based measurements of 130806-2 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Green 1 26.8 100 
Blue 1 28.4 100 
Red 1 29.4 100 
Table 3.4-11 Number based measurements of 130806-2 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Green 1 26.6 100 
Blue 1 27.6 100 
Red 1 28.7 100 
 
The discrepancy between the Zave value and the intensity, volume, and number based 
mean particle sizes shown in Tables 3.4-9 to 3.4-11 is due to the fact that Zave is the 
average particle size of all particle sizes determined and in this case there may be 
some low intensity small particle sizes that are not showing with much intensity hence 
lower average size was obtained. The size measurements of 130806-2 obtained from 
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Zave = 17.3 ± 0.2 nm 
Figure 3.4-16 Size distribution plots of 
130806-2 based on intensity measurements 
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the Zetasizer (ca. 17 nm) were also different from the size distribution observed in the 
TEM image (ca. 10 nm) of the same sample. The discrepancy between the results 
obtained from the Zetasizer and TEM will be discussed later in this section, where a 
plot of the mean particle size obtained from the Zetasizer versus the mean particle size 
obtained from TEM is illustrated. 
 
Citrate reduction is commonly known to produce colloids of near monodisperse 
character. This was confirmed by the monomodal size-distribution illustrated by the 
Zetasize results shown in Table 3.4-12 to 3.4-14 and Figure 3.4-17. 
 
Table 3.4-12 Intensity based measurements of 070806-1 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Green 1 32.2 100 
Blue 1 32.6 100 
Red 1 32.7 100 
Table 3.4-13 Volume based measurements of 070806-1 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Green 1 31.7 100 
Blue 1 32.3 100 
Red 1 32.1 100 
Table 3.4-14 Number based measurements of 070806-1 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Green 1 30.8 100 
Blue 1 31.4 100 
Red 1 31.2 100 
 
As listed in Table 3.3-1, sample 070806-2 had higher concentration (0.014 mol/L) of 
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Figure 3.4-17 Size distribution plots of 
070806-1 based on intensity measurements 
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tri-potassium citrate than sample 070806-1, thus the mean particle size of this sample 
was expected to be higher than 070806-1. The size results of 070806-2 shown in 
Table 3.4-15 to 3.4-17 have confirmed the hypothesis. Once again there must be a 
large number of smaller particles which do not “show up on the radar” which are 
dragging down the Zave. 
 
Table 3.4-15 Intensity based measurements of 070806-2 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Green 1 31.2 100 
Blue 1 32.5 100 
Red 1 32.7 100 
Table 3.4-16 Volume based measurements of 070806-2 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Green 1 31.3 100 
Blue 1 32.4 100 
Red 1 32.6 100 
Table 3.4-17 Number based measurements of 070806-2 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Green 1 30.8 100 
Blue 1 32.2 100 
Red 1 32.2 100 
 
When the concentration of the citrate reducing agent was increased to 0.029 mol/L 
(Sample 070806-3) aggregation occurred. The plot of the size distribution based on 
intensity measurement of the sample is shown in Figure 3.4-19. The mean particle 
size measurements were not reported here as the quality of the measurement was 
actually failed by the Zetasizer. However, the two size distributions shown in the 
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Figure 3.4-18 Size distribution plots of 
070806-2 based on intensity measurements 
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Figure 3.4-19 were able to indicate that 070806-3 was not stable (ie it contained 
aggregated colloidal particles) compared to the citrate-reduced gold colloids prepared 
using 0.007 and 0.014 mol/L citrate reducing agent (Sample 070806-1 and 070806-2). 
 
 
In this thesis, the general procedure for preparing protected gold colloids using 
arabinogalactan followed the methodology reported previously by Mucalo et al 50. 
This involved the mixing of arabinogalactan with the starting KAuBr4 salt before the 
reduction step was carried out. However, as heat was involved in the citrate reduction 
method, there was concern that the arabinogalactan could degrade to unknown 
byproducts during the boiling, hence as a precaution, the arabinogalactan was added 
to the gold colloids after heating and cooling of the colloid. 
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Figure 3.4-19 Size distribution plots of 070806-2 based on 
intensity measurements. Two size distributions are present 
(showing aggregation had occurred in the colloidal sample) 
with the larger more highly scattering particles giving rise 
to the distribution at higher particle sizes 
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Figure 3.4-20 is the intensity-based size distribution plot of the citrate-reduced Au 
colloids prepared using 0.007 mol/L citrate without added AG (Sample 160806-1A). 
The intensity, volume, and number based size results are listed in Table 3.4-18 to 
3.4-20. 
 
Table 3.4-18 Intensity based me0asurements of 160806-1A 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Blue 2 26.5 84.6 
    229 15.4 
Red 2 27.3 66.4 
    197.3 33.6 
Table 3.4-19 Volume based measurements of 160806-1A 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Blue 1 25.9 99.9 
Red 1 26.6 99.8 
Table 3.4-20 Number based measurements of 160806-1A 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Blue 1 24.9 100 
Red 1 25.9 100 
 
Theses results clearly suggested that aggregation had occurred in the colloidal sample 
(because two size distributions were detected as illustrated in Figure 3.4-20). 
 
Figure 3.4-21 and Tables 3.4-21 to 3.4-23 are the Zetasizer size results of the AG 
protected Au colloids generated from use of 0.014 mol/L tri-potassium citrate (Sample 
160806-1B). From the intensity, volume, and number based size results of 160806-1A 
(unprotected) and 160806-1B (AG protected), there was a clear difference in size 
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Figure 3.4-20 Size distribution plots of 
160806-1A (unprotected) based on 
intensity measurements 
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between the AG protected and the unprotected colloids. Unprotected colloids clearly 
had larger particle size (along with two size distributions exhibited) than the protected 
colloids. This indicated that aggregation must have occurred soon after the colloids 
were prepared. With protected colloids, arabinogalactan was able to prevent 
aggregation by adsorbing on to the surface of the colloidal particles and inducing 
steric repulsion between them. 
 
Table 3.4-21 Intensity based measurements of 160806-1B 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Blue 1 34.2 100 
Red 1 32.4 100 
Table 3.4-22 Volume based measurements of 160806-1B 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Blue 1 31.6 100 
Red 1 33.6 100 
Table 3.4-23 Number based measurements of 160806-1B 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Blue 1 30.4 100 
Red 1 32.6 100 
 
 
The Zetasizer size results for the citrate-reduced Au colloids generated using 0.014 
mol/L citrate (unprotected) (Sample 160806-2A) are reported in Tables 3.4-24 to 
3.4-26 and Figure 3.4-22. The results suggest that large coalesced (aggregated) 
particles were formed in this sample of colloids rather than the formation of large 
flocs made up of small loosely held together particles as observed for the sample 
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Figure 3.4-21 Size distribution plots of 
160806-1B (AG protected) based on 
intensity measurements 
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160806-1A. The TEM image of 160806-2A (see Figure 3.4-13) showed that both 
coalesced colloidal particles and flocs of loose particles had formed in this sample of 
citrate-reduced Au colloids. 
 
Table 3.4-24 Intensity based measurements of 160806-2A 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Blue 1 44.1 100 
Red 1 45.2 100 
Table 3.4-25 Volume based measurements of 160806-2A 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Blue 1 43.7 100 
Red 1 45.1 100 
Table 3.4-26 Number based measurements of 160806-2A 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Blue 1 42.3 100 
Red 1 44.0 100 
 
 
The size measurements of 0.014 mol/L citrate-reduced Au colloids with added AG 
(Sample 160806-2B) are reported in Table 3.4-27 to 3.4-29 and Figure 3.4-23. The 
results further illustrated that citrate-reduced Au colloids were stable with AG added 
after the preparation. The TEM image of 160806-2B (shown in Figure 3.4-14) also 
confirmed that the stability of these citrate-reduced colloids was better (since little 
aggregation between colloidal particles was observed in the TEM image of 
160806-2B) than the sample without added AG (160806-2A). 
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Figure 3.4-22 Size distribution plots of 
160806-2A (unprotected) based on intensity 
measurements 
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Table 3.4-27 Intensity based measurements of 160806-2B 
Spectrum No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Blue 1 27.6 100 
Red 1 29.1 100 
Table 3.4-28 Volume based measurements of 160806-2B 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Blue 1 27.3 100 
Red 1 28.7 100 
Table 3.4-29 Number based measurements of 160806-2B 
Spectrum 
No. of 
Distributions 
Mean (nm) 
Peak 
Area 
Blue 1 26.9 100 
Red 1 28.2 100 
 
 
The discrepancy between the size distributions obtained from the Zetasizer and the 
TEM images was noted. A non-linear relation between the particle sizes measured by 
TEM and Zetasizer is illustrated by Figure 3.4-24. This non-linear relationship 
between the size results obtained from the two techniques could be explained by the 
size-detection limit of the Zetasizer. As shown earlier, the particle size from the 
Zetasizer for the larger particles are not reliable given they could represent aggregates 
present only in a small quantity, thus the Zetasizer might have overrated the particle 
size (ie the plot shown in Figure 3.4-24 has flattened at larger particle size). 
 
Despite the size discrepancy, the Zetasizer was still a technique to use to indicate the 
stability of the colloidal dispersion (as the size distribution plots obtained from the 
Zetasizer could qualitatively indicate the real size distribution in the samples). 
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Figure 3.4-24 Correlation plot of particle sizes measured by TEM and Zetasizer 
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4. BIAcore Sensitivity Enhancement 
Using the Gold Colloids Generated 
from this Study 
4.1 Introduction 
As mentioned earlier in Section 2.4.3 in Chapter 2, SPR technology can study the 
ligand-analyte interactions by monitoring the changes in mass/refractive index on the 
surface of a sensor chip, where the SPR phenomenon occurs. However, it suffers from 
low sensitivity when the technique is used to detect small molecules with masses < 2 
kDa. Two ways of overcoming the low sensitivity of SPR for detecting small 
molecules have been reported by Mitchell et al 14. The first was to immobilise the 
small molecule (the analyte) and then to use antibody as the ligand to bind to the 
surface. Usually, antibody (the ligand) is immobilised on the sensor surface, and the 
small molecule (the analyte) is passed over this surface for analysis. Since the change 
in mass on the sensor surface is negligible (due to the small mass of the small 
molecule), the sensitivity of the SPR technique is insufficient to detect the small mass 
change. Thus the detection of small molecules using SPR technology is difficult. 
However, when the small molecule is immobilised on the sensor surface and the 
antibody (which has a higher overall mass than the small molecule) is flowed over the 
sensor surface the SPR technique becomes more sensitive (due to the higher overall 
mass change on the surface). This indirect measurement of progesterone concentration 
was used in this study. The second means of signal enhancement method as reported 
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by Mitchell et al was to couple the ligand (the antibody) with a high mass label such 
as a gold colloidal particle (enhancement species), which would enhance the binding 
signal intensity by providing a more massive component to cause RI changes by 
accumulation at the BIAcore gold chip interface. Signal enhancement achieved 
through accumulation of mass on the surface of the sensor chip can be illustrated by 
Figure 4.1-1. 
 
 
 
 
Figure 4.1-1 SPR Sensorgram illustrating how the analyte response is enhanced by accumulation of 
mass at the chip interface. 1) the binding of the ligand (monoclonal antibody) which gives rise to the 
“ligand response”. 2) the signal enhancement step which involves the binding between the 
enhancement species with the ligand. The accumulation of mass on the surface of the sensor chip gives 
rise to a much higher signal response. This is the “enhanced response”. 3) the regeneration step washes 
away the analyte and the enhancement species. The response is reduced back to the baseline so that the 
sensor surface is fully regenerated and ready for the next analysis. 
 
Three major steps were carried out in developing the assay for indirect measurement 
of progesterone concentrations. These were: 1) preparation of the sensor chip surface, 
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which involved immobilisation of progesterone on the coupling layer of the sensor 
chip (see Section 4.3 in Chapter 4). 2) determination of the optimum concentration of 
the enhancement species and the level of signal enhancement using the enhancement 
species (see Section 4.4.3 in Chapter 4). The objective of this experiment was to 
achieve high (> 13 fold) level of signal enhancement using lowest possible 
concentration of the enhancement species. 3) determination of the limit of detection 
(LOD) of the progesterone assay developed from the previous step (see Section 4.6 in 
Chapter 4). 
 
4.2  Preparation of Buffer Solutions Used for 
Sensor Chip Preparation 
4.2.1 Preparation of pH 4.0, 0.01 mol/L sodium acetate 
immobilisation buffer 
The preparation of pH 4.0, 0.01 mol/L sodium acetate immobilisation buffer was 
followed the procedure described in the study by Mitchell et al 30. 0.6866 g of sodium 
acetate (BDH Chemical Ltd, Poole, England) was dissolved in 5 mL of 18 MW Milli 
Q deionised water to make 1 mol/L sodium acetate solution. 400 mL of the 1 mol/L 
sodium acetate solution was diluted with 39.6 mL of Milli Q deionised water to make 
40 mL of 0.01 mol/L sodium acetate. This buffer solution was then titrated to pH 4.0 
with 5mol/L HCl. The buffer was stored in a closed sample tube at ~4 °C in a 
refrigerator. 
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4.2.2 Preparation of the pH 2.0, 0.01mol/L glycine 
regeneration buffer 
0.3758 g of 99% glycine (Sigma, St. Louis, MO, USA) was dissolved in 5 mL of 18 
MW Milli Q deionised water to make 1 mol/L glycine regeneration buffer solution. 
400 mL of the 1 mol/L glycine solution was diluted with 39.6 mL of Milli Q deionised 
water to make 40 mL of 0.01mol/L glycine. This regeneration buffer was then 
adjusted to pH 2.0 with 5 mol/L HCl. The buffer was stored in a closed sample tube at 
~4 °C in a refrigerator. 
 
4.3 Sensor Chip Preparation 
4.3.1 Preparation of the CM5 sensor chip 
The CM5 sensor chip is a commercially available pre-modified sensor chip containing 
a carboxymethylated dextran coupling layer covalently bonded to the gold film of the 
sensor chip (see Figure 4.3-1). The immobilisation of molecules is achieved through 
covalent coupling of amine, thiol, aldehyde, or carboxyl groups with the dextran layer, 
which contains carboxylic groups. The dextran layer is approximately 100 nm thick 
31. 
 
The CM5 sensor chip was purchased from BIAcore AB in Uppsala, Sweden, which is 
now part of GE Healthcare. 
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Figure 4.3-1 Dextran layer on the gold sensor surface 
 
For this study, progesterone molecules (from Sigma Chemical Co.) were immobilised 
on the sensor chip surface through ovalbumin (OVA) with a polyethylene glycol (PEG) 
linkage. The progesterone-OVA conjugate used in the study was the 
progesterone-4-OVA (P4-PEG-OVA) analogue previously described by Wu et al 56. 
Preparation of the P4-PEG-OVA conjugate was not required in this study as 4.8 
mg/mL P4-PEG-OVA conjugates previously prepared by Wu et al. were available for 
use. These had been stored at -20°C and were defrosted before use. 
 
Two flow-cells were prepared for the analysis of progesterone. A reference flow-cell 
containing immobilised OVA was prepared along with a sample flow-cell containing 
immobilised P4-PEG-OVA conjugates. The reason for preparing a reference flow-cell 
is to monitor and also subtract the non-specific binding that the analytes (the 
monoclonal antibody and the enhancement species) might exhibit with OVA. The 
immobilised P4-PEG-OVA flow-cell was used to monitor the progesterone-antibody 
interactions. 
 
In order to immobilise OVA onto the dextran layer of the sensor chip, surface 
activation was required before the protein could be coupled with the carboxyl groups 
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of the dextran layer. Activation was achieved by injecting a mixture of 1:1 
3-dimethylaminopropyl carbodiimide hydrochloride (EDC) (BIAcore AB, Uppsala, 
Sweden) and N-hydroxysuccinimide (NHS) (BIAcore AB, Uppsala, Sweden) through 
the reference flow-cell using 100 mL of the mixture over 20 minutes at 5 mL/minute 
(this is often expressed as 100 mL/ 20 minutes). 
 
10 mg/mL OVA was prepared by dissolving OVA (Albumin from Chicken egg white, 
Sigma) in 18 MΩ deionised water. 0.5 mg/mL OVA was then prepared by diluting 
the 10 mg/mL OVA prepared in pH 4.0, 0.01 mol/L sodium acetate. 150 mL of the 0.5 
mg/mL of OVA was injected in the same flow-cell over 30 minutes at a flow-rate of 5 
mL/minute. The OVA became attached to the activated dextran layer via amine 
coupling. 
 
The surface of the reference flow-cell was deactivated to prevent any active sites from 
coupling with undesired molecules such as the monoclonal antibody, which would be 
later injected as analytes (see later). 100 mL of ethanolamine hydrochloride (EAH) 
(BIAcore AB, Sweden) was flowed through the reference flow-cell over 20 minutes at 
a flow-rate of 5 mL/minute. 10 mL of 0.01 mol/L glycine at pH 2.0 was then flowed 
through the reference flow-cell over 30 seconds (at a flow-rate of 20 mL /minute) 
twice to wash off any unbound OVA. 
 
The immobilisation of OVA reference flow-cell and P4-PEG-OVA sample flow-cell 
can be illustrated in Figure 4.3-2 (in the case of OVA immobilisation, progesterone 
molecule should be absent from the diagram). 
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Figure 4.3-2 Schematic diagram illustrating surface immobilisation with P4-PEG-OVA. 1. the carboxyl 
groups of the dextran layer is activated with EDC/NHS mixture; 2. a P-4-OVA conjugate was 
immobilised on one of the activated site on the dextran layer; 3. Deactivation of free activated carboxyl 
sites on the dextran layer. 
 
The sample flow-cell was immobilised with 0.5 mg/mL P4-PEG-OVA. 1:1 EDC/NHS 
mixture was injected at 100 mL over 20 minutes into the sample flow-cell. 0.5 mg/mL 
of P4-PEG-OVA was prepared in pH 4.0, 0.01 mol/L sodium acetate. 150 mL of it was 
then injected into the same sample flow-cell over 30 minutes at a flow-rate of 5 
mL/minute. The surface of the sample flow-cell was deactivated with an injection of 
100 mL EAH over 20 minutes at a flow rate of 5 mL/minute. The surface was then 
washed four times with 10 mL pH 2.0, 0.01 mol/L glycine for 30 seconds at a 
flow-rate of 20 mL/minute. The sensorgram of the P4-PEG-OVA immobilisation on 
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the CM5 chip is illustrated in Figure 4.3-3. The level of 500 mg/mL OVA binding (in 
the reference flow-cell) and 500 mg/mL P4-PEG-OVA binding (in the sample 
flow-cell) on the CM5 chip was ca. 9900 and 9200 RU respectively. The surface was 
assessed with 100 mg/mL mAb for quality of the immobilisation. The 100 mg/mL 
mAb was flowed over the reference and sample flow-cell surfaces at 60 mL/ 3 minutes 
(60 mL for 3 minutes at flow-rate of 20 mL/minute). The level of mAb binding was ca. 
70 RU (see Figure 4.3-4). The levels of 500 mg/mL OVA and 500 mg/mL 
P4-PEG-OVA binding should be similar to the values defined above for every 
immobilisation. 
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Figure 4.3-3 Sensorgram of P4-PEG-OVA immobilisation on the CM5 chip. 1) Surface activation with 
EDC/NHS. 2) 500 mg/mL P4-PEG-OVA immobilisation. 3) Surface deactivation with EAH. 4) four 
surface washes with pH 2.0, 0.01 mol/L glycine. The large increase in responses observed for 1) and 3) 
were caused by solvent effect (change in refractive index due to solvent) rather than binding on the 
sensor surface. A) Response (ca. 1050 RU) due to surface activation. B) Response (ca. 9200 RU) 
cuased by P4-PEG-OVA binding after the unbound P4-PEG-OVA was washed away. 
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Figure 4.3-4 Sensorgram showing the binding of 100 mg/mL mAb on the immobilised progesterone 
(CM5 chip) surface. The surface was regenerated with Regen Buffer 1. The spikes shown in the 
sensorgram were due to the solvent effect (change in refractive index due to Reg Buffer 1) rather than 
to any actual binding. 
 
4.3.2 Preparation of the Self-assembled Monolayer (SAM) 
sensor chip 
A self-assembled monolayer (SAM) chip is a sensor chip which allows users to 
customise the gold surface with binding sites according to their own specification. 
Unlike the commercially available CM5 chip, which is supplied with a pre-bound 100 
nm layer of dextran, the SAM chip allows the user to coat a thinner (< 100 nm) 
coupling layer on top of the gold surface. This thinner coupling layer should result in 
an increase in SPR sensitivity, as it then brings any interactions under scrutiny closer 
to the gold surface where the SPR phenomenon (i.e. field created by the evanescent 
wave) is at its strongest. The disadvantage of using the SAM chip with its thinner 
Regeneration 
Binding of 100 mg/mL mAb 
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coupling layer is that the surface becomes more susceptible to degradation than the 
dextran layer on CM5 chips. 
 
Beakers used in preparing the SAM were treated with a solution containing 15 mL of 
concentrated (51%) sulphuric acid (H2SO4) (J.T.Baker, NJ, USA) and 5 mL of 30% 
hydrogen peroxide (H2O2.) (Labserv, New Zealand). The treatment involved allowing 
the H2SO4/H2O2 solution to stand in the beakers for 30 minutes, after which the 
solution was discarded, and the beakers rinsed with 18 MΩ deionised water. A 
mixture of 25 mL 18 MΩ deionised water and 5 mL of analytical grade ammonia 
(NH3) (Biolab, New Zealand) was added into the beakers before the beakers were 
placed into a sonication bath for 30 minutes. After that time, the beakers were rinsed 
with 18 MΩ deionised water and dried with compressed nitrogen gas. A gold sensor 
chip was placed into one of the beakers, which contained a mixture of 15 mL H2SO4 
and 5 mL H2O2. The beaker containing the gold sensor chip immersed in the solution 
was then covered with tinfoil and incubated at 50°C for 30 minutes. Once, the gold 
surface had been cleaned with the H2SO4/H2O2 solution, the gold sensor chip was 
rinsed with 18 MΩ deionised water and dried with compressed nitrogen gas. The 
chip was placed into another beaker, which contained a mixture of 9 mL 0.01 mol/L 
11-mercepto-1-undecanol (11-MUOH) and 1 mL 16-merceptohexadecanoic acid 
(16-MUA). The beaker was covered with tin foil and stored in the dark at room 
temperature for approximately 24 hours. The coated sensor chip was taken out of the 
solution and was firstly rinsed well with ethanol and secondly by 18 MΩ deionised 
water before being dried with a stream of nitrogen gas. Finally, the sensor chip was 
encased into a plastic chip holder by following a guided procedure in the SAM kit 
manual provided by the BIAcore manufacturers. 
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The OVA and P4-PEG-OVA immobilisation procedures described in Section 4.3.1 
were carried out with the SAM chip. A reference flow-cell was prepared with 0.5 
mg/mL OVA; and a sample flow-cell was prepared with 0.5 mg/mL of P4-PEG-OVA. 
The sensorgram of the immobilisation procedure using the SAM chip is shown in 
Figure 4.3-5. The P4-PEG-OVA binding response was at ca. 2300 RU after the 
surface was washed with 0.01 mol/L glycine pH 2.0 for three times. 
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Figure 4.3-5 Sensorgram of the P4-PEG-OVA immobilisation on the SAM chip. 1) Surface activation 
with EDC/NHS. 2) 500 mg/mL P4-PEG-OVA immobilisation. 3) Surface deactivation with EAH. 4) 
three surface washes with pH 2.0, 0.01 mol/L glycine. The large increase in responses observed for 1) 
and 3) were caused by solvent effects (change in refractive index due to solvent) rather than binding on 
sensor surface. 
 
The newly prepared P4-PEG-OVA surface was checked with 100 mg/mL mAb for 
quality of the surface prepared. The 100 mg/mL mAb was injected into the reference 
and sample flow-cells at 60 mL over 3 minutes. The surface was regenerated with 0.05 
1 
2 
3 
4 
 97
mol/L sodium hydroxide + 10 mL/ 100 mL acetonitrile regeneration buffer (Reg 
Buffer 1) at 10 mL over 0.5 minute (see Figure 4.3-6). 
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Figure 4.3-6 ensorgram showing the binding of 100 mg/mL mAb on the immobilised progesterone 
(SAM chip) surface. The surface was regenerated with Regen Buffer 1. The spikes shown in the 
sensorgram were due to solvent effects (change in refractive index due to Regen Buffer 1) rather than 
being caused by binding. 
 
 
mAb binding 
Regeneration 
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4.4 Progesterone-antibody analysis using 
BIAcore SPR technology 
4.4.1 Introduction 
As mentioned earlier, progesterone was the small molecular (analyte) being studied, 
and the monoclonal anti-progesterone antibody raised in rats (Sigma, St. Louis, MO, 
USA) was the binding ligand. This monoclonal antibody (mAb) binds specifically 
with the immobilised progesterone and it was able to give reproducible responses 
from BIAcore within an experimental error of ± 5% 14. As the concentration of mAb 
is dropped to around 2 mg/mL, the response from BIAcore became too low and the 
technique becomes unable to distinguish between samples that are at or below this 
concentration of 2 mg/mL. The use of enhancement molecules, however, was able to 
increase the signal responses through mass accumulation on the surface of the sensor 
chip, thus enabling the instrument to distinguish between samples with < 2 mg/mL 
mAb concentrations (ie. these enhancement molecules act to lower the limit of 
detection, LOD). 
 
Enhancement was achieved by a sequential method. The mAb was firstly flowed pass 
the sensor chip surface with immobilised progesterone, and interaction between mAb 
and the immobilised progesterone occurred. The enhancement species was then 
flowed pass the mAb inducing an interaction between the enhancement species with 
the mAb. Essentially, after doing this there were two layers on top of the immobilised 
progesterone (see Figure 4.4-1).
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Figure 4.4-1 Sensorgram showing SAb-Au conjugate enhancement of the mAb response signal. 1) The 
mAb binding response (A). 2) SAb-Au conjugate binding on top of the surface-bound mAb inducing a 
higher response (B). 3) & 4) Regeneration of the sensor surface. 
 
Binding gold colloids alone to mAb was studied by Mitchell et al, and the study 
showed that the gold colloids was able to improve the signal response by about 2 fold 
57, which meant that the response with gold colloids attached to the mAb was twice as 
high as the response generated by mAb alone. Signal enhancement using secondary 
antibody (SAb) and SAb-gold conjugate was also carried out by Mitchell et al. The 
secondary antibody used in the study by Mitchell et al was anti-rat immunoglobulin G 
(IgG) raised in rabbits (R5128, Sigma). The enhancement achieved by SAb (IgG) 
alone was around 8 fold, whilst the SAb-gold conjugate was able to improve the 
signal response by about 13 fold overall 57.  
 
In this Chapter, the enhancement effect of SAb-gold conjugate was studied using the 
gold colloids generated earlier in the study. The SAb-gold conjugate was prepared 
1 
2 
3 4 
A 
B 
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with more concentrated (compared with the preparation by Mitchell et al) and 
stabilised gold colloids described in Section 4.4.2.1. The use of Albumin, Bovine 
(BSA) in the preparation of SAb (IgG) and SAb-Au conjugate was able to reduce the 
non-specific binding of these enhancement species with the sensor chip surface 31. A 
dilution buffer made up of 0.3 mol/L sodium chloride + 1 mL/ 100 mL PEG 400 
(Prolab, Fountenay sous bois, France) + HBS buffer were also reported by Jing et al 58 
to reduce the level of non-specific binding of the SAb-Au conjugate enhancement 
species on the BIAcore sensor chip surface. It was shown in the previous study by 
Jing et al 58 that mixing the SAb-Au conjugate 1:1 with the dilution buffer could 
reduce the non-specific binding of the SAb (IgG) with the immobilised progesterone 
on the sensor chip surface. The effectiveness of this dilution buffer to reduce 
non-specific binding is shown in Section 4.5.1. 
 
The SAb-Au conjugate signal enhancement analysis was carried out with two 
different sensor chips namely CM5 and SAM sensor chips in this study. The CM5 is 
the sensor chip that the previous study on progesterone was based on. The CM5 100 
nm-thick coupling layer (described previously), however, can limit the signal 
responses from the instrument as antigen-antibody interactions are happening > 100 
nm above the gold surface, where the evanescent electric field induced by the gold 
surface is not at its strongest. The SAM sensor chip is an alternative sensor surface 
that allowed a thinner coupling layer to be coated onto the gold surface. As the 
coupling layer is thinner, the antigen-antibody interactions are occurring closer to the 
surface and more within the gold evanescent field, thus the signal responses, in theory, 
should be significantly higher compared to signal responses from the CM5 sensor 
chip. 
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4.4.2 Preparation of Materials for Progesterone-antibody 
analysis 
4.4.2.1 Preparation of Au sols 
Earlier investigations on the gold colloids showed that arabinogalactan was effective 
in stabilising Au colloids prepared by the three different reduction methods. However, 
when preparing SAb-Au conjugates from the three Au colloids only sodium 
borohydride reduced Au colloids remained stable in the presence of the SAb (IgG). 
The gold in the hydrazine and citrate reduced colloidal systems aggregated 
immediately after conjugation with the SAb (IgG). This was suspected to be due to 
the change in pH of the gold colloids prior to conjugation (though aggregation did not 
occur immediately after pH adjustment). Since the gold conjugation with SAb (IgG) 
was carried out at pH 8.5-9.0, pH adjustment was required for all hydrazine (decrease 
pH) and citrate reduced (increase pH) gold colloids (see Section 3.4.2 in Chapter 3 for 
pH measurements of the gold colloids). The change in ionic strength in the colloidal 
dispersion might have affected the overall charge in the colloidal system, and hence 
causing aggregation. 
 
The procedure for preparation of sodium borohydride reduced Au colloids was similar 
to the procedure described in Section 3.3.2 in Chapter 3. The only difference was that 
more diluted gold colloids were prepared than previously. The preparation was  
carried out using the same starting concentration of KAuBr4 solution defined in 
Section 3.3.2 in Chapter 3. The resulting colloids were then diluted with 5 g/L 
arabinogalactan by the various dilution factors defined later in this chapter. The 
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procedure for preparing the gold colloids is as follows. 
 
0.0072 mol/L of KAuBr4 solution was used for the preparation. ca. 0.05 g of 
arabinogalactan was dissolved in each of two 5 mL aliquots of the KAuBr4 solution. 
0.036 mol/L and 0.072 mol/L sodium borohydride samples were prepared in 18 MΩ 
deionised water. The 5 mL aliquots of 0.0072 mol/L KAuBr4 solution and the two 
sodium borohydride solutions were then cooled to ~4°C. After cooling, the KAuBr4 
solutions were stirred at a medium speed and 5 mL of each concentration of sodium 
borohydride was added dropwise to the respective 5 mL aliquots of KAuBr4 solutions 
with stirring. The stirring was continued for a further 30 seconds after the addition of 
sodium borohydride. The Au colloids were left at room temperature for a few hours to 
ensure completion of reaction and then stored at ~4°C. The colloids were later diluted 
for the “optimum Au colloids concentration study” with 5 g/L arabinogalactan by 
various dilution factors (see later). 
 
4.4.2.2 Preparation of buffer solutions 
Regeneration and dilution buffers were prepared freshly on the day of analysis. 
 
Regeneration buffer was used to regenerate the surface of the sensor chip. The 
characteristic of a good regeneration buffer is its ability to wash away materials 
coupled to the immobilised molecules without damaging or compromising the sensor 
chip surface. In this study, 0.05 mol/L sodium hydroxide + 10% v/v acetonitrile (Reg 
Buffer 1) and 0.05 mol/L sodium hydroxide + 20% v/v acetonitrile (Reg Buffer 2) 
were the regeneration buffers used. 0.1 mol/L sodium hydroxide was prepared by 
dissolving sodium hydroxide pellets (Scharlau, Spain) in 18 MΩ deionised water. It 
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was then diluted in 18 MΩ deionised water to make 0.05 mol/L sodium hydroxide. 
The 0.05 mol/L sodium hydroxide stock solution was stored at ~4°C. On the day of 
analysis, 200 mL of neat acetonitrile was added to 1800 mL of 0.05 mol/L sodium 
hydroxide to make 2 mL of the Reg Buffer 1. 400 mL of neat acetonitrile was added to 
1600 mL of 0.05 mol/L sodium hydroxide to make 2 mL of the Reg Buffer 2. 
 
The dilution buffer was made up of 0.3 mol/L sodium chloride + 1 mL/100 mL 
PEG400 + HBS buffer. It was prepared freshly on the day of analysis by dissolving 
17.5 mg sodium chloride in 990 mL HBS buffer, which was then mixed with 10 mL of 
PEG 400 before it was vortex mixed. 
 
4.4.2.3 Preparation of monoclonal antibody (mAb) 
The original concentration of monoclonal anti-progesterone (mAb) raised in rat 
(P1922, Sigma) was 17 mg/mL. 500 mg/mL mAb was made by adding 5 mL of the 17 
mg/mL mAb to 165 mL of HBS-EP buffer (BIAcore AB, Sweden). Different 
concentrations of mAb were then prepared by diluting the 500 mg/mL mAb in 
HBS-EP buffer. Samples were vortex mixed after preparation. 
 
4.4.2.4 Preparation of secondary antibody (IgG) 
Anti-rat immunoglobulin G (IgG) raised in rabbits was used in this study. The 
concentration of the stock solution of SAb (IgG) (R5128, Sigma) was 22.5 mg/mL. 
Lower concentrations of SAb were prepared following a procedure in preparing 
SAb-Au conjugates, which will be described in the next section of this chapter. Serial 
dilution was carried out with the original concentration of SAb (IgG); for example, 
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0.4 mg/mL SAb (IgG) was prepared by firstly diluting 20.4 mL (using Eppendorf 
micropipettes) of 22.5 mg/mL SAb (IgG) with 79.6 mL of 18 MΩ deionised water to 
make 100 mL of 4.6 mg/mL SAb (IgG). This 100 mL of 4.6 mg/mL SAb (IgG) was 
then further diluted with 1000 mL of 18 MΩ deionised water. Finally, 50 mL of 10 
g/100 mL Bovine (BSA) prepared by dissolving 10 mg of BSA (Sigma, Albumin, 
Bovine, A7030 Lot 082K0768) in 100 mL of 18 MΩ deionised water was added to 
the diluted SAb (IgG) to make 1150 mL of 0.4 mg/mL SAb (IgG). 
 
4.4.2.5 Preparation of SAb-Au conjugate 
To prepare 1150 mL of 0.4 mg/mL SAb-Au conjugate, 20.4 mL of 22.5 mg/mL SAb 
(IgG) was firstly being diluted with 79.6 mL of pH8.5 - 8.9 (18 MΩ deionised) water 
(which had been adjusted to that pH with 1 mol/L sodium hydroxide) to make 100 mL 
of 4.6 mg/mL SAb (IgG). 1000 mL of gold colloids (prepared from the procedure 
described in Section 4.4.2.1), which had also been pH adjusted to pH 8.5 - 8.9 with 1 
mol/L hydrochloric acid, was then added to the 100 mL of the 4.6 mg/mL SAb (IgG) 
while it was vortex mixed. The mixture was agitated on a test-tube shaker at 320 rpm 
for 5 minutes before incubation at ~4°C for approximately 18.5 hours. After this 
period, 50 mL of 10 g/ 100 mL BSA was then added to the conjugate during vortex 
mixing. 
 
During the enhancement study (see Section 4.4.3), different concentrations of the SAb 
(IgG) and gold colloids were used. However, the preparation procedure remained the 
same. 
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4.4.3 Signal Enhancement Study Using SAb (IgG) and 
SAb-Au Conjugates 
4.4.3.1 Introduction 
In this chapter, the enhancement effect of secondary antibody and secondary-gold 
conjugate was studied using the CM5 sensor chip. The particle-size effect (of the Au 
colloids used) was also studied. The two samples of gold colloids prepared in Section 
4.4.2.1 were conjugated with SAb (IgG), and their levels of enhancement were 
studied with different mAb concentrations. 
 
Preliminary tests such as non-specific binding and optimum concentration 
determinations were essential in designing a progesterone competition assay (see 
Section 4.6 for more details on competition assay). Non-specific binding is an 
important issue for BIAcore. As the instrument is based on monitoring the changes in 
mass/refractive index that occurs on the sensor chip surface, species other than the 
ligand, mAb, (ie. SAb (IgG) or SAb-Au conjugate) may also bind to the surface and 
would be detected as the ligand (mAb). Therefore, it was important in this study to 
determine the non-specific binding of SAb (IgG) and SAb-Au conjugate and to 
subtract the level of non-specific binding from the true binding responses (ie the 
responses caused by the combination of mAb and SAb-Au conjugate rather than the 
responses from SAb-Au alone). 
 
The optimum concentrations of mAb, SAb (IgG), and Au colloids (with fixed 
concentrations of arabinogalactan used) for running immunoassays (analysis for 
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antibody-antigen interactions) were determined by a series of concentration analyses. 
In some analyses, the concentration of the mAb was fixed in the first of three analyses. 
Different concentrations of SAb (IgG) were then conjugated with a fixed 
concentration of gold colloids present. Enhancement tests (described by Figure 4.4-1 
in Section 4.4.1) are carried out for each concentration of SAb-Au conjugate. The 
signal responses obtained for each concentration of SAb-Au were plotted against the 
concentration of SAb (IgG) used to prepare the SAb-Au conjugates (binding curve), 
and the lowest concentration at which the SAb-Au signal response is near the 
maximum in the binding curve determined to be the optimum SAb (IgG) 
concentration. By fixing the concentration of SAb (IgG) and the Au colloids, the 
optimum concentration of mAb can then be determined. When all three optimum 
concentrations of mAb, SAb (IgG) and Au colloids are obtained, an signal 
enhancement level can be determined. Consequently, an assay for determining the 
LOD for progesterone can then be carried out. 
 
The schematic process of determining the optimum concentration of mAb, SAb (IgG) 
and gold colloids for running progesterone immunoassay is illustrated for clarity in 
Figure 4.4-2. 
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Figure 4.4-2 Four key steps required for the development of the progesterone immunoassay 
 
4.4.3.2 Non-specific binding studies 
The enhancement species was made up of three different components, namely SAb 
(IgG), gold colloids, and arabinogalactan (AG). Each of these might contribute to the 
non-specific binding on the immobilised progesterone surface. Therefore, each 
component along with the SAb-Au conjugate were prepared and tested on the CM5 
1. Determine the optimum concentration of SAb (IgG) by preparing SAb-Au 
conjugates with different concentration of SAb (IgG) with fixed concentration 
of Au colloids. Test the conjugates with fixed concentration of mAb. 
2. Determine the optimum concentration of Au colloids by preparing SAb-Au 
conjugates with fixed concentration of SAb (IgG) (ie. optimum SAb (IgG) 
concentration determined from 1) and different concentrations of Au colloids. 
Test the conjugates with fixed concentration of mAb. 
3. Determine the optimum concentration of mAb by testing different 
concentrations of mAb with the optimum concentration of SAb-Au conjugate 
determined from the first two steps. 
4. Once the optimum concentrations of mAb and SAb-Au conjugate are 
determined, these conditions can then be applied to the progesterone-mAb 
competition assay (see Section 4.6). 
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sensor chip with immobilised progesterone. 
 
The gold colloids alone was firstly analysed for non-specific binding using the CM5 
chip. The 1:1 diluted colloidal gold was further diluted at 1:1 ratio with the (0.3 mol/L 
+ 1 mL /100 mL PEG400 + HBS) dilution buffer. It was “Quickinjected” into the 
reference and sample flow-cell at 40 mL over 2 minutes for the non-specific binding 
test. The surface was then regenerated with the Reg Buffer 1 at 10 mL over 0.5 
minute. 
 
The effect of using AG solution versus the HBS solution on the extent of non-specific 
binding was then studied. In order to determine the role (if any) that AG played in the 
non-specific binding of SAb-Au conjugate, a mixture of 5 g/L AG and 100 mg/mL 
SAb (IgG) were tested with and without the 1:1 dilution with the dilution buffer. The 
concentrations specified were the final concentrations after dilution with either HBS 
buffer or the dilution buffer at 1:1 ratio. The SAb (IgG) samples were analysed by 
BIAcore using the same injection procedures described above for gold colloids. 
 
Lastly, SAb-Au conjugates with final concentration of 17.5 and 100 mg/mL were 
tested for non-specific binding. The samples were diluted with the dilution buffer (0.3 
mol/L + 1 mL /100 mL PEG400 + HBS) at 1:1 ratio. 
 
The non-specific binding study using the SAM sensor chip was also carried out. 
SAb-Au conjugates prepared by adding 1:2 diluted gold colloids with different 
concentrations of SAb (IgG) were tested for their levels of non-specific binding. Each 
concentration of SAb-Au conjugate was injected (without the target analyte, mAb) 
through the reference and sample flow-cells at 40 mL over 4 minutes. Reg Buffer 2 
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was then used to regenerate the surface by injecting at 10 mL over 0.5 minute to the 
same reference and sample flow-cells. 
 
4.4.3.3 Signal enhancement using SAb (IgG) vs. signal enhancement 
using SAb-Au conjugate 
Analyses were carried out to confirm experimentally that SAb-Au conjugates have a 
greater signal response enhancement than SAb (IgG) alone. Gold colloids were 
prepared by the procedure described in Section 4.4.2.1. The colloids were diluted 1:1 
with 5 g/L AG. The diluted samples were then conjugated (by following the procedure 
for preparing the SAb-Au conjugate described in Section 4.4.2.5) with two different 
concentrations of SAb (IgG) to make 35 and 200 mg/mL SAb-Au conjugates. 35 and 
200 mg/mL SAb (IgG) were also prepared without the gold colloids. The SAb-Au 
conjugates and the SAb (IgG) were diluted 1:1 with the dilution buffer before they 
were being analysed. The final concentrations of SAb (IgG) in the gold conjugated 
and unconjugated samples were 17.5 and 100 mg/mL. 
 
25 and 100 mg/mL of mAb were prepared by the procedure described earlier in 
Section 4.4.2.3. The level of enhancement using the conjugates and the SAb (IgG) 
were tested with the two concentrations of mAb. The injection scheme was based on 
the study by Mitchell et al. The mAb was injected into the reference and sample 
flow-cell of a modified CM5 chip (using “Quickinjection”) at 60 mL over 3 minutes. 
This was followed by the enhancement species at 40 mL over 2 minutes. The surface 
of the sensor chip was regenerated twice with Reg Buffer 1 at 10 mL over 0.5 minute 
per injection. 
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4.4.3.4 Effect of Particle Size on Signal Enhancement 
The borohydride reduced Au colloids prepared in Section 4.4.2.1 had two different 
particle size distributions. These are illustrated by the size results of sample 130806-1 
and 130806-2 in Section 3.4.5 in Chapter 3. The colloids were used to study the effect 
of particle size on signal enhancement. The study was carried out on a CM5 sensor 
chip. 
 
2.3 mg/mL and 400 mg/mL SAb (IgG) were used to make conjugates with Au colloids 
prepared by the procedure shown in Section 4.4.2.1. The concentrations of SAb (IgG) 
were only preliminary concentrations (concentrations that were estimated based on 
previous studies by Mitchell et al and Jing et al). For each size of gold colloids, three 
conjugates were prepared by the procedure described in Section 4.4.2.5. These 
included a blank sample containing 1000 mL Au colloids + 100 mL deionised water + 
50 mL 10 g/ 100 mL BSA; a sample with 1000 mL Au colloids + 100 mL of 2.3 mg/mL 
SAb (IgG) + 50 mL 10 g/ 100 mL BSA; and a sample with 1000 mL Au colloids + 100 
mL of 400 mg/mL SAb (IgG) + 50 mL 10 g/ 100 mL BSA. The conjugates were diluted 
in a 1:1 ratio with the dilution buffer before the analysis. After dilution, the final 
concentrations of SAb (IgG) in SAb-Au conjugates prepared from 2.3 mg/mL and 400 
mg/mL SAb (IgG) were 100 and 17.5 mg/mL respectively. 
 
25 mg/mL and 100 mg/mL of monoclonal anti-progesterone were prepared by the 
procedure described in Section 4.4.2.3. The 25 mg/mL mAb was “Quickinjected” at 
60 mL over 3 minutes through the reference and sample cells. This was followed by a 
“Quickinject” of a sample of the six SAb-Au conjugates at 40 mL over 2 minutes. The 
surface was regenerated with Reg Buffer 1, which was “Quickinjected” twice at 10 
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mL over 0.5 minute. This process was repeated until all six SAb-Au conjugates were 
tested against both concentrations of mAb. 
 
The particle size effect was not tested using the SAM chip. This will be discussed in 
Section 4.5. 
 
4.4.3.5 Secondary Antibody – Gold Conjugate Binding Curve 
SAb-Au conjugate has two factors which can influence its level of enhancement: 1) 
the concentration of gold colloids used (this was studied by monitoring the effect of 
varying concentration of Au colloids with fixed concentration of mAb and SAb (IgG)), 
and 2) the concentration of SAb (IgG) used (the optimum concentration of SAb (IgG) 
was determined by measuring the level of enhancement of SAb-Au conjugate using 
various concentrations of SAb (IgG) while holding the concentration of mAb and the 
gold colloids fixed). 
 
The gold colloids were diluted by dilution factors of 2, 2.5, and 3 with 0.5% w/v AG 
solution. Samples diluted two-folds were prepared by adding 1 mL of the as-prepared 
gold colloids to 1 mL 5 g/L AG solution. Colloids diluted 2.5 folds were prepared by 
adding 1 mL of the as-prepared gold colloids to 1.5 mL of 5 g/L AG solution. Colloids 
diluted 3 folds were prepared by adding 1 mL of the as-prepared gold colloids to 2 mL 
of 5 g/L AG solution. The preparations were carried out by using Eppendorf 
micropipettes. 
 
SAb-Au conjugates with SAb (IgG) concentration of 0.4 and 2.3 mg/mL were 
prepared with the different concentrations of gold colloids according to the procedure 
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described above. The conjugates were then diluted 1:1 with the (0.3 mol/L sodium 
chloride + 1 mL/ 100 mL PEG 400 + HBS) dilution buffer. The 17.5 and 100 mg/mL 
SAb-Au conjugates were then analysed by BIAcore on the CM5 chip using fixed 
concentrations (5 mg/mL) of mAb in each. “Quickinjection” was the injection mode 
used for delivering the samples to the sensor chip surface. The mAb was injected 
through the reference and sample flow-cells at 60 mL over 3 minutes. It was followed 
by the SAb-Au conjugate at 40 mL over 2 minutes. Reg Buffer 1 was then injected 
twice at 10 mL over 0.5 minute. All samples were analysed using this procedure. 
 
Upon identifying the optimum concentration of gold colloids to use, this parameter 
was kept fixed and the SAb-Au conjugates were prepared by varying the 
concentration of SAb (IgG) at 0, 50, 100, 200, 400, and 800 mg/mL using the 
borohydride reduced gold colloids with smaller (ca. 10 nm) particle size (130806-1). 
For gold colloids with bigger (ca. 16 nm) particle size (130806-2), the SAb (IgG) 
concentrations were 0, 10, 17.5, 25, and 50 mg/mL (different concentration scheme 
was used for the larger colloids due to the different responses that the larger colloids 
gave in comparison with the smaller colloids (see Section 4.5). The samples were 
analysed by BIAcore using the same sequential injection scheme: 1) 5 mg/mL mAb 
was injected through the reference and sample flow-cells at 60 mL over 3 minutes. 2) 
the SAb-Au conjugate at 40 mL over 2 minutes. 3) Reg Buffer 1 injected twice at 10 
mL over 0.5 minute. 
 
When determining the optimum concentrations of Au colloids on the SAM chip, gold 
colloids with 1:1 and 1:2 dilutions with 5 g/L AG solution were prepared. SAb-Au 
conjugates with final SAb (IgG) concentration of 100 mg/mL were then prepared with 
these two different concentrations of gold colloids. The conjugates were tested with 
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2.5 mg/mL mAb (mAb concentration was determined by “trial and error”), which was 
injected first at 60 mL over 3 minutes. It was followed by the conjugate at 40 mL over 
4 minutes. The surface was regenerated with Reg Buffer 2 twice at 10 mL over 0.5 
minute. 
 
When determining the optimum concentration of SAb (IgG) to use in SAb-Au 
conjugate on the SAM chip 0, 25, 50, 100, and 200 mg/mL SAb-Au conjugates were 
prepared with 1:2 diluted gold colloids. These were tested again with 2.5 mg/mL mAb 
using the same injection conditions defined above. 
 
4.4.3.6 Monoclonal Antibody Binding Curve 
The monoclonal antibody (mAb) binding curve was determined by fixing the 
concentration of SAb-Au conjugate and plotting the level of signal responses of the 
conjugate versus the different concentrations of mAb used. 
 
The concentration of SAb (IgG) in SAb-Au conjugates was fixed at 100 mg/mL for 
gold colloids with smaller particle size and 17.5 mg/mL for gold colloids with bigger 
particle size (see Section 4.5.3 in Chapter 4 on how these SAb (IgG) concentrations 
were obtained). 0, 2, 5, 15, and 25 mg/mL of mAb were prepared in HBS-EP buffer. 
The enhancement effect of the two SAb-Au conjugates was tested against each 
concentration of mAb (starting from the lowest concentration). This was carried out 
by injecting, firstly, the mAb at 60 mL over 3 minutes through the reference and 
sample flow-cells using “Quickinjection”. This was followed by “Quickinjecting” one 
of conjugates at 40 mL over 2 minutes through the same flow-cells. The surfaces of 
both flow-cells were regenerated with two injections of Reg Buffer 1 at 10 mL over 
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0.5 minute. The responses generated from mAb and SAb-Au conjugates were plotted 
against the concentration of mAb. Level of signal enhancement was calculated from 
the slopes of the plots. 
 
For the SAM sensor chip, the optimum concentration of mAb was identified by fixing 
the SAb (IgG) concentration at 100 mg/mL in the SAb-Au conjugate. The conjugate 
was prepared with 1:2 diluted gold colloids, and it was tested with 0, 0.5, 1, and 2.5 
mg/mL mAb. Each sample of mAb was injected into the reference and sample 
flow-cell at 60 mL over 3 minutes. The conjugate was then injected through the same 
flow-cells at 40 mL over 4minutes. The surface was regenerated with Reg Buffer 2 
twice at 10 mL over 0.5 minute. 
 
4.4.3.7 Binding curves for a fresh CM5 sensor chip 
A new progesterone surface was prepared on a new CM5 sensor chip by the procedure 
described in Section 4.3.1 (The reason for preparing a new CM5 surface is discussed 
in Section 4.5.4). The optimum mAb, SAb (IgG), and gold concentrations were 
determined again. 
 
The SAb (IgG) concentration in SAb-Au conjugate was determined by fixing the 
concentration of gold colloids at 1:1 dilution (prepared by following procedure 
described in Section 4.4.2.1) and mAb concentration at 2 mg/mL. The non-specific 
binding of the SAb-Au conjugate at different SAb (IgG) concentrations were also 
analysed. The injection procedure was exactly the same as before apart from the 
SAb-Au conjugate, which was injected at 40 mL over 4 minutes instead of 40 mL over 
2 minutes. 
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The Au concentration binding curve was not determined, as the optimum dilution 
ratio of 1:1 was carried forward from the earlier study. The optimum mAb 
concentration was determined by fixing the SAb (IgG) concentration of the SAb-Au 
conjugate and the gold concentration. The concentration of mAb was varied from 0, 2, 
2.5, and 3 mg/mL. 
 
4.5 Signal Enhancement Results & Discussions 
4.5.1 Non-specific binding study 
The non-specific binding of the SAb-Au enhancement species was mainly contributed 
to by the SAb (IgG). Table 4.5-1 contains the non-specific binding determined from 
the experiments described in Section 4.4.3.2 of each species in the SAb-Au conjugate. 
It showed that arabinogalactan and the gold colloids exhibited little (< 10 RU) 
non-specific binding on the immobilised progesterone surface. The responses listed in 
Table 4.5-1 were obtained from the sensorgrams obtained from direct injection of 
each species (listed in Table 4.5-1) without injecting the analyte (mAb) beforehand. 
An illustration of how the non-specific binding responses were obtained from the 
sensorgrams is shown in Figure 4.5-1. 
 
 116 
0 100 200 3 00 40 0 50 0
-5 00
0
5 00
10 00
15 00
20 00
R
es
po
ns
e 
U
ni
t (
R
U
)
T im e  (se con d s)
 S A b  (Ig G ) w ith o u t d ilu tio n  b u ffe r
 S A b  (Ig G ) w ith  d ilu tio n  b u ffe r
 
Figure 4.5-1 Sensorgrams of the non-specific binding study of SAb (IgG). The sensorgram shown in 
black was SAb (IgG) without the (0.3 mol/L NaCl + 1 mL/100 mL PEG + HBS) dilution buffer. The 
non-specific binding was ca.870 RU. SAb (IgG) with added dilution buffer (shown in red) showed 
significantly lower level (ca. 7 RU) of non-specific binding on the progesterone surface (CM5 chip). 
 
The non-specific binding of gold colloids was always analysed after 1:1 dilution with 
the (0.3 mol/L sodium chloride + 1 mL/ 100 mL PEG400 + HBS) dilution buffer. This 
is a precautionary procedure to prevent permanent damage to the sensor surface. In 
the non-specific binding study, the effect of lowering the non-specific binding of SAb 
(IgG) was tested. The signal response of the sample “SAb (IgG) 100 mg/mL + 0.5% 
w/v AG without the dilution buffer” ( 876.9 RU) was similar to the signal response of 
“SAb (IgG) 100 mg/mL” (885.8 RU). This suggested that AG was ineffective in 
lowering the non-specific binding of SAb (IgG). The results clearly showed that with 
the addition of the (0.3 mol/L sodium chloride + 1 mL/ 100 mL PEG400 + HBS) 
dilution buffer was responsible for the reduction of the SAb (IgG) non-specific 
binding. 
Regeneration 
SAb (IgG) non-specific binding 
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Table 4.5-1 Non-specific bindings of the enhancement species on CM5 sensor chip (average responses 
from measurement of three replicates of each sample) 
Sample 
1:1 Dilution with Dilution Buffer? 
(Yes/No) 
Non-specific 
Binding (RU) 
SAb (IgG) 100 mg/mL No 885.8 ± 35.5 
SAb (IgG) 100 mg/mL Yes 6.2 ± 0.3 
0.5% w/v Arabinogalactan No -0.8 ± 0.2 
0.5% w/v Arabinogalactan Yes 2.6 ± 0.6 
SAb (IgG) 100 mg/Ml + 0.5% w/v AG No 876.9 ± 28 
SAb (IgG) 100 mg/Ml + 0.5% w/v AG Yes 8.2 ± 0.3 
Au colloids (small size) Yes -0.3 ± 0.2 
Au colloids (large size) Yes 2.1 ± 1.8 
Au (small size) + 17.5 mg/mL SAb Yes 1.9 ± 0.4 
Au (small size) + 100 mg/mL SAb Yes 7.3 ± 0.3 
Au (large size) + 17.5 mg/mL SAb Yes 6.1 ± 0.8 
Au (large size) + 100 mg/mL SAb Yes 7.6 ± 0.8 
 
The non-specific bindings of different concentrations of SAb-Au conjugates (prepared 
from small-sized colloids) on a SAM sensor chip were listed in Table 4.5-2. The 
non-specific binding of the SAb-Au conjugate had significantly increased on the 
SAM surface compared to the CM5 surface. The non-specific binding of the 100 
mg/mL SAb-Au sample (with small size Au colloids) on the CM5 surface was ca. 7.3 
RU. Compared to the same concentration of SAb-Au conjugate on the SAM surface 
(ca. 27.8 RU), there was about a 20 RU increase in non-specific binding. This, 
however, was expected. Since the coupling layer of SAM was thinner than CM5 (as 
mentioned in Section 4.3.2), the surface-analyte interactions are monitored more 
within the surface Plasmon region, thus SAM would be more sensitive in detecting 
any mass changes on the surface of the sensor chip than would the CM5 chip. Hence 
there would be an enhancement not only of specific binding responses but also 
non-specific binding responses.. 
 118 
Table 4.5-2 Non-specific binding of SAb-Au conjugates on SAM surface (average responses from 
measurement of three replicates of each sample) 
Concentration of Sab (IgG) 
(mg/mL) 
Non-specific binding (RU) 
0 1.4 ± 0.4 
25 4.9 ± 1.2 
50 12.8 ± 0.5 
100 27.8 ± 2.8 
200 30.9 ± 0.9 
 
4.5.2 Enhancement effect of particle size & SAb-Au 
The effect of SAb-Au conjugate containing different particle size of gold colloids in 
the conjugates is summarised in Table 4.5-3. The enhancement effects of these species 
were compared with the enhancement level of SAb (IgG) alone. As shown in Section 
4.1 and 4.4.1, the enhancement response was the signal response obtained when the 
SAb-Au conjugate was passed over the mAb (see Figure 4.4-1 in Section 4.4.1), 
which was bound to the immobilised progesterone. The enhancement ratios shown in 
Table 4.5-3 were calculated from the SAb-Au enhancement signal response over the 
mAb signal response. High enhancement ratios were highlighted in the table. The 
errors in enhancement ratio were calculated from the total percentage error involved 
in the mAb and enhancement responses. 
 
As the results showed, the enhancement ratio was at the highest (13 fold signal 
enhancement) when low concentrations of SAb (IgG) (17 mg/mL) were conjugated 
with Au colloids containing larger particles, or high concentration of SAb (IgG) (100 
mg/mL) were conjugated with Au colloids containing smaller particles. This finding 
might be explained by the packing arrangement of the SAb-Au conjugate on the 
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sensor surface. When large particles were involved, the large mass of the colloidal 
particles might be able to induce large changes in the refractive index on the sensor 
surface; however, steric crowding might have limited the number of the SAb-Au 
conjugates that could be bound to the sensor surface. Hence, the signal enhancement 
ratio of the SAb-Au conjugate (with 17 mg/mL SAb (IgG) and large colloids) was 
similar to the signal enhancement ratio of the SAb-Au conjugate (with 100 mg/mL 
SAb (IgG) and small colloids), as it did not have steric hindrance issue and more 
SAb-Au conjugates were able to be packed/bound to the sensor surface. 
 
Table 4.5-3 Comparison of response signals of SAb (IgG), SAb-Au conjugate, and particle effect on 
CM5 surface (average responses from measurement of three replicates of each sample) 
  
mAb (25 
mg/mL) 
Response (RU) 
SAb-Au 
Enhancement 
(RU) 
Enhancement 
Ratio 
SAb (17 mg/mL) 20.3 ± 0.4   45.4 ± 1.7 2.2 ± 6% 
SAb-Au 130806-1 (Small) 19.9 ± 0.4 59.0 ± 1.6 3.0 ± 5% 
SAb-Au 130806-2 (Large) 20.1 ( 0.5 260.2 ( 18.1 13.0 ( 9% 
      
SAb (100 mg/mL) 20.5 ± 0.5 101.4 ± 1.4  4.9 ± 4% 
SAb-Au 130806-1 (Small) 21.6 ( 1.4 281.0 ( 10.5   13.0 ( 10%  
SAb-Au 130806-2 (Large) 21.7 ± 0.2 210.1 ± 11.4 9.7 ± 6% 
 
  
mAb (100 
(g/mL) 
Response (RU) 
SAb-Au 
Enhancement 
(RU) 
Enhancement 
Ratio 
SAb (17 (g/mL) 69.5 ( 1.4  137.2 ± 2.2 2.0 ± 4% 
SAb-Au 130806-1 (Small) 73.4 ± 1.9 198.3 ± 5.3 2.7 ± 5% 
SAb-Au 130806-2 (Large) 70.7 ± 1.1 866.4 ± 20.6 12.3 ± 4% 
      
SAb (100 mg/mL) 73.3 ± 1.5  309.2 ± 7.7 4.2 ± 5% 
SAb-Au 130806-1 (Small) n/a n/a n/a 
SAb-Au 130806-2 (Large) n/a n/a n/a 
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SAb-Au conjugates with 100 mg/mL SAb (IgG) were not tested against the 100 
mg/mL mAb. Given the level of SAb (IgG) enhancement was already at around 300 
RU, the SAb-Au conjugates enhancement might be too high (> 1000 RU), in which 
case, the regeneration procedure would be difficult and the sensor surface might be 
damaged irreversibly by the permanently bound species. 
 
4.5.3 Binding curves of the first CM5 sensor chip used 
As mentioned in Section 4.4.3.5, the optimum concentration of SAb-Au conjugate is 
determined by the lowest concentration of SAb (IgG) and Au colloids that can 
produce the highest possible signal response. In Figure 4.5-2, the response obtained 
from SAb-Au conjugate made from undiluted Au colloids (with smaller size) was at 
ca. 68 RU. The response of SAb-Au made from 1:1 diluted Au colloids (with smaller 
size) was ca. 64 RU. As the Au colloids dilution increased to 1:2, the response 
decreased considerably to ca. 38 RU. Therefore, the optimum concentration of 
smaller-sized Au colloids was roughly at 1:1 dilution (or dilution factor of 2) of the 
Au colloids prepared in Section 4.4.2.1 (which was equivalent to Au colloids prepared 
from ca. 0.0036 mol/L KAuBr4 solution). The optimum concentration of larger-sized 
gold colloids was also at 1:1 dilution of the Au colloids prepared in Section 4.4.2.1 
(see Figure 4.5-3). The Au concentration binding curve of the Au colloids with larger 
particle sizes has an unusual shape which might be caused by the inconsistent particle 
size (shown in Section 3.4.4 in Chapter 3) in the sample of gold colloids. 
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Figure 4.5-2 Response signals of SAb-Au conjugate (100 mg/mL) with different concentration of Au 
colloids (130806-1) at 5 mg/mL mAb concentration (each data point was averaged from the 
measurement of three replicates) 
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Figure 4.5-3 Response signals of SAb-Au conjugate (17.5 mg/mL) with different concentrations of Au 
colloids (130806-2) at 5 mg/mL mAb concentration (each data point was averaged from three replicate 
of measurements) 
 
The SAb-Au conjugate binding curve is shown in Figure 4.5-4 and Figure 4.5-5 for 
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SAb-Au conjugates prepared from smaller and larger Au colloids respectively. Figure 
4.5-4 shows that at SAb (IgG) concentration of 800 mg/mL the SAb-Au (with smaller 
Au colloids) conjugate had the highest signal response (ca. 47 RU). The signal 
response, however, was only about 8 RU higher than the response from 100 mg/mL 
SAb (IgG) concentration. Thus 100 mg/mL was chosen as the optimum concentration 
of SAb (IgG) for preparing SAb-Au conjugate. 
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Figure 4.5-4 Binding curve of SAb-Au conjugate using borohydride reduced Au colloids (smaller 
particle size, ca. 10 nm). Signal responses were given rise by SAb-Au conjugate at different 
concentrations of SAb (IgG) at 5 mg/mL mAb. (each data point was averaged from three replicates of 
measurement) 
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Figure 4.5-5 Binding curve of SAb-Au conjugate using borohydride reduced Au colloids (larger 
particle size, ca. 16 nm). Signal responses are due to the SAb-Au conjugate at different concentrations 
of SAb (IgG) at 5 mg/mL mAb (each data point was averaged from three replicates of measurement) 
 
For gold colloids with larger particle sizes the optimum concentration of SAb (IgG) 
was at ca. 18 mg/mL. The binding curve in this experiment has demonstrated an 
unusual shape compare to the binding curve of SAb-Au made from gold colloids with 
smaller particle size in Figure 4.5-4. There was no clear explanation for why the shape 
of the curve is as observed. However, one possible reason for the unusual shape could 
be the inconsistent particle size in the colloidal sample. As shown in Section 3.4.4 in 
Chapter 3, the particle size distribution of the borohydride reduced Au colloids 
(130806-2), which contained larger particles, was relatively polydisperse compared 
those measured for borohydride reduced Au colloids with smaller particles (130806-1). 
The 130806-2 Au colloids have particles mainly in the 10 nm size range, but it also 
has particles in the 25-35 nm range. As the 130806-2 Au colloids exhibited a bimodal 
particle size distribution, the binding of SAb-Au conjugates on the sensor surface 
could involve some very different sizes of Au colloids (in which case perhaps packing 
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issues at the surface could be a factor). Thus the shape of the binding curve was less 
predictable compared to the binding curve obtained from SAb-Au conjugate 
generated from a more monodisperse Au colloids (130806-1). 
 
Figure 4.5-6 contains two overlaid sensorgrams, which illustrate different levels of 
100 mg/mL SAb-Au binding with two different concentrations of mAb. 
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Figure 4.5-6 Sensorgrams of signal enhancement using 100 mg/mL SAb-Au conjugate with 15 and 25 
mg/mL mAb 
 
The mAb binding curve with 100 mg/mL SAb-Au conjugate (with smaller colloids) is 
shown by Figure 4.5-7. The black line is a plot of the responses from the different 
concentrations of mAb, and the red line indicates the SAb-Au conjugate (with smaller 
Au colloids) and 100 mg/mL SAb (IgG)) enhancement with different concentrations of 
mAb. The enhancement effect of SAb-Au conjugate was calculated from the slopes 
(shown by the equations on the plot) of the two straight lines. The SAb-Au 
mAb binding 
SAb-Au binding 
Regeneration 
Extra regeneration 
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enhancement ratio was 12.6 fold higher than the signal responses produced by mAb 
alone. The enhancement ratio was calculated from the ratio between the two slopes. 
The enhancement level achieved in this study was very similar to the enhancement 
ratio (ca. 13 fold) reported by Mitchell et al. However, the level of enhancement in 
this study was achieved with the 100 mg/mL SAb-Au conjugate instead of the 800 
mg/mL SAb-Au conjugate prepared by Mitchell et al. This means the SAb-Au 
conjugate developed in this study was more efficient (compared to the SAb-Au 
conjugate made by Mitchell et al) in achieving the same level of signal enhancement 
as in the study by Mitchell et al. This represents an advance made in this study over 
the previous study by Mitchell et al by use of the non-citrate generated Au colloids as 
signal enhancement species. 
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Figure 4.5-7 mAb binding curve with (red) and without (black) SAb-Au enhancement (small colloids). 
The non-specific binding response of the SAb-Au conjugate has been subtracted from the plot. 
 
MAb binding curve with SAb-Au conjugate with large Au colloids and 100 mg/mL 
SAb (IgG) is shown by Figure 4.5-8. The enhancement level was 12.3 fold higher 
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than the level of response from the mAb alone. 
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Figure 4.5-8 mAb binding curve with (red) and without (black) SAb-Au enhancement (larger colloids). 
The non-specific binding response of the SAb-Au conjugate was subtracted off from the plot. 
 
The optimum mAb concentration was determined from the enhanced signal responses. 
The signal response after SAb-Au enhancement should be no more than 150 RU, as 
any responses higher than 150 after enhancement would result in problems with 
regenerating the sensor surface. From Figure 4.5-7 and 4.5-8, the optimum mAb 
concentration of both systems was at around 10 to 15 mg/mL, since the corresponding 
enhancement responses were around 100 to 150 RU respectively. 
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4.5.4 Binding curves of a newly prepared CM5 sensor chip 
After the preliminary tests were done, a new progesterone surface was immobilised 
onto a new CM5 sensor chip, and retested with the optimum conditions determined 
from the previous CM5 chip. The results showed the responses were slightly different 
from the previously determined mAb, SAb (IgG), and gold optimum concentrations. 
Therefore, the optimum mAb, SAb-Au concentrations were re-determined. 
 
One of the differences between the sensorgrams obtained from the previous CM5 
surface and sensorgrams from the new CM5 surface is that of the binding of the 
SAb-Au conjugate. The SAb-Au binding had “high” and “low” points shown on the 
sensorgram below. This characteristic was not observed in the sensorgrams from the 
previous CM5 surface (see Figure 4.5-6 in Section 4.5.3). In Figure 4.5-6, the 
SAb-Au binding did not have the large decrease (from “high” point to “low” point) in 
response as observed in Figure 4.5-9. Therefore, the binding level (the signal response) 
of SAb-Au on the previous CM5 surface was easy to determine, as there was only a 
point on the sensorgram which indicated the response given by the SAb-Au. The 
SAb-Au signal response on the new CM5 surface, however, had two points which 
might indicate the level of binding of SAb-Au conjugate on the sensor surface (see 
Figure 4.5-9). This made the determination of SAb-Au signal response difficult. The 
study later found that the “high” and “low” points had similar true responses 
(responses after subtracting the non-specific binding of SAb-Au conjugate from the 
enhancement responses) (see “True Binding” in Table 4.5-4). Thus only “high” points 
were used in the determination of mAb binding curve and the progesterone-mAb 
competition assay in Section 4.6. 
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Figure 4.5-9 Sensorgram of SAb-Au enhancement on a new CM5 surface 
 
Table 4.5-4 Non-specific and signal enhancement of SAb-Au conjugate on new CM5 surface 
  
Non-specific Binding 
(RU) 
Sab-Au Enhancement 
(RU) 
True Binding (RU) 
SAb-Au 
Sample 
(mg/mL) 
High Point Low Point High Point Low Point High Point Low Point 
0 83.2 ± 2.4 9.0 ± 0.4 88.8 ± 0.6 8.2 ± 0.2 5.6 ± 3.0 -0.8 ± 0.6 
12.5 82.4 ± 1.2 9.0 ± 0.4 88.9 ± 1.0 12.2 ± 0.4 6.6 ± 2.2 3.2 ± 0.8 
25 81.0 ± 1.5 7.7 ± 0.5 87.7 ± 0.9 11.3 ± 0.2 6.7 ± 2.4 3.6 ± 0.7 
50 82.0 ± 1.5 8.2 ± 0.4 94.7 ± 1.5 17.3 ± 0.6 12.8 ± 3.0 9.1 ± 1.0 
100 82.7 ± 0.8 8.9 ± 0.3 107.8 ± 2.2 33.3 ± 2.3 25.1 ± 3.0 24.3 ± 2.6 
200 88.2 ± 0.5 15.2 ± 0.6 141.5 ± 2.0 64.9 ± 1.1 52.4 ± 2.5 49.7 ± 1.7 
 
Three replicates of measurement of each concentration of SAb (IgG) were carried out 
like previous experiments. The errors in the true binding values were calculated from 
the total error involved in the non-specific binding and SAb-Au enhancement values. 
High point 
Low point 
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Figure 4.5-9 True SAb-Au enhancement at “High” and “Low” points 
 
200 mg/mL SAb-Au conjugate (with 1:1 diluted gold colloids) was chosen as the 
optimum concentration for running the competition assay (see Section 4.6) as the 200 
mg/mL SAb-Au conjugate had the highest signal response reported in Figure 4.5-9. 
 
The regeneration procedure was also different with the new progesterone surface. The 
regeneration procedure was normally carried out twice to fully regenerate the surface 
from > 150 RU (after SAb-Au enhancement). With the new surface, however, it took 
at least five regenerations to get the baseline from ca. 150 RU back down to 
approximately zero. This meant the concentration of mAb needed to be lowered in 
order to bring the SAb-Au response down to a certain level at which point surface 
regeneration could be carried out with only two injections of the regeneration buffer. 
 
The mAb binding curve is shown by Figure 4.5-10. The mAb binding curve should be 
similar to Figure 4.5-7. However, as Figure 4.5-10 shows, the correlation between the 
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RU value and mAb concentration was not linear. The optimum mAb concentration (3 
mg/mL) was still determined from the plot despite the non-linearity of the results. 
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Figure 4.5-10 mAb binding curve with 200 mg/mL SAb-Au conjugate enhancement (with 1:1 diluted 
gold colloids) on the new CM5 surface 
 
4.5.5 Binding curves for the SAM sensor chip 
From the binding curves, it was evident that the reduced thickness of the coupling 
layer had increased the mAb and SAb-Au responses on the SAM surface. The 
SAb-Au binding curve is shown in Figure 4.5-11. At 100 mg/mL SAb (IgG), the 
SAb-Au conjugate had already caused an enhanced response of around 170 RU with 
2.5 mg/mL mAb. Compared to the surface on the CM5 chip, this was over 4 times 
greater than the response given by the 100 mg/mL SAb-Au conjugate, which caused 
only a ca. 40 RU response from use of twice the amount of mAb (5 mg/mL). This 
shows that the SAM chip is a more sensitive surface for progesterone immunoassays 
and which could potentially lead to lower LOD value for the mAb binding ligand. 
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Figure 4.5-11 SAb-Au binding curve (at 2.5 mg/mL mAb concentration) using the SAM surface 
 
The signal enhancement ratio of the SAM surface was calculated from the mAb 
binding curve shown in Figure 4.5-13. The enhancement ratio was calculated to be ca. 
29 fold higher than the mAb response alone. This level of signal enhancement ratio 
through SAb-Au conjugate was more than twice the signal enhancement ratio 
achieved through the same enhancement species using the CM5 sensor chip (see 
earlier). The primary disadvantage, however, was the regeneration procedure – for the 
removal of SAb-Au conjugates from the SAM chip. This proved to be very difficult. 
Reg Buffer 1, which contained 0.05 mol/L sodium hydroxide + 10 mL /100 mL 
acetonitrile was used to regenerate the SAM surface initially. However, due to the 
SAb-Au conjugate developed in this study, complete regeneration was not possible 
even with a stronger regeneration buffer (0.05 mol/L sodium hydroxide + 20 mL /100 
mL acetonitrile, Reg Buffer 2) (see Figure 4.5-12). 
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Figure 4.5-12 Sensorgram showing 100 mg/mL SAb-Au conjugate enhancement of response from 2.5 
mg/mL mAb. The red dotted line indicates the residue response (ca. 60 RU) after 2 regenerations of the 
progesterone surface on the SAM chip. It was suspected that SAb-Au conjugates were irreversibly 
deposited on the sensor surface. 
 
Possibly what happened was that the gold exhibited a greater affinity for the gold on 
the surface (which is more denuded presumably relative to the CM5 chip) so that it 
was harder to remove. The gold colloids could also be binding to the layers 
pre-deposited on the gold SAM. 
 
The consequence of this is that the surface could be easily damaged by the materials 
that were remained on the surface. Thus the number of active sites (number of 
immobilised progesterone molecule) that are free for mAb binding on the sensor 
surface can decrease. As a result, the responses generated by the sensor surface also 
decreases (since less mass can now be bound on the sensor surface). This was thought 
to be the cause of the non-linearity of the SAb-Au enhancement shown in the mAb 
Baseline 
Baseline 
after 
regeneration 
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binding curve (see Figure 4.5-13). Indeed, the damaged surface might have induced 
variability in responses, which were encountered from time to time during the 
determination of the optimum mAb, SAb-Au concentrations using the SAM chip. 
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Figure 4.5-13 mAb binding curve with (red) and without (black) 100 mg/mL SAb-Au enhancement 
using the SAM chip 
 
Despite the problem with surface regeneration, the research using the SAM sensor 
chip was continued to the next stage, at which a progesterone-mAb competition assay 
was carried out with 2.5 mg/mL mAb using 100 mg/mL SAb-Au conjugate (with 1:2 
diluted Au colloids) as signal enhancement species. 
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4.6 Progesterone – mAb Competition Assay 
4.6.1 Introduction 
One of the methods for assaying the concentration of progesterone in “real samples”, 
such as milk or blood serum, is by adding an excess of known concentration of 
monoclonal anti-progesterone (mAb) to a sample with unknown concentration of 
progesterone.  The mAb would interact with the progesterone in the flowing sample, 
and cause a reduction in the concentration of free mAb in the mixture. The limited 
amount of free mAb remaining in the sample can then be detected by complexation 
with the immobilised progesterone on the sensor chip. This process is called a 
“competition assay”, as immobilised progesterone is competing against free 
progesterone in the sample for the limited amount of mAb (see Figure 4.6-1). 
  
 
 
 
 
 
Figure 4.6-1 Schematic diagram showing the principle behind the progesterone-mAb competition assay. 
1) The progesterone sample is firstly mixed with a known excess concentration of mAb. 2) Since the 
1 
2 
3 4 
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mAb is in excess, after it has been mixed with the progesterone a small amount of free (not bound with 
progesterone) mAb is still present in the sample. 3) The sample is flowed over the sensor surface with 
immobilised progesterone. Free mAb will bind to the immobilised progesterone while 
progesterone-mAb complexes are flowed pass without interacting with the surface. 4) SAb-Au 
conjugates are then flowed pass over the surface-bound mAb for signal enhancement. 
In order to determine the LOD of the assay, it is essential to obtain a competition 
assay standard binding curve. The concentration of progesterone in a “real sample” 
can be calculated from the equation 30 that describes the shape of the curve. 
 
b
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-
=
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Where, 
y = response 
x = concentration 
a = maximum response 
b = minimum response 
c = concentration at 50% response 
d = slope of the line at the mid-point 
 
The detection limit of an immunoassay is also calculated using the equation defined 
above. The response, y, of the LOD is generally defined as the signal response of a 
blank sample (ie. Sample with the highest concentration of mAb) less two standard 
deviations (sometimes three standard deviations) of the mean signal response of the 
blank sample 30. The LOD concentration can then be calculated providing all the other 
parameters in the equation are obtained from the competition assay standard binding 
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curve. The sensitivity can be described by the LOD of the assay, or it can be 
expressed by the slope (signal per unit concentration change) of the approximated 
straight line in the middle-region of the binding curve. 
 
The standard binding curve is obtained by running a progesterone-mAb competition 
assay using mixtures of different concentrations of progesterone standards and a 
known concentration of mAb. The curve is a plot of Response Unit (RU) (obtained 
from free mAb) versus the concentrations of progesterone in the progesterone-mAb 
mixtures. A typical standard binding curve is illustrated in Figure 4.6-1. At near zero 
concentration of progesterone, the concentration of free mAb is at the highest, thus 
this region of the curve has high signal responses. When the concentration of 
progesterone is increased the concentration of free mAb in the sample decreases. This 
leads to a drop in response to near zero, or to the level of non-specific binding of 
SAb-Au conjugate if enhancement species are used. A straight line can be 
approximated at the mid-region of this curve (see Figure 4.6-2). 
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Figure 4.6-2 Assay Standard Curve Using 10nm-Streptavidin / Biotinylated Antibody Pre-Incubation 
(43.75 mg/mL final mAb concentration) studied by Mitchell et al. The signal responses decreased as the 
concentration of mAb decreased or the concentration of progesterone in the sample increased. 
 
In this study, progesterone-mAb competition assays were carried out using the 
stabilised SAb-Au conjugate methodology developed earlier. The assays were carried 
out using progesterone standards, and the sensitivity was determined from the 
resulting standard binding curves (similar to the standard binding curve illustrated in 
Figure 4.6-2). 
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4.6.2 Sample preparation for progesterone-mAb competition 
assay 
The mAb, SAb-Au conjugate, dilution buffer, and regeneration buffer were all 
prepared according to the procedures described in Section 4.4. A sample of gold 
colloids with the same recipe as 130806-1 (0.0072 mol/L of KAuBr4, 0.5% w/v 
arabinogalactan, and 0.036 mol/L sodium borohydride) was prepared by following the 
procedure described in Section 4.4.2.1. The colloidal sample was diluted with 5 g/L 
AG solution in a 1:2 ratio (10 mL of the Au colloids was diluted with 20 mL of 5 g/L 
AG solution) The sample was stored in a sample tube at ~4°C. 100 mg/mL SAb-Au 
conjugate was prepared with the gold colloids by following the procedure described in 
Section 4.4.2.5. 
 
A 10 mg/mL progesterone standard was prepared in a glass vial by dissolving 
progesterone (Sigma, St. Louis, MO, USA) with 99.8% N, N-dimethylformamide 
(DMF) (Sigma, St. Louis, MO, USA). 10 mL of the 10 mg/mL progesterone solution 
was then diluted in 990 mL of HBS-EP buffer to make 1000 mL of 100 mg/mL 
progesterone. A white precipitate of progesterone was formed when progesterone in 
DMF was added to HBS-EP buffer (this is because the P4 is relatively hydrophobic 
and prefers to remain dissolved in the DMF and comes out in aqueous solutions 
comprising the HBS-EP buffer). To minimise the amount of precipitated progesterone, 
a hundred-fold dilution was made instead of a ten-fold dilution (as the latter dilution 
factor resulted in more precipitation than the one hundred-fold dilution). A series of 
known concentrations of progesterone was prepared by sequential ten-fold dilutions 
with HBS-EP buffer. 100 mL of the 100 mg/mL progesterone prepared earlier was 
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diluted in 900 mL of HBS-EP buffer to make 1000 mL of 10 mg/mL progesterone stock 
solution. This dilution process was repeated for the preparation of 1 mg/mL, 100, 10, 1 
ng/mL, 100, 10, 1 pg/mL, 100, 10, and 1 fg/mL progesterone solutions. 
 
5 mg/mL mAb was prepared by the procedure described in Section 4.4.2.3. The 5 
mg/mL mAb was then mixed with each of the progesterone standards in a 1:1 dilution 
ratio. The resulting concentrations of mAb and progesterone were therefore halved (ie 
after mixing with the progesterone standard, the concentration of mAb in the mixture 
was 2.5 mg/mL). 
 
4.6.3 Development of the progesterone-mAb competition 
assay using CM5 sensor chip 
The newly prepared CM5 sensor chip described in Section 4.4.3.7 was used for the 
competition assay. The fresh surface was immobilised with P4-OEG-OVA and a 
reference flow-cell was immobilised with OVA. The procedure for these 
immobilisation experiments was described in Section 4.3.1. 
 
Before the competition assay was carried out, the non-specific binding of SAb-Au 
conjugate was checked again. The 100 mg/mL SAb-Au was injected (using 
“Quickinjection”) into the reference and sample flow-cell at 40 mL over 4 minutes. 
The non-specific binding of 100 mg/mL SAb-Au on the new CM5 chip was ca. 85 RU, 
which was significantly higher than the non-specific binding of 100 mg/mL SAb-Au 
on the first CM5 chip (ca. 7 RU). 
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After completion of the check on non specific binding with the SAb-Au conjugate, the 
competition assay was run using 100, 10, 1 ng/mL, 100, 10 pg/mL progesterone 
standards. A 6 mg/mL mAb solution was prepared in HBS-EP buffer and 150 mL of 
the 6 mg/mL mAb was then mixed with 150 mL each of the progesterone standards. 
Each progesterone/mAb sample was subsequently injected (using “Quickinjection”) 
into the reference and sample flow-cells on the BIAcore at 60 mL over 3 minutes. A 
200 mg/mL SAb-Au conjugate with 1:1 diluted gold colloids (10 mL of Au colloids 
prepared by the procedure described in Section 4.4.2.1 was added to 10 mL of 5 g/L 
AG) was prepared. It was diluted again (in a 1:1 mixing ration) with the (0.3 mol/L 
sodium chloride + 1 mL/ 100mL PEG400 + HBS-EP) dilution buffer before it was 
injected into the reference and sample flow-cells at 40 mL over 4 minutes. This 
prolonged injection rate allowed more interaction time for the SAb-Au conjugate and 
surface bound mAb. The surface was regenerated twice with Reg Buffer 2, which 
consisted of 20 mL/100mL acetonitrile in 0.05 mol/L NaOH solution, at 10 mL over 
0.5 minute. The increased concentration of acetonitrile in the regeneration buffer 
allowed more vigorous removal of the surface-bound SAb-Au conjugates. 
 
Each sample of progesterone/mAb was analysed three times and the standard binding 
curve (which was a plot of signal responses from each sample versus the 
concentration (in log scale) of the progesterone standards used in the assay) was 
obtained. 
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4.6.4 Development of progesterone-mAb competition assay 
using SAM sensor chip 
The coupling layer of the SAM sensor chip was prepared by the procedure described 
in Section 4.3.2. The coupling layers on the reference and sample flow-cells of the 
SAM sensor chip were immobilised with 500 mg/mL of OVA and 500 mg/mL of 
P4-PEG-OVA respectively. The immobilisation procedure is also described in section 
4.3.2. 
 
5 mg/mL mAb along with 10, 1 pg/mL, 100, 10, 1, and 0.1 fg/mL progesterone 
standards were prepared by the procedure described in Section 4.6.2. The low 
concentrations of progesterone (compared to the progesterone-mAb competition assay 
using the CM5 chip) were used in this assay because the SAM chip was proven (as 
shown in Section 4.5.5) to be very sensitive in the detection of mAb with SAb-Au 
enhancement. Therefore the LOD of the progesterone-mAb competition assay using 
the SAM chip was expected to be low compared to the progesterone-mAb carried out 
on the CM5 chip. 100 mg/mL SAb-Au conjugate with 1:2 diluted gold colloids was 
prepared according to the previous procedure described in Section 4.4.2.1. 150 mL of 
the 5 mg/mL mAb was mixed with 150 mL of each of the progesterone standards 
before each sample was injected (using “Quickinjection”) into the reference and 
sample flow-cells at 60 mL over 3 minutes. The 100 mg/mL SA-Ab conjugate was 
injected after previous injection of a progesterone-mAb sample. The injection rate for 
the SAb-Au conjugate was at 40 mL over 4 minutes. Reg Buffer 2 was used to 
regenerate the sensor surface. It was injected twice, and depending on the 
effectiveness of regeneration, the injection was varied between 10 mL over 0.5 minute 
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and 20 mL over 1 minute. Each sample of progesterone/mAb was analysed three times 
and the standard binding curve (which was a plot of signal responses arising from 
each sample versus the concentration (in log10 scale) of the progesterone standards 
used in the assay) was obtained. 
 
4.7 Results & Discussion - Competition Assay 
4.7.1 Competition assay using the CM5 sensor chip 
Figure 4.7-1 shows the standard binding curve of the progesterone-mAb competition 
assay carried out on the CM5 chip. This figure shows the plot of the responses arising 
from the different concentrations of progesterone/mAb samples versus the 
concentration of progesterone standards (in log scale) used in the experiment. The 
hyperbolic shape of the binding curve in this experiment was similar to the 
progesterone-mAb binding curve (shown in Figure 4.6-1 in Section 4.6.1) obtained by 
Mitchell et al. However, the range between the highest response (response given rise 
by the blank sample (contained no progesterone)) and the lowest response (response 
given rise by 100 mg/mL SAb-Au conjugate alone) was only ca. 40 RU. This low 
response range suggested that the progesterone-mAb competition assay developed on 
the CM5 chip is not practical for analysis of real progesterone samples (ie. milk 
samples or samples of unknown concentrations of progesterone), since the the 40 RU 
working range spanned a wide range of progesterone concentrations (from ca. 10 
pg/mL to ca. 10 ng/mL of progesterone) (see the middle part of the binding curve in 
Figure 4.6-1), so the responses arising from two concentrations of progesterone (say 
for example 20 pg/mL and 40 pg/mL) are similar, making the distinguishing of the 20 
pg/mL from the 40 pg/mL progesterone sample impossible by using this 
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progesterone-mAb assay developed on the CM5 chip. 
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Figure 4.7-1 Progesterone-mAb competition assay binding curve using CM5 surface 
 
The results from the competition assay also suggested that the CM5 surface was 
inappropriate for carrying out progesterone immunoassay because of the high level of 
non-specific binding, which after accounting for led to low true responses. The 
inconsistent responses from the two CM5 sensor chips prepared were also a concern 
for the viability of this type of surface (ie. the dextran coupling layer) for running the 
progesterone immunoassay. 
 
Despite the concerns, the progesterone-mAb competition assay was still carried out as 
a comparison to the competition assay carried out on a SAM chip. 
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The error bars in the plot were determined by the Student’s T test (95% confidence 
with 2 degrees of freedom). The LOD concentration was not calculated from the 
equation shown in Section 4.6.1. Due to the narrow range of response across the 
whole assay, the assay might not be valid and reliable. Hence, the calculated LOD 
value might be meaningless. Furthermore, to obtain a valid LOD value for the assay, 
the competition assay was required to be repeated for a number of times, and the error 
involved in the LOD could then be calculated from the standard deviation between the 
LOD values. Due to time constraint, this was not carried out in this study. Therefore, 
the only conclusion that this competition assay binding curve could make is that the 
LOD value was mostly likely to be in the 5-20 pg/mL range. This work will be 
discussed in Chapter 5 as one of the tasks to be repeated in future studies. 
 
4.7.2 Competition assay using the SAM sensor chip 
Since the SAM was able to improve the signal responses of mAb using the SAb-Au 
conjugate by ca. 29 fold (compared to ca. 13 fold mAb signal enhancement using 
SAb-Au using the first CM5 chip), the progesterone-mAb competition assay was 
expected to be significantly more sensitive and less problematic than the assay carried 
out on the CM5 sensor chip. The competition assay binding curve is shown in Figure 
4.7-2. 
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Figure 4.7-2 Progesterone-mAb competition assay binding curve using SAM surface 
 
The binding curve shown above shows that the working range (the difference between 
the highest response given rise by the blank progesterone/mAb sample and the 
non-specific binding response of the 100 mg/mL SAb-Au conjugate) was ca. 95 RU, 
which was more than twice the working range of the assay carried out on the CM5 
chip (see Section 4.7.1). The higher working range of 95 RU suggests that this assay 
(developed on the SAM chip) was more applicable in progesterone analysis than the 
assay developed on the CM5 chip, as the responses arising from two different 
concentrations of progesterone (say for example 20 fg/mL and 40 fg/mL progesterone 
samples) were more distinguishable (due to the higher working range). 
 
The LOD value could not be calculated for this competition assay because only one 
reliable assay (using the SAM) was obtained during the MSc study. To obtain a 
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meaningful LOD value for this assay, the competition assays should ideally be done in 
triplicate. The mean LOD value (along with the standard deviations of the mean LOD 
value) of the three assays could then be calculated. The only conclusion can be 
gleaned from Figure 4.7-2 is that the LOD of this assay is in the 5-20 fg/mL region, 
which is about a thousand times more sensitive than the assay developed on the CM5 
chip (LOD of ca. 5-20 pg/mL). 
 
During the study, attempts to reproduce the progesterone-mAb competition assay 
using the SAM chip were carried out; however, the sensor chip was damaged due to 
the irreversibly deposited SAb-Au conjugates on the sensor surface. Thus the mAb 
binding responses arising from the progesterone/mAb samples with SAb-Au 
conjugate enhancement became inconsistent. Due to time constraint, the binding 
curve (Figure 4.7-2) obtained in this study was unable to be replicated. It is suggested 
in Chapter 5 that this work (obtaining progesterone-mAb competition assay binding 
curves using the SAM chip) should be repeated in future studies. 
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5. Conclusions 
The first part of the study which was concerned with finding the best gold colloid 
preparation to use in the BIAcore SPR-based experiments found that arabinogalactan 
was mostly a good stabilisation or protection agent for the colloids against 
aggregation, providing that appropriate ratios of reducing agent and arabinogalactan 
were used. In the case of colloids prepared by reduction with hydrazine hydrate, 
however, the use of 5 g/L arabinogalactan was insufficient to prevent the colloids 
from aggregating. For sodium borohydride and tri-potassium citrate, however, 5 g/L 
arabinogalactan was able to stabilise most of the colloidal gold samples, providing the 
reducing agent was around £10 times the concentration of the gold salt used. Sodium 
borohydride reduced gold colloids were mostly small in size. The diameter of the 
colloidal particles was predominantly below 10 nm. However, if the concentrations of 
the gold salt and the reducing agent were increased, small distributions (< 2%) of 
particles were found in the 20-35 nm range (using TEM data) in the 
borohydride-reduced colloidal sample. Citrate reduced gold colloids on the other hand 
were predominately around 17-20 nm. The citrate-reduced gold colloids prepared in 
this study were susceptible to aggregation without the addition of 5 g/L 
arabinogalactan. However, with added 5 g/L arabinogalactan (synergistically with 
citrate in the colloidal system) the citrate-reduced gold colloids had exhibited 
prolonged stability (ie. colloidal particles stayed longer in solution without 
aggregation). This was clearly illustrated in the TEM images of the protected and 
unprotected gold colloids generated by citrate reduction. 
 
AG-protected sodium borohydride reduced gold colloids were ultimately chosen for 
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preparing SAb-Au conjugates because of the stability that these colloidal samples 
possessed. Citrate and hydrazine reduced gold colloids were also subjected to the SAb 
(IgG) conjugation procedure for BIAcore analysis; however, precipitation occurred 
during the conjugate preparation. As citrate and hydrazine reduced gold colloids 
required pH adjustment to pH 8.5-9.0 and addition of electrolyte before SAb (IgG) 
conjugation, it was reasoned that these steps were responsible for bringing about the 
destabilisation of the colloids. 
 
The second part of this study investigated the use of the stable SAb-Au conjugate 
(produced from using the AG-stabilised borohydride-reduced gold colloid) in the 
progesterone immunoassay developed by Mitchell et al 31. The study was firstly 
carried out using a CM5 sensor chip. By determining the optimum SAb-Au 
concentrations from a series of tests, the SAb-Au conjugate was found to enhance the 
mAb response signal by approximately 13 fold (which was similar to the 
enhancement achieved by Mitchell et al); however, in contrast to that earlier study, the 
signal enhancement achieved in the present study was produced by a much lower 
concentration of SAb-Au conjugate (100 mg/mL of SAb (IgG)) compared to 800 
mg/mL of SAb (IgG) used by Mitchell et al 31. 
 
Two CM5 sensor chips were used during the development of the progesterone 
immunoassay. The second CM5 chip was found to give inconsistent responses 
compared to the immobilised progesterone surfaces on the first CM5 chip surface 
immobilised. The non-specific binding level of the progesterone surface on the second 
CM5 chip was also far greater than on the first CM5 chip used. This posed a problem 
when running a progesterone-mAb competition assay as the high level of SAb-Au 
non-specific binding significantly lowered the true signal responses from the mAb 
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with SAb-Au enhancement. The CM5 surface was thus deemed unfit for the 
progesterone immunoassay pending further study. The study then focussed on the use 
of the SAM sensor chip. When determining the optimum concentrations of mAb and 
SAb-Au conjugate for running an assay, the study found the SAb-Au conjugate was 
able to enhance the binding signal of mAb on the immobilised progesterone surface 
by approximately 29 fold (which was just over twice the SAb-Au signal enhancement 
ratio achieved using the (first) CM5 chip prepared). The estimated LOD of the 
progesterone assay developed on the CM5 and SAM chips were 5-20 pg/mL and 5-20 
fg/mL respectively. However, these LOD values are only estimates, as valid LOD 
values require the competition assay to be replicated. Attempts were made to replicate 
the competition assay using the SAM chip; however, due to sensor surface damage 
(from permanently bound SAb-Au conjugate on the surface), the result obtained 
earlier using the SAM chip could not be reproduced. 
 
Even though the true sensitivity of the progesterone immunoassay developed in this 
study was not determined, the SAb-Au conjugate enhancement species (generated 
with stabilised borohydride-reduced gold colloids) prepared here had achieved 
stability and signal enhancement ratio that previous study by Mitchell et al could not 
achieve. Further work is required to realise the full potential of the SAb-Au 
enhancement species created in this study. 
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5.1 Recommendations for further study 
It has been shown in this study how regeneration of the SAM sensor chip was 
challenging with the SAb-Au conjugate. Hence, any future study should be devoted to 
improving the regeneration procedure. This can be achieved by developing new 
regeneration buffers which minimise the loss of signal enhancement. 
 
The second objective should be to repeat the progesterone-mAb competition assay 
using the new optimised regeneration condition. 
 
The gold colloids can also be utilised in other immunoassays studies, as 
immunoassays for detecting molecules other than progesterone may give different 
SPR responses from the one given by the SAb-Au conjugates developed in this study. 
 
Lastly, SAb (IgG) conjugation with other metal colloids such as silver, palladium, or 
platinum could be explored in future investigations. Other systems such as fullerene, 
nanocomposites (for example, gold colloids with silver shell) could also be considered 
as a novel (and more massive entity-wise) mass enhancement species. 
 
The studies described above should be carried out on a SAM sensor chip given the 
better working range of enhancement that is achievable on this chip compared to the 
CM5 chip. 
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Appendix A 
Table A-1 Gold colloids prepared from various concentrations of KAuBr4, AG, and sodium borohydride 
Sample 
[AuSols] 
%w/v 
[AG] 
%w/v 
Ratio 
[Au]:[AG] 
[NaBH4] 
%wt 
Ratio 
Au : 
NaBH4 
Ratio 
AG : 
NaBH4 
Stability 
(S/U) Initial Colour pH A350 
070606-2 0.08% 0.20% 0.4 0.31 0.2 0.6 S Purple/Brown  3.69 
010606-3 0.10% 0.50% 0.2 0.31 0.3 1.6 S Red/Brown        9.86 4.27 
200406-2 0.10% 0.50% 0.2 0.31 0.3 1.6 S Purple/Red        9.64  
130306-2 0.10% 0.50% 0.2 0.30 0.3 1.7 S Purple/Blue        9.64  
130306-2 0.10% 0.50% 0.2 0.30 0.3 1.7 S Purple      11.25  
190706-4 0.10% 0.20% 0.5 0.20 0.5 1.0 S Purple/Red      10.12 4.50 
190706-5 0.10% 0.50% 0.2 0.20 0.5 2.5 S Purple/Red      10.11 4.57 
190706-2 0.20% 0.50% 0.4 0.31 0.6 1.6 S Purple      10.00 8.39 
300506-1 0.20% 5% 0.0 0.31 0.6 16.1 S Purple/Blue        9.57 7.94 
300506-2 0.20% 0.50% 0.4 0.31 0.6 1.6 S Purple        9.87 8.46 
200406-1 0.20% 0.50% 0.4 0.31 0.6 1.6 S Purple        9.45  
130306-1 0.20% 0.09% 2.2 0.30 0.7 0.3 S Purple      10.97 8.22 
160506-2 0.20% 0.50% 0.4 0.30 0.7 1.7 S Purple/Red        9.57 8.80 
080306-1 0.10% 0.50% 0.2 0.09 1.1 5.6 S Red/Brown        9.17 5.06 
080306-1 0.10% 0.50% 0.2 0.09 1.1 5.6 S Red/Brown        9.82 4.41 
190606-1 0.04% 0.09% 0.4 0.03 1.2 3.1 S Red/Brown        8.80 1.70 
190606-4 0.07% 0.17% 0.4 0.03 2.3 5.6 S Red/Brown        8.55 3.90 
190606-3 0.08% 0.20% 0.4 0.03 2.7 6.7 S Red/Brown        8.19 4.58 
070606-4 0.06% 0.17% 0.4 0.31 0.2 0.5 U Blue/Black  2.21 
070606-3 0.06% 0.17% 0.4 0.31 0.2 0.5 U Blue/Black   
010606-1 0.10% 0.50% 0.2 0.31 0.3 1.6 U Blue/Black   
190706-1 0.10% 0.50% 0.2 0.31 0.3 1.6 U Purple/Blue      10.37 4.32 
140606-3 0.15% 0.36% 0.4 0.31 0.5 1.2 U Blue/Black   
140606-2 0.16% 0.40% 0.4 0.31 0.5 1.3 U Blue/Black   
300506-3 0.20% 0.05% 4.0 0.31 0.6 0.2 U Purple      10.04 6.61 
140606-1 0.20% 0.50% 0.4 0.31 0.6 1.6 U Blue/Black      10.01 8.39 
130306-1 0.20% 0.09% 2.2 0.30 0.7 0.3 U Purple/Blue        9.50 8.05 
190706-3 0.11% 0.29% 0.4 0.03 3.5 9.3 U Red        4.36 5.39 
190606-2 0.11% 0.29% 0.4 0.03 3.9 9.6 U Red/Brown        4.21 2.70 
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Table A-2 Gold colloids prepared from various concentrations of KAuBr4, AG, and hydrazine hydrate 
Sample 
[AuSols] 
%w/v 
[AG] 
%w/v 
Ratio 
[Au]:[AG] 
[HH] 
%w/v 
Ratio 
[AG]:[HH] 
Ratio 
[Au]:[HH] 
Stability 
(S/U) Initial Colour pH A350 
090206-1 - 10 0.05% 0.50% 10.0% 1% 50.0% 5.0% S Dark Purple/Red 11.52-11.78   
170206-1 0.04% 0.05% 80.0% 5% 1.0% 0.8% S Clear Dark Purple/Red 12.81   
170206-2 0.05% 0.50% 10.0% 5% 10.0% 1.0% S Dark Purple/Red 12.85   
210206-5 0.06% 0.03% 200.0% 10% 0.3% 0.6% S Clear Dark Red     
230206-1 0.05% 0.50% 10.0% 5% 10.0% 1.0% S Purple 12.89 2.06 
170206-3 0.04% 0.05% 80.0% 1% 5.0% 4.0% S Brick Red 12.17   
270206-1 0.05% 0.03% 166.7% 5% 0.6% 1.0% U Purple 12.65 2.26 
280206-1 0.10% 0.50% 20.0% 5% 10.0% 2.0% U Dark Purple/Red     
280206-2 0.10% 0.50% 20.0% 10% 5.0% 1.0% U Dark Blue/Black     
220206-1 0.06% 0.50% 12.0% 5% 10.0% 1.2% U Dark Purple/Red     
220206-2 0.06% 0.05% 120.0% 5% 1.0% 1.2% U Dark Purple/Red     
220206-3 0.06% 0.05% 120.0% 10% 0.5% 0.6% U Dark Blue/Black     
030306-1 0.05% 0.25% 20.0% 5% 5.0% 1.0% U Dark Purple/Red 8.85 2.18 
030306-2 0.05% 0.25% 20.0% 5% 5.0% 1.0% U Purple 9.53 2.35 
070306-1 0.10% 5.00% 2.0% 10% 50.0% 1.0% U Dark Blue/Black 13.19 4.03 
200206-1 0.20% 0.03% 666.7% 10% 0.3% 2.0% U Dark Blue/Black 13.36   
200206-2 0.20% 0.25% 80.0% 10% 2.5% 2.0% U Dark Blue/Black 13.30   
200206-3 0.20% 1% 20.0% 10% 10.0% 2.0% U Dark Blue/Black     
210206-1 0.10% 0.03% 333.3% 10% 0.3% 1.0% U Dark Blue/Black     
210206-2 0.04% 0.03% 133.3% 10% 0.3% 0.4% U Purple     
210206-3 0.12% 1% 12.0% 10% 10.0% 1.2% U Dark Blue/Black     
210206-4 0.12% 5% 2.4% 10% 50.0% 1.2% U Purple     
210206-6 0.09% 0.03% 300.0% 10% 0.3% 0.9% U Purple     
 
